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THESIS ABSTRACT
Investigating the Epidemiology of Human African
Trypanosomiasis in Western Tanzania
Human African trypanosomiasis (HAT) or sleeping sickness is a debilitating vector-borne
disease which is fatal if left untreated. In Tanzania 4 million people, living in rural
communities are at risk of HAT; this is a disease of major socio-economical and public
health importance. Human African Trypanosomiasis was first reported in Tanzania in
1922. Since then endemicity has been reported in 10 regions of mainland Tanzania, with
over 91% of the recent cases reported from only three regions of the western part of the
country.
This thesis started by reviewing the existing sleeping sickness historical records in
Tanzania aiming at exploring the evidence of Trypanosoma brucei gambiense existence
in Tanzania.
Historical documentation suggested that probably gambiense sleeping sickness did occur
in Tanzania. However, there is no enough scientific evidence to confirm the existence of
this form of the disease in Tanzania.
This thesis further estimated the under-reporting of Trypanosoma brucei rhodesiense in
the endemic areas of Tanzania using an established model. Using data from the 2000-
2004 outbreak of T.b.rhodesiense in Urambo, the model predicted 45% under-reporting.
All unreported cases were assumed to be unreported deaths as sleeping sickness is
invariable fatal if left untreated. These under-reported findings were then used to
recalibrate the burden of T.b. rhodesiense (using Disability-Adjusted Life Years -
DALYs), as a metric. The burden imposed on rural communities of Tanzania by'
rhodesiense sleeping sickness was found to be high. The costs of hospitalization are also
very high considering the long duration of hospital stay (25 days mean hospital stay) for
sleeping sickness patients in Urambo.
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Finally the thesis investigated spatial and behavioural risk factors for rhodesiense
sleeping sickness in Urambo district Tanzania, using a matched case control study both at
the village and within the village scales.
Statistically significant clustering was observed at the village level (P = 0.001). However
there was no significance association in an individual village's analysis. There was an
increased risk of sleeping sickness in homesteads with a previous history of sleeping





1.1 Neglected Tropical Diseases and Zoonoses
Neglected Tropical Diseases are defined as diseases affecting almost
exclusively poor and powerless people (WHO, 2007a). Those affected normally
reside in rural areas or urban slums of low-income countries. Often the diseases
have been eliminated and forgotten about in wealthier developed countries.
NTDs are a group of 14 chronic disabling infections that sometimes kill and
often disfigure their victims (WHO, 2008). They include Chagas disease,
onchocerciasis, lymphatic filariasis, soil-transmitted helminthiasis, trachoma,
Guinea worm, cysticercosis/zoonotichelminths, Buruli ulcer, human African
trypanosomiasis (HAT), leishmaniansis, leprosy, yaws and dengue/dengue
haemorrhagic fever. Many of these neglected tropical diseases are of parasitic
origin with some having a zoonotic reservoir. The World Health Organization
(WHO) defines zoonoses as a group of diseases or infections that are naturally
transmitted from vertebrate animals to humans (WHO, 1959); meaning that
animals play a very important role in maintaining zoonotic infections in nature.
There are more than 868 diseases which fall in the category of zoonotic
infections; these include those of viral, bacterial, protozoa, helminth and fungal
origin (Taylor et al., 2001).
NTDs and zoonoses are devastating obstacles to human settlement and the
socioeconomic development of already impoverished communities. It has been
documented that approximately 1.2 billion people (-16% of the global
population) suffer from one or more NTDs (Balasegaram, 2008; WHO, 2007b)
while about 2.7 billion people worldwide subsist on less than $2 per day
(WHO, 2007b). NTDs and zoonoses affect the world's poorest people, they are
not subject to compulsory reporting in most of the affected countries, and are
therefore not perceived as major public health burdens when compared to other
infectious diseases such as HIV/AIDS, tuberculosis and malaria.
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Nevertheless NTDs are the most prominent and probably the most devastating
public health constraints obstructing the achievement of the Global Health
Agenda in the developing world, particularly in most of the sub Saharan
African (SSA) countries.
The greatest impact of the neglected diseases is the way they induce poverty,
stigmatize, and disable people as well as inhibiting them from being able to
care for themselves or their families. Most of these diseases do not lead to
epidemiologic emergencies, and consequently attract little attention from the
media and the public sector (Balasegaram, 2008). Furthermore, the private
sector does not necessarily consider this group of diseases as a lucrative target,
a phenomenon which severely hampers spending on research and development
of specific drugs, vaccines and diagnostic tools (Trouiller, 2002). As a result
they continue to maintain a very low profile in the communities and are often
forgotten or left out when most of the public health agendas are formulated
(Banerji, 2003; Trouiller, 2002).
There is a grave risk posed by this group of diseases to the world's poorest
communities, and the impact these diseases have on those countries in
achieving the millennium development goals (MDGs). The MDGs are set of
eight goals set by the Millennium Declaration, and adopted by 189 world
leaders and signed by 147 heads of state and governments at the United Nations
Millennium summit in September 2000; the target of these goals is to eliminate
extreme poverty, hunger, and disease by 2015. In realising this global challenge
the WHO has grouped NTDs and zoonoses in a category which follows the
priorities detailed below in order to enable proper planning of strategies to
enhance control and eventually eliminate some of these diseases (WHO,
2007a). Success in developing strategies which would enable the control of
these groups of diseases will have a direct impact in achieving several
Millennium Development Goals. These were further sub divided into "tool-
ready" and "tool-deficiency" categories.
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The tool ready category includes those diseases for which powerful and
inexpensive control tools are currently available. The second category is the
diseases which rely on costly and difficult-to-manage tools. A good example of
tool deficiency diseases is HAT.
1.2 Global Burden of Neglected Tropical Diseases
Reliable epidemiological data are lacking in most of developing world,
particularly SSA. In realization of this short-fall the World Bank and World
development report on investing in health recommended the use of cost
effective intervention packages for countries under different levels of
development (World Bank, 1993). The Global Burden of Disease (GBD) study
was therefore developed with the help of Harvard University under the
sponsorship of WHO in collaboration with a global network of over 100
scientists (Murray and Lopez, 1996a; World Bank, 1993). The principal aim
was an attempt to assess in an objective manner using a global scale, the
importance of different conditions that result in adverse health outcomes, with
the aim of prioritizing interventions. The study used a standard unit of health
metric measure, disability adjusted life years (DALYs). The results which can
easily be incorporated in comparing cost and effects of different interventions
aimed at reducing the burden of disease. DALYs is the sum of years of life lost
due to premature mortality (YLL) and years of life lived with disability (YLD)
(Lopez et al., 2006). The public health burden imposed by HAT was estimated
to be 1.5 million DALYs in 2002 (WHO, 2004); the disease is ranked second
and fourth amongst the most important vector-borne diseases in Africa in terms
ofmortality and DALYs respectively (Lash and Aschengrau, 1999). The global
figure for the burden for sleeping sickness, calculated using a conservative
estimate of 50,000 cases per year, is 1.78 million DALYs per year (Murray,
1994)
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1.3 Trypanosomiasis; The Disease and Aetiology
HAT which is also known as sleeping sickness, is a severe debilitating disease
which is always fatal if left untreated. The disease in humans is caused by
Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense.
It is the most complex of the endemic tropical diseases, it flourishes in
impoverished rural parts of Africa, where it is estimated to affect some 70,000
people in SSA (Garcia et al., 2006). The disease is spread through the bite of
infected tsetse flies Glossina spp.). HAT is the third most important vector
borne disease behind leishmania (Molyneux et al., 1996). Around 300,000 -
500.000 people are thought to be infected with HAT, with the mortality rate
estimated to be approximately 50,000 annually (WHO, 2004). A few days
following a bite of an infected tsetse a painless nodular skin lesion or chancre
develops, lasting for about fourteen days. During this initial stage (early stage),
there is marked generalized body malaise, fever and sometimes a satellite
lymphadenopathy. Later as the trypanosomes invade tissue fluids, lymph, blood
and bone marrow one may experience a transient local oedema, sensational
hyperaesthesia (Kerandels sign), intermittent fever sometimes accompanied by
headache, pains in the joints, splenomegaly and lympadenopathy (Apted, 1970).
As the disease progresses further to the meningo-encephalitic stage (late stage),
the parasites invade the cerebrospinal fluid (CSF) and brain tissues. The disease
progressively leads to a variety of clinical manifestations, including headache,
irritability, tremors, ataxia, convulsions, change in personality, somnolence
particularly during the day time, pronounced wasting and finally may end up in
coma followed by death in the absence of treatment (Dumas, 1988).
1.3.1 Trypanosomes; The Causative Organism
Trypanosomes are group of kinetoplastid protozoan parasites, belonging to the
subphylum mastigophora.
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The trypanosomes of medical importance are Trypanosoma cruzi, which causes
Chagas disease in South America, and Trypanosoma brucei s.l., which causes
trypanosomiasis in SSA.
1.3.2 Classification
Trypanosomes are classified under the sub-kingdom protozoa, phylum
Sarcomastigophora, order Kinetoplastida, family Trypanosomatidae and genus
Trypanosoma. This genus has two groups, Salivaria and Stercoraria.
Transmission is either by inoculation of metacyclics with the saliva (Salivaria)
or by contamination of mucosa or broken skin with trypanosomes in the
vector's faecal material (Stercoraria). Within the Salivaria the main subgenera
are: Duttonella (species: Trypanosoma vivax, and Trypanosoma uniforme);
Nannomnas (species: Trypanosoma congolense and Trypanosoma simiae); and
Trypanozoon (species: T. brucei, T. evansi and T. equiperdum) (Hoare, 1970).
T. vivax and T. congolense are the main causes of disease in domestic cattle in
SSA.
Mechanical transmission may occur in situations where a biting insect passes
the infection from an infected to an uninfected animal in the course of
interrupted feeding. This model of transmission has proved to be sufficiently
effective in maintaining T. vivax and T. evansi in South and Central America,
and the latter species in North America and Asia (Sumba et al., 1998).
However, the time elapsed between feeds plays a crucial role for effective
transmission, because trypanosomes die as soon as blood dries. Also large
biting insects such as tabanids and even tsetse flies are more likely to act as
mechanical vectors as they carry relatively large volumes of blood. Mechanical
transmission may also occur when dogs, cats and wild carnivores feed on fresh
carcases infected with trypanosomes (Laveran, 1906; Moloo et al., 1973).
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The salivarian group are the only pathogenic trypanosomes that cause sleeping
sickness in man and nagana in domestic animals in endemic countries of SSA.
In man the disease is caused by T.b. rhodesiense and T. b. gambiense. The
remaining species cause disease in animals, but are not infective to humans due
to their sensitivity to human serum that hinders their survival in man.
However, the disease is possible for individuals lacking lytic factor, this has
been reported recently in India (Joshi, 2005)
1.3.3 The Life Cycle of Trypanosome
Tsetse flies are the only known vector for Trypanosoma brucei. There are
about 31 species and subspecies of tsetse flies present in Africa, but only some
of them are capable of transmitting trypanosomes. Their life span varies from
an average of one to six months. They prefer mostly warm, humid and shady
areas. Parasites are ingested from an infected mammalian host by the tsetse
flywhich if susceptible remains infective for life. However, only a small
number of infected tsetse flies can maintain high levels of relative transmission
cycles. Tsetse flies take up trypanosomes from the host during feeding. The
trypanosomes pass through the midgut then penetrate the gut wall and migrate
to the ectoperitrophic space.
Once in the ectoperitrophic space between midgut epithelium and the
peritrophic membrane, the stumpy form trypomastigotes transform to
procyclics. Only small proportions of tsetse flies which have taken up
trypanosomes develop a mature infection and it takes about 3-4 weeks.
Available documentation shows that only teneral flies are capable of
developing a mature infection. Although there is no clear explanation for this,
currently available research findings suggest that, low levels of gut lectin
present in newly ecloded flies, and also poorly developed peritrophic membrane
play role in making the teneral flies more susceptible to trypanosome infection
(Lehane and Msangi, 1991).
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In an established infection procyclics move to the proventriculus after rapid
proliferation which takes about 10-12 days, and subsequently migrate as
epimastigotes via the hypopharynx to the salivary glands. Development is
complete once the trypanosomes develop through the epimastigote stage
becoming mammalian-infective metacyclic trypanosomes which can take up to
28 days. Figure 1.1 shows various T. brucei morphological stages.
Transmission occurs when mammalian host is bitten by infected tsetse during
feeding. During tsetse feeding metacyclic trypanosomes are injected into the
dermal tissue of the mammalian host. The metacyclics rapidly transform into
long slender bloodstream forms (BSF), which then multiply by binary fission
and subsequently invade the lymphatic, blood system and later the central
nervous system. Beside the long slender forms, morphologically different, non-
proliferating stumpy forms are observed at peak and declining parasitaemia in
the blood of the host. It is these stumpy forms are able to continue the life-cycle
in the insect vector.
Figure 1.1 The diagram showing human infective trypanosome developmental












(in tsetse midgut) (IN MAMMAL )
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A number of hosts have been identified to be harbouring trypanosomes varying
from domestic and wild vertebrates.
Among the vertebrate hosts are mammals both domestic such as cattle
((Maudlin et al., 1990; Onyango et al., 1966; Stephen, 1970a) and wild
mammals such as bushback (Heisch, 1958), amphibians and fish (Connor
1989), reptiles such as Monitor lizards (Njagu et al., 1999) and avians
(Apanius, 1991).
1.3.3.1 Wild Hosts
It is known that wild hosts play an important role in maintaining
trypanosomiasis (Heisch, 1958; Kinghorn, 1925). The fact that a large number
of wild animal hosts are known to harbour infection, but do not develop the
symptoms of disease suggests they may play a role as reservoir hosts. The most
important host among the wild reservoirs are animals such as bushback
(Heisch, 1958), bovids and suids (Geigy, 1971), hartebeest (Geigy, 1971),
hyena (Awan, 1971, 1979; Geigy, 1971), warthogs (Awan, 1971, 1979), zebra
(Mulla, 1988), waterbuck (Awan, 1971, 1979; Geigy, 1971) and lions (Geigy,
1971). Historically, bushback is among the most remembered in the
epidemiology of trypanosomiasis among the wild animal host due to the fact
that the first human infective trypanosome was isolated from this species
(Heisch, 1958).
1.3.3.2 Domestic Hosts
Bruce (1910) showed by injection of an infected blood sample from a domestic
cow into a monkey that cows could act as reservoirs of infection Since then a
number of domestic hosts such as cattle (Gibson, 1983; Onyango et al., 1966;
Robson, 1973; Stephen, 1970b; Welburn et al., 2001b), goats (Stephen, 1970b),
sheep (Fairbairn, 1948; Stephen, 1970b), dogs (Gibson, 1983) and pigs (Okuna
et al., 1986; Stephen, 1970b) have been identified as important hosts for
trypanosomes.
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It is worth pointing out that despite the fact that domestic animals have been
identified as important hosts for trypanosomes; they respond differently to
infection depending on a number of factors such as breed of animal; in West
Africa for example the Zebu cattle are more susceptible than the dwarf breeds
such as the N'dama and Muturu, in East Africa on the other hand, pure-breed
and grade animals are more susceptible to trypanosomiasis than the indigenous
cattle (Stephen, 1970b).
Several other factors are believed to play part in influencing the clinical
manifestation of trypanosomiasis these include; nutritional condition of the
animal, concomitant viral, parasitic or bacterial infection, stressful condition
resulting from vaccination, trekking, thirst and finally climatic condition such
as unstable temperature (Stephen, 1970b).
In Tanzania, there have been a number of studies conducted to show the
association between domestic animal reservoirs and sleeping sickness. During
the Tinde experiments a number of T. b .rhodesiense strains were continuously
passaged through domestic animals, and even after several years still
maintained their infectivity to humans. (Ashcroft, 1959; Corson, 1936;
Fairbairn, 1948)
1.4 Epidemiology of African Trypanosomiases
HAT has probably existed in East Africa for many centuries but the disease
itself was not described until the late 19th early 20th century by European
colonialists (Hide, 1999). Among the two protozoan subspecies, T. b.
gambiense and T. b. rhodesiense, the latter is the least investigated of sub
species and is the main focus for this thesis; this parasite is found in eastern and
southern Africa causing acute illness lasting for several weeks.
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The epidemiology is complex and transmission cycles are subject to interaction
between humans, tsetse flies and the animal reservoirs both domestic and
wildlife.
In Eastern Africa, T. b. rhodesiense is the species responsible for human
disease, and the main reservoirs are both domestic and wild animals (Fevre et
al., 2001; Onyango et al., 1966). Since animal reservoirs play an important role
in transmission, understanding the epidemiology of T. b. rhodesiense in humans
as well as in its animal reservoir is essential for the accurate prediction of
effective control options for HAT (Coleman and Welburn, 2004).
The fact that trypanosomiasis affects both humans and animals, trypanosome
parasites are a dual constraint to human and animal health, and as such, have
serious impact on rural livelihood. Studies conducted in both East and West
Africa have shown that there is a substantial percentage of domestic animals
which are reservoirs of human infective trypanosomes (Mehlitz et al., 1982;
Robson, 1973). Further studies confirmed that domestic cattle and their
demographic characteristics are major risk factors for the spread of human
infective parasites. In this context targeting treatment of domestic cattle is seen
as an important method for controlling human disease (Fevre et al., 2001).
Such treatments also have significant impact on the cattle trypanosomes,
resulting in improvements in animal health. Hence effective control measures
for HAT can only be achieved through controlling the causative vectors (see
later) as well as providing necessary treatment to all affected humans as well as
identifying and providing treatment to all potential reservoir hosts in the
respective area.
In T. b .gambiense disease, the classical human-fly-human transmission cycle
occurs in both endemic and epidemic situations (Commitee., 1998; WHO,
1998).
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Difficulties in differentiation of T. b. brucei and T. b. rhodesiense have led to
controversies over the importance of reservoir of the infection of human disease
in both domestic livestock and wild animals. The development of blood
incubation infectivity test (BIIT) by Rickman and Robson (1970), which test
the parasites ability to survive challenge with human serum in mice models,
plays a very big role in distinguishing the two sub-species. The test was
developed based on the theory that T. b. brucei can not survive after five hours
incubation in human serum at 37°C (Rickmann, 1970). This test was later
modified further by Awan and Dillmann (1973).
The potential human infective trypanosomes have been successful isolated
using BIIT technique in studies conducted in Uganda (Enyaru, 1992; Kakaire et
al., 1993; Okuna etal., 1986).
In more recent studies using BIIT, Waiswa et al (2003) demonstrated that a
wide range of domestic livestock (including pigs), harbour human infective
trypanosomes (Waiswa et al., 2003).
1.4.1 Distribution of Trypanosomes in Sub Saharan Africa
The distribution of trypanosome-infected and potentially infected livestock in
SSA is closely related to that of the tsetse species of the genus Glossina.
The distribution is also limited by ecological conditions varying from 14° North
from Senegal (West Africa) to 10° North in Somalia (Eastern part of Africa)
and Latitude 20° S, to the northern fingers of Kalahari and Namibia deserts.
This covers about 11 million km2, over 37 countries, including half of the
available arid land. Meaning that climatic conditions, temperature and
ecological vegetation are very important parameters in determining the
distribution of the tsetse (Molyneux et al., 1996). Figure 1.2 shows disease
distribution ofHAT across Africa.
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Figure 1.2 Map showing the distribution of human African trypanosomiasis
B Countries reporting no cases
■ Countries reporting under 100 cases
B Countries reporting between 100& 1000 cases
B Countries reporting more than 1000 cases
Savannah species (those of the Morsitans group) are good vectors of pathogenic
trypanosomes of livestock. Population of savannah species feed mainly on
mammalian hosts, particularly bovids such as the buffalo's as well as antelope,
cattle, sheep, goats and suids such as bush pigs and warthogs. In contrast the
riverine tsetse (those of the Palpalis group) prefers a wide range of hosts
including reptiles and humans. The major difference between suids and bovids
is that the former infect flies particularly with T. simiae and T. godfreyi, while
bovids are mainly source of T .vivax and T. congolense. The epidemiology of
non tsetse-transmitted trypanosomiasis such as T. evansi is influenced by
several factors such as seasonal outbreaks, whereby biting flies in this case
(Tabanids, Stomoxys and others) are influenced by important seasonal climatic
differences. The epidemiology is also influenced by host preferences and
diurnal behaviour patterns of the various local species of tabanids and other
biting flies.
The distribution of two forms of the diseases (Gambian and Rhodesian) can
also be easily separated by their geographical location.
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The Great African Rift Valley forms a rough boundary between the eastern
distribution of the T. b. gambiense and the western distribution of the T. b.
rhodesiense (Welburn et al., 2001a/ More techniques have been developed to
discriminate the strains of trypanosomes using isoenzyme characterization
(Gibson, 1983), and polymerase chain reaction (PCR) the move which made it
possible to study the origin of the disease, the epidemic development and
maintenance (Fevre, 2001; Fevre et al., 2001; Picozzi et al., 2002).
1.5 Diagnosis of Human African Trypanosomiasis
Although there are some differences in the techniques that are used to diagnose
HAT most of the presenting symptoms are very similar. However, it is very
important to be able to tell the two infections apart, as the clinical course of
Rhodesian sleeping sickness is much faster than in Gambian sleeping sickness.
In Rhodesian sleeping sickness death can occur within four to six months of
infection whereas it can take years for this to happen with the Gambian form.
Presently the most commonly used tests in the field are microscopy using thin
or thick blood films, micro haematocrit centrifugation techniques (HCT) or
Woo test (Woo, 1970), Mini Column or Quantitative Buffy Coat (Murray et al.,
1977) and CATT test, which are believed to increase the sensitivity of
trypanosome detection by several orders ofmagnitude (WHO, 1986).
1.5.1 Clinical Diagnosis
Generally, the clinical diagnosis of sleeping sickness is very difficult due to the
fact that there is no single feature which can be regarded as pathognomonic for
the disease; moreover HAT presents in a similar way clinically to a number of
other infectious diseases. This situation makes it difficult for clinicians to make
immediate diagnosis based on signs and symptoms presented by the patient.
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Therefore proper diagnosis relies on a number of tests including parasitological
and serological. In the case of positive serology results, parasitological
confirmation is also required.
1.5.2 Parasitological Diagnosis
Parasitological diagnosis relies upon demonstration of parasites in the blood,
lymph and glandular aspirates or cerebral spinal fluid (CSF). Sometimes, due to
periodicity of parasitaemia, the number of parasites may sometimes be very
low, in these cases multiple sampling and concentration techniques are often
necessary in order to detect the parasites. This is particularly common with T. b.
gambiense due to scarcity and infrequent appearance of the parasites in the
blood.
In line with all above listed diagnostic methods, stage determination is one of
the most important aspects in the diagnosis of HAT as it determines the line of
treatment. This is determined using WHO criteria, where lumber puncture is
performed and cerebral spinal fluid (CSF) obtained and is mainly based on the
white cell count (WCC) or protein content. Consequently the diagnosis of late
stage trypanosomiasis is reached upon one of the following criteria (WHO,
1998): CSF WCC > 5 cells/pl or the total CSF protein > 37 mg (lOOmL)"1 (as
measured by dye-binding protein assay) or both criteria with or without the
presence of trypanosomes in the CSF. It has been, however, been documented
that the presence of white blood cells in the CSF is by itself sensitive enough
for the diagnosis of central nervous involvement as the combination of above
criteria Miezan et al. (1998). In first stage HAT, all the CSF parameters are
absolutely normal. That means CSF WCC absent or less than 5 cells/pl, and the
absence of proteins in the CSF (WHO, 1998). In rural areas where most of the
cases occurs, under field conditions and in less specialized laboratories and in
most of the rural areas, stage determination is usually conducted using direct
examination ofCSF for the presence of trypanosomes.
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Also in order to increase the sensitivity, the CSF sample can be centrifuged
(Cattand and de Raadt, 1991; Woo, 1970). CSF protein can be quantified using
either precipitation or the calorimeter method.
1.5.3 Serological Diagnosis
A number of serological tests have been developed for the diagnosis of HAT,
including: latex agglutination test (Buscher et al., 1999), enzyme-linked
immunosorbent assay (ELISA) test (Buscher et al., 1999; Luckins, 1977;
Nantulya, 1988; Nantulya et al., 1992) and card agglutination test for
trypanosomiasis (CATT) (Magnus et al., 1978).
CATT which is the most commonly used today is a rapid, simple agglutination
assay for T. b. gambiense specific antibody, which uses antigenic reagent based
on T. b. gambiense variable antigen type LiTat 1.3.
A field CATT kit is available and the test is rapid and easy to perform, allowing
several hundred people to be screened in a day, the test is highly sensitive
(Moore and Richer, 2001), however, a number of false positives have been
reported in Uganda and southern Sudan ((Moore and Richer, 2001; MSF-DND,
2001). CATT is most commonly used as a primary diagnostic test for Gambian
sleeping sickness. However, a confirmatory test using parasitological means is
always necessary. Nevertheless CATT still reduces the workload of conducting
parasitological tests in all individuals under survey limiting conditions. In that,
only CATT positive individuals need to be tested by microscopy. However, in
areas afflicted with T. b. rhodesiense, no serological tests are currently
available, All these serological methods have been found to be more sensitive
than most of the parasitological diagnostic techniques used today, nevertheless
most of the serological tests are not able to distinguish between active infection
and a past treated infection (Van Meirvenne et al., 1995). However, the positive
thing about these tests is that they can be used to detect relapse infections in
trypanocidal drug therapeutic studies for the periods when it is not possible to
isolate parasites from peripheral blood (Rae, 1989). Other serological
Chapter 1 16
diagnostic techniques are the immune trypanolysis test (Van Meirvenne et ah,
1995). Both ELISA and immune trypanolysis methods are important and are
very useful in situations where good laboratory facilities exists particularly in
large epidemiological surveys but are not practical for field application
(Buscher and Lejon, 2004).
1.5.3 Molecular Diagnosis
Molecular techniques which includes PCR (Kanmogne et al., 1996;
Kyambadde et al., 2000; Penchenier, 2000), and the newly developed loop
mediated isothermal amplification (Buscher and Lejon, 2004; Notomi et al.,
2000) are advanced technologies which are based on studying the DNA signals
in a sample.
However, due to the costs and specialized equipment required for PCR, and
LAMP still being under evaluation they are not presently available in most of
the laboratories in disease endemic countries.
A number of advanced molecular based techniques have been developed which
detect unique trypanosome species and strains. Techniques such as isoenzyme
characterization (Gibson, 1983; Tait, 1980), restricted fragment length
polymorphism (RFLP) (Hide, 1991, 1994), the PCR amplification technique
using minisatellite markers analysis (MacLeod et al., 2000) and the analysis of
variability in mobile genetic elements PCR (MGE-PCR) (Tilley, 2003). While a
PCR reaction specific to the gene that results in human serum resistance in T. b.
rhodesiense allows identification of this parasite from samples of both T. b.
brucei and T. b. gambiense (Welburn et ah, 2001b). This amplification has
recently been improved on by Picozzi et al. (2008) who designed a multiplex
incorporating a single copy gene present in T. brucei s.l. The inclusion of GPI-
PLC as an internal control indicates whether sufficient genomic material is
present in the PCR reaction for the detection of a single copy gene. Recently
primers have been designed to the internal transcribed spacer gene and the use
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of a nested PCR (Cox et al., 2005) allows the identification of all clinically
important trypanosomes in single PCR.
1.5.4 Loop-Mediated Isothermal Amplification (LAMP)
Loop-mediated isothermal amplification or LAMP is a novel DNA
amplification technique, developed recently in by a Japanese company called
Eiken Chemicals (Notomi et al., 2000). LAMP promises hope for the solution
of the difficulties encountered for the sensitive diagnostic tool for HAT in rural
areas; it does not require high precision thermal cycler equipment, gel
electrophoresis or a UV illuminator.
Meaning that, neither amplification nor detection requires expensive or
sophisticated equipment that would restrict it utilization to modern and well
equipped laboratories.
Most importantly, the technique is highly specific, rapid and efficient and has
several advantages as compared to traditional molecular tools. It is documented
that amplification occurs in less than one hour and may even take less than 30
minutes (Nagamine 2002). The LAMP reaction proceeds under isothermal
conditions, (between 60 to 65°C), which can simply be maintained using water
bath, and it does not require purified DNA for efficient DNA amplification.
DNA can be amplified directly from heat treated blood samples as well as CSF
and normal serum (Poon et al, 2005; Njiru et al, 2007). This makes the
technique one of the most cost effective molecular tools as it removes the need
for DNA extraction step, which is time consuming and also very costly.
1.6 Control of Human African Trypanosomiasis
Despite significance advances in technology, the control of HAT which used to
be a top priority during colonial era remains a nightmare. This is probably due
to a number of factors with the major one being political instability in most of
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the affected countries which followed after independence gained in early 1960s
(Pepin and Meda, 2001). It is clear that T. b. gambiense and T. b. rhodesiense
are harboured within different mammalian reservoir hosts, and as the clinical
progression of the two parasites also presents differently, it is obvious that even
the control strategies will be different. The control of gambiense HAT which is
probably less complicated relies entirely on case detection and treatment
provision mainly using active case finding. On the other hand the active case
finding in the control of rhodesiense HAT is less important due to
unavailability of sensitive diagnostic facilities, moreover an additional effort is
necessary to control the infecting parasites in the animal reservoirs. However,
principally most of the control strategies are more or less the same for both
parasites and are detailed below.
1.7 Treatment of Human African Trypanosomiasis
The control ofHAT depends mainly on chemotherapy, with effective treatment
entirely determined by proper stage determination of the disease.
The currently available treatments for HAT, particularly the Rhodesian form
depends entirely on a narrow choice of drugs that came on the market over 50
years ago. The situation is not much better in the treatment of the Gambian
form; however, a new drug has come on the market in the last 20 years. The
dugs tend to be scarce, in some cases highly toxic, difficult to use and patients
require hospitalization. Moreover there are increasing reports of resistance
(Croft, 1999; Matovu et al., 2001) to all dugs used to treat HAT, The treatment
for early stage infections of the disease entirely relies only on two drugs,
pentamidine and suramin for gambiense and rhodesiense respectively, although
suramin can be used for the treatment of early stage gambiense, pentamidine is
preferred for the treatment of T. b. gambiense today. Melarsoprol remains the
drug of choice for the treatment of late stage of both forms of sleeping sickness.
Melarsoprol developed in 1949 is a fast acting drug, capable of eliminating the
parasites from the blood and lymph within 24 hours of treatment in most cases,
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however, this drug is highly toxic most commonly recoded side effect been
encephalopathic syndrome which occurs in 5-7% of all treated cases with
fatality of 10-70% of those patients (Commitee., 1998; Pepin and Milord, 1994;
WHO, 1998). For those with the Gambian form of the disease where melarsprol
treatment has failed, eflornithine can be used. However, eflornithine has many
drawbacks which limit its use on a large scale (Kuzoe, 1993). Its mode of
administration is complicated requiring a large dose of 400 mg/kg/day
administered intravenously in four equal doses which are administered every 6
h for 14 days in a hospital. The cost of treatment per patient has been estimated
at US$500 (US$210 for drugs, US$200 intravenous fluid, perfusion kit, and
US$70 costs of hospitalization).
However, despite the eflornithine providing the best alternative therapy to
melarsoprol for gambiense sleeping sickness, it is ineffective alone against T. b.
rhodesiense infection (Kuzoe, 1993).
Treatment failure due to sleeping sickness has been reported in several
countries, most of them being gambiense endemic countries including Uganda
(Hutin et al., 2004) and southern Sudan (Hutin et al., 2004; Moore and Richer,
2001). However, treatment failure may be a result of several factors, the most
important ones been patient's immune system, parasitic drug resistance and
individual variation to infection. It is worth mentioning that patient immune
system is a very important factor the treatment of HAT in most of the disease
endemic countries, it is known that, proper functioning immune system is
important for fast healing from any disease condition. Most of the HAT
endemic countries face a major infectious disease challenge such as human
immunodeficiency virus (HIV), which suppresses body immunity, and
therefore contributes to treatment failures. There are very limited studies to
show relationship between HAT treatment and HIV particularly rhodesiense
HAT, but available studies show that HAT patients co-infected with HIV
respond very poorly to eflornithine treatment (Pepin et al., 1992).
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In animal African trypanosomiasis, the use of drugs for the prevention and
treatment of the disease has been important for decades (Leach and Roberts).
The only concern is the development of resistance to these commonly used
drugs by the parasite. The most widely used chemoprophylactic drug and also
the least expensive is isometamidium chloride,(Eisler et al., 2003). This drug
has been in use for over 20 years and it gives a protection of 3-6 months against
all the three animal African trypanosome species. Other drugs which have
proven to be effective for the control are Ethidium, Presidiums, Homithidium
bromide and Diminazene aceturate (Berenil®, Hoechst Germany). Diminazene
aceturate is also effective against all the three forms of animal African
trypanosomes.
However, the development of resistance to these drugs has been widely
reported in East Africa (Eisler et al., 2003; Kibona et al., 2006; Mulageta et al.,
1997; Shinyangwe et al., 2004). Nevertheless, apart from the widespread
resistance observed to these drugs, and also despite their extensive use in
disease control, the drugs are expensive and time consuming to administer,
hence they are not seen as suitable options for long-term use in solving the
problem of animal African trypanosomiasis.
1.7.1 Immunological Control
Attempts to develop a reliable vaccine against African trypanosomiasis have
been an unachievable dream as parasites ability to change the composition of its
exposed surface antigen. Since the conventional approaches to the control of the
disease have largely met with failure, there has been renewed interest in
identifying novel aspects of the biology, chemistry and molecular biology of
trypanosomes that might be exploited to develop new targets for the vaccine. If
developed, then vaccination could form the best option for this disease (Hadjuk
et al., 1992).
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1.7.2 The Trypanosome Variable Surface Glycoprotein (Vsg)
4
The surface of both the metacyclic trypanosomes that enter the mammal during
tsetse fly meal and the subsequent proliferating bloodstream forms are covered
with a mono-layer of a variable surface glycoprotein (VSG). The VSG forms a
barrier between conserved protein in the cell membrane and the effectors
molecules of the host immune system (Sayed 2000).
Once host antibodies that recognize any one VSG reach a high enough titre the
trypanosomes expressing that particular VSG are killed.
The persistence of an infection, despite the host mounting an immune response,
is dependent on antigenic variation of the VSG (Cross, 1978). This occurs
through stochastic chances in which a single VSG gene is expressed from
repertoire of possibly a thousand. The long term persistence of T. brucei
infection, for example, is dependant on evasion of the host immune response
through a complex system of antigenic variation based on the VSG which
forms a protective mono-layer over the cell surface. The switch in VSG
expression occurs either through gene conversion of the active VSG expression
site or through inactivation of one VSG expression site and activation of one of
the ~20 other VSG expression sites.
1.7.3 The Use of Trypanotolerant Animals
Some breeds of indigenous domestic animals, especially cattle have significant
degree of trypanotolerance and are capable of thriving in tsetse infested areas,
where susceptible breeds cannot survive (Shaw and Hoste, 1987). Increasing
the number of such trypanotolerant animals may result in a significant reduction
in the number of new infections and hence resulting in control of
trypanosomiasis in livestock. Such cattle have been imported into countries
such as Gabon and Democratic Republic of Congo (DRC), where they are
successfully being raised on several large ranches (Shaw and Hoste, 1987).
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However, despite trypanotolerant animals offering a considerable potential as
an alternative means of raising cattle in tsetse infested areas, they currently
represent only 5% of the cattle population in SSA. Therefore their limited
availability and because of their small size, they are not preferred by farmers
who always aspire for better products. This is probably why wide scale
programmes have been limited.
1.7.4 Vector Control
To date, a variety of methods have been used in an attempt to reduce the tsetse
fly populations. These include the use of insecticides applied on odour-baited
traps or applied as aerosols by aerial or ground spraying (MacLennan, 1980).
Cattle dipping or pour on is another method used to kill tsetse. In this method
insecticides such as deltamethrin which is capable of killing up to 100% of
alighting flies within two weeks are used. However, in order to achieve
sufficient outcome with this technique, domestic livestock must be present in
the area in sufficient numbers, with cattle representing a highest proportion of
the host complex and most of the cattle have to be presented for treatment on
regular basis. Unfortunately, the cost of insecticides is a serious constraint for
the sustainability of this method (Eisler et al., 2003). In recent years the use of
insecticides such as DDT and dieldrin has lost favour among tsetse control
institutions due to environmental concern.
Also treated areas are easily re-invaded necessitating costly re-treatment
programmes. Furthermore, all these methods do not provide immediate cattle
protection from being infected by trypanosomes.
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1.7.5 Sterile Insect Technique
Theoretically, the low reproductive capacity and infrequent mating of the
female tsetse flies makes them ideal candidates for control by genetic
techniques. The sterile insect technique (Shaw and Hoste, 1987; Shaw) involves
the release of male flies that have been sterilized by gamma irradiation into the
environment to compete with the wild males in mating (Cossman et al., 2003).
This method has proved successful in Zanzibar where Glossina austeni males
sterilized by gamma irradiation were dispersed by air over the whole island in
1994. No wild tsetse has been caught since September 1996. Eradication of G.
austeni from Zanzibar was declared at the end of September 1997 (Saleh et al.,
1998).
However, this method has many pitfalls, including the enormous costs of
implementation, low density of target population required for the SIT to be
effective (Politzar and Cuisane, 1998) and also the method works best in
isolated areas in order to avoid re-invasion by new migrant flies.
1.7.6 Environmental Control
Environmental control can also be used to reduce tsetse populations. These
were popular in the early stages of the 20th century and include Bush clearing
and elimination of wild animals which may act as reservoirs of disease.
However, these measures have been declared environmentally unsound as
although bush clearing makes the habitat unsuitable for tsetse habitation; this
method has disadvantages, including decrease in soil fertility, soil erosion and
adverse effects on water supplies. Whereas elimination of wild animal hosts is
not popular method as African economies rely on tourism industry as a source
of foreign income and wild animals are among the major attractions for tourists.
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1.7.7 Biological Control
Biological control involves the use of natural enemies of the tsetse vector such
as parasites and predators like fungi, bacteria and parasitic mites. In order to be
successful, biological control organisms generally have to originate from a
different geographical or ecological area from the potential pest to be
controlled. Otherwise it would be expected that the control and target
organisms would be sufficiently adapted to one another that no significant
degree of control would be easily maintained over a long period of time. Most
trials of parasites on tsetse flies have used insects that occur naturally in tsetse
habitats, which may partly explain the lack of success.
Bacteria and fungi have been used in experimental studies to show that they
could be potential candidates for the control of trypanosomiasis. These include
Pseudomonas aeruginosa, Serratia marcescens and Bacillus sphaericus,
(Kaaya and Darji, 1989). The advantage of using biological control methods
includes the fact that they do not affect the environment negatively and it is a
self-sustaining method. Once the entomopathogens are introduced in the
environment, they will multiply and attack their intended targets naturally.
There are, however, a few shortfalls such as the difficulty in choosing a suitable
method of formulating and dispersal of the pathogens and the chances of
adaptation of the insect target to the pathogen-host relationship, (Kaaya and
Darji, 1989).
1.8 Sleeping Sickness in Tanzania
In Tanzania, HAT remains a major socio-economic and serious public health
problem in rural communities. Four million people are at risk which can cause a
big development crisis that affects many sectors. It has drastically affected
human and animal health, economic and social progress reducing life
expectancy of rural communities and deepening poverty.
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Available documentation shows that, the first case of HAT in the country was
reported in Maswa district (Mara region) in 1922. Since then endemicity has
been reported in nine regions of mainland Tanzania. Like in many other
countries of sub-Saharan Africa, the disease was successfully controlled in the
1960s, but made a dramatic re-emergence in the late 1980s. Little has been
done in terms ofmanagement of the disease over the past decade. This is due to
limited resources available for the control of HAT. Effective control options for
HAT are mainly based on medical surveillance, consisting of early case
detection and treatment, vector control as well as treatment of reservoir hosts.
Tanzania is currently affected only by T. b. rhodesiense, 4-5 million people are
at risk of infection and only 1% of the population is under any regular
surveillance (Komba et al., 1997). The disease occurs in nine endemic regions
of mainland Tanzania, namely Kigoma, Tabora, Rukwa, Mbeya, Arusha,
Manyara, Lindi, Ruvuma, and Kagera (NIMR 2002). The estimated annual
average is 264 cases, although this figure may not represent the true magnitude
of the disease burden in the country due to poor diagnostic capacity and also
disease under-reporting (Kibona et al., 2002). Over the past 40 years, the
number of new cases reported annually has rarely risen above 500. However,
despite the endemic nature of the disease, occasional upsurges into epidemics
proportional to socio-ecological changes in the infested areas have also been
reported (Kibona 2001). Figure 1.3 shows the disease distribution across
Tanzania.
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In Tanzania, however, control of human African trypanosomiasis has been
complicated by a number of factors, including inadequate surveillance and
other control activities. There are only few health facilities with the capacity to
diagnose and treat the disease in most of the disease endemic villages.
Moreover, poor infrastructure leads to poor accessibility to centres with the
capacity to diagnose and treat the disease. Another important factor is the
migration of people from disease endemic areas to non endemic areas; the aim
of their migration being to explore good pasture for farming and their herds.
There is also an increase in human activities and settlement in reserve areas
looking for the fertile land.
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Surveillance and control activities have been concentrated to the western parts
of the country mainly in Kigoma and Tabora and Rukwa region, which are
considered to be high transmission foci (Kibona et al., 2002).
Some of the control measures have been noted in the northern areas of the
country, particularly in the main transport routes of Serengeti National Park
(SENAPA), which since colonial times have been known to be low endemic
foci for the disease. The park authorities have discouraged any kind of tsetse
control activities inside SENAPA. Despite having severe tsetse infestation in
most parts of the park, park authorities prevent any activity which involve
killing of tsetse as they consider tsetse to be an important part of ecosystem
(Mlengeya, 2001).
Recent records shows that cases of HAT still exist in some of the old foci of
Tanzania, and also some silent foci are reporting re-emergence, moreover there
have been reports of several cases of HAT amongst tourists returning home
from tour trips in Serengeti National Park in 2000/2001 (Kibona 2001;
Mlengeya, 2001). This has increased concern at both National and International
levels taking into account the importance of SENAPA as an important tourist
destination with more than 90,000 tourists visiting the park every year
(TANAPA, 2002). Fortunately efforts to put the condition under control were
successful using insecticide impregnated targets (IIT) in selected areas,
although the maintenance costs in the National Parks has proved to be
expensive due to high rates of destruction of the targets by wild animals
particularly elephants, rhinoceros and baboons. (TANAPA, 2004)
There have been several publications from Tanzania on the association between
sleeping sickness infection and wildlife populations.
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Some of the research includes; the study to investigate an outbreak of human
trypanosomiasis in Mwanza district, Tanganyika territory (Davey, 1924), while
Moloo (1974) conducted a survey in Musoma district on the role of the vector
in the transmission ofRhodesian sleeping sickness.
Following recrudescence of HAT in 1964 and an increase of annual incidences
in SENAPA, concerns were raised as the region had been declared free and was
developing as an important tourist destination. A large-scale survey on human
African trypanosomiasis was conducted mainly in SENAPA and Ikoma Game
Reserve and several villages of the neighbourhood of these sanctuaries (Geigy,
1971; Moloo et al., 1971; Onyango and Woo, 1971). Findings from these
studies revealed that 10% of the 115 wild animals sampled were infected with
T. brucei sub-species. In a follow up study conducted two years later, Geigy
and Kauffmann (1973) isolated further T. brucei subgroup strains. A more
recent study conducted in the same area revealed that out of 220 samples from
15 different wildlife species, both warthogs and cattle were positive for human
infective sub-species (Kaare et al., 2002).
In summary, HAT appears to be a disease of major socio-economic and public
health importance in rural communities, where more than four million people
are at risk. The disease is endemic in nine regions of mainland Tanzania.
Between 1996 and 2004, 2460 cases of HAT were reported with over 95% of
cases reported from only three regions of the Western zone, Moreover several
relapses have been reported after drug treatment, and there have been no studies
to determine whether both forms of HAT co-exist in Tanzania particularly in
areas where refugees from DRC have settled. In addition and in common with
other neglected diseases, there is paucity of good quality data on the burden
imposed by the disease and the risk factors associated with infection. This
thesis attempts to address some of these issues by conducting targeted field
studies in affected areas as follows:
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1.9 Objectives
The objectives of this thesis are divided as follows: Chapter II reviews the
historical data of HAT in Tanzania since the disease was first recorded more
than 80 years ago, with the aim of attempting to find the evidence of Gambian
sleeping sickness in Tanzania and also to try to establish when exactly sleeping
sickness occurred for the first time in Tanzania.
Chapter III, uses established methodology (Odiit et al., 2005) to investigate the
level of Rhodesian sleeping sickness under-reporting in disease endemic areas
of Tanzania.
Chapter IV uses the findings from Chapter III to recalibrate the quantification
of burden of Rhodesian sleeping sickness in Tanzania, using DALYs, as a
measure.
Chapter V investigates the risk factors for rhodesiense sleeping sickness in
Urambo, Tanzania through a matched case-control study, both at the village and
within the village scales.
Chapter VI: summarizes the conclusions which can be drawn from the findings
of this thesis and proposes the way forward towards further studies and options
for control of HAT in Tanzania.
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CHAPTER TWO:




Descriptions of human African trypanosomiasis (HAT) or sleeping sickness is
have been made since before 1700. In the literature, the first descriptions were
made by European colonists in the late 16th and early 17th centuries. In 1742,
the English naval surgeon John Atkins (1665-1757) described the disease as a
"sleepy distemper" (Ormerod, 1961), while in 1792, Thomas Winterbottom
who was a Physician to the Sierra Leone Colony found a disease and described
it as "negro lethargy". It was described that slaves who presented with swelling
of the posterior lymph nodes (which is associated with African
trypanosomiasis) were rejected by their shippers. In 1857, David Livingston
(1813-1859) described it as a "fly disease" (Vickerman, 1997). Livingston *
recorded that a significant proportion of the cattle he carried along Limpopo
valley, Zambezi River and at the banks of the Lakes Nyasa and Tanganyika
died after they had been bitten by tsetse flies (Buxton, 1948). In east Africa,
the disease has been confined to specific areas (foci), and many epidemics have
ravaged these foci during recorded history starting 1900 onwards (Hide, 1999).
The first recorded major epidemic of sleeping sickness was the Busoga focus in
Uganda where T. b. gambiense was thought to be the causative agent of the
disease, although at that time the more familiar East Africa subspecies, T. b.
rhodesiense had yet to be described.
2.1.1 Evidence of First Sleeping Sickness Appearance in
Tanganyika (Tanzania)
Although available documentation suggest that sleeping sickness was first
recorded in the Tanganyika Territory (now Tanzania) in 1922. Considerable
debate about this still goes on about when exactly sleeping sickness appeared in
Tanzania; there is possibility that the disease may have been present even
before 1900. In tracing the origin of the human trypanosomiasis outbreak in
Mwanza district, Davey (1924) wrote that a blood film from a case which died
in Mwanga native hospital examined in 1919, confirmed a heavy trypanosome
infection, it is improbable that this was the first case.
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He suggested that the disease had been endemic in Usmao sultanate (Maswa)
for several years. According to Davey (1924), a considerable number of
sleeping sickness cases escaped detection within fifty miles of a medical station
for four years. At the moment T. b. rhodesiense is still present in western
regions of Tanzania. The Rhodesian form of sleeping sickness is believed to
have reached Tanzania from Zambezi river basin in Mozambique (then
Portuguese East Africa) across Ruvuma river in 1910 (Fairbairn, 1948). Having
gained a foothold in the South-east fly belt, involving Ruvuma, Mtwara, Lindi
and Morogoro regions, the disease spread (by both riverine and woodland
tsetse) northwards to the fly belt between Lakes Tanganyika and Victoria
(Apted, 1970).
2.1.2 Evidence That Gambian Sleeping Sickness has
occurred In Tanzania
Available documentation suggest that cases of Gambian sleeping sickness
occurred in Tanganyika during the German rule, before 1914 (Buxton, 1948).
From his illustration (Med.Berichte deustchen Schutzgebiete 1908, 1909),
Buxton described that human sleeping sickness occurred along the whole extent
of the shores of Lake Tanganyika, where G. palpalis was the predominant
species. It is also believed that both T. b. gambiense and T. b. rhodesiense
existed in the country in separate epidemics, the first being recorded at the turn
of the eighteenth century (Buxton, 1948; Kihamia et al., 1991). It is
documented that T. b. gambiense spread from West Africa through Belgian
Congo (now DRC) into Uganda and subsequently reached Bukoba and Shirati
in 1902 (Mwaluko et al., 1991). Fairbairn (1948) documented that, T. b.
gambiense sleeping sickness reached German East Africa (now Tanzania) from
Uganda in the early years of the last century. This situation prompted the
Germans (then colonizing the Territory) to establish camps in Kigarama on the
west shore of Lake Victoria and Shirati on the eastern side of the lake in 1907
(Fairbaim, 1948). Despite enquires by a German doctor (Dr. Feldmann) in
1903; natives of Ukerewe revealed that sleeping sickness was not new to the
people.
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In local vernacular people of Ukerewe named the disease Ruti and Msiro
although there was no evidence of major epidemics in the area (Clyde, 1961).
However, Dr Feldmann who was then stationed in Bukoba revealed cases in
migratory workers returning from Uganda (Kihamia et al., 1991). The first
autochthonous cases were reported in 1904 from Kome Island in Lake Victoria,
an area which was infested with Glossina palpalis (now suggested to be
Glossina fuscipes fuscipes). A second focus was found amongst villagers living
along the North-eastern shores of Lake Tanganyika in Kigoma and Ujiji. On the
eastern shores of Lake Tanganyika it is believed that T. b. gambiense was
contracted across the shores of Lake Tanganyika from western shore of the
Lake in the Belgian Congo (DRC) (Temu, 1981). The disease was rampant and
the Germans, then colonizing Tanganyika, resorted to stringent control
measures such as effective bush clearing and strict control of population
movements. The disease was almost eradicated by 1914 (Temu, 1981). By the
end of the First World War, only a few cases of sleeping sickness were found
from small persistent foci near the Rwanda-Burundi frontier (Duggan, 1970).
Gerald F. Sayers reported that, the first known case of sleeping sickness
occurred in the territory in 1918, with no further cases until 1922 when a
number of cases were found in the neighbourhood ofMaswa (Sayers, 1930). A.
J. Oliver, the then Western Region Regional Development Officer, in his 1962
report on tsetse survey and control for Lake Tanganyika, confirmed cases of
Gambian sleeping sickness for the first time in 1924 (Oliver, 1962). Between
1924 and 1933, a fairly low but steady rate of infection was maintained (Temu,
1981), with none reported between 1934 and 1952. In 1953 a sudden outbreak
occurred with 163 cases recorded (Oliver, 1962). This abated following
intensive surveys, compounded with spraying campaigns, clearing of settlement
boundaries and treatment of all cases. A total of 38 Gambian sleeping sickness
cases were recorded in Kagunga (Kigoma) between 1957 and 1958, however,
these are believed to be the last cases of Gambian sleeping sickness in
Tanganyika (Oliver, 1962).
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2.1.3 Patterns of Sleeping Sickness Distribution in
Tanzania
In another debate, the spread of sleeping sickness from Mozambique to the
southern part of the country arises from the shores of Lakes Tanganyika and
Nyasa (Fairbairn, 1948). John Iliffe documented that sleeping sickness followed
a decade or two behind 1914. It was confined to the upper Ruvuma valley and
the shores of Lakes Victoria and Tanganyika, where several people contracted
the disease during the war (Iliffe, 1979). He called sleeping sickness the
"natural disaster" of the 1890s, and further explained that it was an "ecological
catastrophe fundamental to Tanganyika 20th century history" (Iliffe, 1979). He
also reported that the deserted fields quickly relapsed to bush, and were soon
reinfested with tsetse flies. Cattle began to die of trypanosomiasis followed by
appearance of the disease in men characterised by fever and lassitude followed
by to coma and death. It has also been reported that as early as 1915, a number
of deaths were characterized by the swelling of legs in the vicinity of the Mtate
River (Maclean, 1926). Dr. F.I.C.Apted documented that, sleeping sickness
existed around Lake Ruvuma as early as 1911 from where it slowly diffused
northwards through the eastern fly belt to involve the Eastern Province in the
late 1920s (Apted, 1970). David Clyde (1962) documented that in August 1911
sleeping sickness crossed Rhodesia and Mozambique and broke out in a new
area, the Ruvuma area near Songea (Clyde, 1962). He also wrote that, Prof
Beck who was transferred to Lindi in 1908 to take the responsibility of
Regional civil medical officer, spent much of his time investigating the spread
of sleeping sickness down the Ruvuma river until his capture in 1916 (Clyde,
1962). However, according to the existing reports, the earliest foci appear to
have existed in Maswa and Ufipa in Mara and Rukwa regions respectively,
where severe epidemics were reported in the territory around 1920, or some
years earlier. These foci involved the greater part of the Western province. As
early as 1932, 11,000 cases of sleeping sickness had been reported, out of them
3000 cases reported in one year (1930), and more than 2,000 in a single district
(Apted, 1970).
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People who lived in the infected areas were dispersed far and wide due to fear
of infection and subsequent death; the situation which Maclean (Maclean #428)
called "stampede of population". The disease spread rapidly northwards
reaching Tabora by 1926 and Kahama by 1928. And as early as 1930 the
disease had reached Mwanza from where it spread to Ukerewe Island in Lake
Victoria by 1939 (Temu, 1981). It also spread westwards to Kigoma and West
Lake. According to the reports, severe outbreaks in West lake which involved
Ngara district occurred in 1954 (Temu, 1981). If we group the epidemiological
distribution of sleeping sickness in Tanzania regionally since it was first
recorded, then endemicity has been reported in seventeen regions of mainland
Tanzania, which include: Arusha, Lindi, Ruvuma, Kagera, Kigoma, Tabora,
Mbeya, Rukwa, Mwanza, Shinyanga, Kilimanjaro, Morogoro, Iringa, Dodoma,
Singida, Cost and Mara. Figure 2.1 shows the colonial map of Tanganyika
incorporating provinces as well as the location of sleeping sickness foci.
Figure 2.1 Map of Tanganyika Territory showing different epidemics of different
diseases and foci of sleeping sickness (Clyde, 1962)
OPNYONG-NYONG *\
Map of Tanganyika showing Provinces (renamed Regions in ll)62).
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2.1.4 Tsetse Distribution in Tanzania
Historically, seven species of Glossina are of economic importance in
Tanzania, transmitting infection to both human and livestock. In order of
importance, these are Glossina morsitans, Glossina pallidipes, Glossina
swynnertoni, Glossina brevipalpis, Glossina austeni, G. f. fuscipes) and
Glossina longipennis (Daffa et al., 2005). These were distributed as follows
although overlaps of species have existed in many areas (Fairbairn, 1948); G.
morsitans was the predominant species observed mainly in the Western and
Eastern blocks with pockets of both G .pallidipes and G. brevipalpis also
occurring in the same areas. The northern fly block was the main habitat for G.
swynnertoni, and G. palidipes which was also widespread throughout the area
G. brevipalpis was only observed in few isolated areas. The shore of Lakes
Victoria and Tanganyika were the main habitat for G.f fuscipes. However, G.
morsitans has also been reported to have invaded Lake Tanganyika shores from
Malagarasi delta. The regions bordering Kenya extending to Mbulu district
were preferred by G. longipenis. North east and along the coast including the
island of Zanzibar were the main habitat for G. austeni. However, there were
few areas where the overlap of G. morsitans and G. swynnertoni was observed,
including Shinyanga (Mwanza Province) and Babati (Northern Province).
There have been desirable efforts in an attempt to reduce the abundance of
tsetse flies in Tanzania. However, very little eradication has been achieved and
to date all the listed species of tsetse fly still exist in various areas of Tanzania.
Figure 2.2 shows tsetse distribution in Tanzania.
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Figure 2.2 Map showing the distribution of tsetse in different areas Tanzania
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About 50% of rangeland in use in Tanzania is tsetse infested, exposing four
million people and seven million cattle at risk of trypanosomiasis (Daffa et al.,
2005) These tsetse flies have denied livestock a large portion of good grazing
land due to animal trypanosomosis, leading to problems of over-grazing and
soil degradation of tsetse free lands.
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2.1.5 Methods Used for Control of Sleeping Sickness in
Tanzania
Over the past 80 years, various control methods have been applied in Tanzania,
often in combination. These measures have been categorized by Temu (1981)
into four groups as follows: a) system of notification of cases, b) control of
man-fly contact, c) vector control and d) the control of animal reservoirs.
In the system notification, all cases diagnosed in any of Tanzania districts, were
filled onto a notification card and sent to the sleeping sickness unit in Tabora
(now National Institute for Medical Research) which was then the sleeping
sickness headquarters. In line with this system, existed the so called "Pass Card
System" in the east African Territories whereby all people were examined
before they were allowed to travel; the pass was obtained from the chief and it
was countersigned by a "gland boy" after thorough examination of the holder to
ensure the latter was not suffering from sleeping sickness (Granville Edge,
1938). In situations where a positive finding was recorded, the chief was
informed and the person concerned was either sent to the nearest treatment post
or detained to be treated by the itinerant orderly who visited these centers once
every week (Granville Edge, 1938).
In the control of man-fly contact; there was a creation of fly-barriers between
settlements and tsetse bush. Through awareness creation and massive
educational campaigns to people in the risk areas as well as drawing attention
that should incidental biting occur, they were obliged to report any febrile
conditions occurring following the visit to tsetse areas for appropriate medical
check-ups.
The most dominant measure of all the control methods used was the vector
control and was sub divided into four sub-groups as follows:
i) Hand catching - this is probably the most ancient pest control
method. It was effective in the species which are attracted to man
such as G. palpalis (Glasgow, 1970).
Chapter 2 39
ii) It also involved the use of traps and bait animals so as to enhance
the fly catch, this method was usually carried out by the so called
"fly-boys" using hand nets on "fly rounds".
ii) Bush clearing may be partial or total - The method was first employed in
Shinyanga by Swinnerton (1925) and following successes observed, it was
advocated to be adapted to other areas of Tanzania with substantial tsetse
densities.
iii) The use of insecticides - This method was extensively used (Brun et al.,
2001) and involves application of residual insecticides on breeding sites on the
ground, and aerosol applied over wide tsetse habitats by aircrafts. Much of the
insecticide control work was conducted by the Tropical Pesticide Research
Institute (TPRI) Arusha. A good example of this is the control of sleeping
sickness in the Lossitete Forest (Tarimo, 1973)
iv) Sterile Insect Technique -. It involves the release of gamma sterilized male
flies into the environment to compete with the wild males in mating (Vreysen et
al., 2000). This method has been explained in detail in chapter one and it
proved successful in Zanzibar where G. austeni males sterilized by gamma
irradiation were dispersed by air over the whole island in 1994. As a result,
Zanzibar has been free from G.austeni since September 1997 (Saleh et al.,
1998). However this method encountered several difficulties including the
enormous costs of implementation and low density of target population
required for the SIT to be effective (Politzar, 1982).
Finally the control of animal reservoirs which basically focused on game
destruction - experimental game destruction which was conducted in
Shinyanga between 1945-1954 (Potts, 1952). This method was not favored and
did not receive acceptance in Tanzania for several reasons. First; in areas where
game destruction experiments were conducted, flies were constantly driven to
feed on man owing to scarcity of game (Davey, 1924).
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Second, tsetse abundance was not reduced despite considerable number of
animals killed by shooting as well as driven in small detached belts of G.
morsitans (Jackson, 1939).
Despite all control measures detailed above that have been applied in Tanzania,
little has changed in terms of tsetse fly distribution and in fact, the distribution
may have even extended (MacLennan, 1980). Clearing of vegetation and the
destruction of wild animals were widely practiced in the past. These methods
have been shown to be inefficient and are not popular today for environmental
and conservation reasons.
Regression of the tsetse fly has occurred in areas where pasture development
and land cultivation have taken place. Almost all tsetse control methods in use
to date involve the use of insecticides (Tsetse report, 1960), through spraying or
dipping livestock, as well as the use of insecticide impregnated targets. The
methods explained earlier such as aerial spraying are, however, expensive and
their wide use in Tanzania has been limited by the scarcity of funds. Extensive
areas of western Lake Region (now Kagera) were successfully sprayed in the
past although tsetse flies are now reported to be re-invading the area (Temu,
1981). Tsetse traps and insecticides impregnated targets constitute a recent
development that could prove practical and useful in Tanzania. There exists a
paucity of information about when exactly sleeping sickness was recorded in
Tanzania and also it is unclear whether Gambian sleeping sickness ever existed
in Tanzania. In realizing this all available documentation were reviewed and
analyzed for the purpose attempting to fill the existing gap.
2.2 Objective
The aim of the study detailed in this chapter is to review the historical patterns
of sleeping sickness in Tanzania for both Rhodesian and Gambian forms.
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2.3 Material and Methods
The "National Institute for Medical Research (NIMR) Tabora Centre was
established in 1922 as a sleeping sickness unit and was mandated to carry out
trypanosomiasis medical surveillance, treatment of cases and follow up of all
treated patients and also liaison with tsetse control staff. Tabora is located
about 1000 Km west of the capital Dar es Salaam. The author therefore visited
and reviewed all historical records located at the archives at the NIMR Tabora,
Tabora Regional Hospital (Kitete), Kibondo District Hospital, Kasulu District
Hospital, Kabanga Missionary Hospital and Heri Mission Health Centre in
Kasulu (Kigoma).
The author investigated all available hospital reports, sleeping sickness patients
data including patients case notes, annual reports and all other documentation
regarding sleeping sickness since the disease was first reported in Tanzania
(then Tanganyika) more that 86 years ago.
2.3.1 Differentiation of T. b. rhodesiense from T. b.
gambiense
There are several possible approaches to differentiate T. b. rhodesiense from T.
b. gambiense from archival samples and records; the first is the use of
molecular techniques, which requires availability of genetic materials from the
patients, which can be in the form of stored samples or historical slides (Picozzi
et al., 2005; Radwanska and Chamekh, 2002; Welburn et al., 200la). Second is
the use of statistical methods to analyze the archival records. There are very
limited sleeping sickness studies, where such methodologies have been
demonstrated. One of them is the study conducted by Dr. M. Odiit in Tororo in
1997, where he used the duration of symptoms of patients, who died from
Rhodesian sleeping sickness within a week of seeking treatment in LIRI
Hospital in Tororo (Odiit et al., 1997).
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In a separate study Dr. E. M. Fevre in 2004, reanalysed the 1900 - 1920
sleeping sickness epidemic using survival analysis of the clinical course of
illness from first onset to distinguish the two forms of the disease; the results
obtained enabled the suggestion of the possible organisms responsible for the
1901-1920 epidemics in Uganda (Robays et al., 2007). Since it was not possible
to obtain such archival genetic patient materials, which would have provided an
easier option to address the question of the possible existence of Gambian
sleeping sickness in Tanzania, the current review therefore analyses available
historical data using statistical methods.
2.3.2 Archival Records
Existing documentation suggests that sleeping sickness may have been present
in Tanzania before World War I (WWI)(Clyde, 1961).
However, due to poor storage programmes in hospital archives which lack
proper storage of documentation such as old hospital reports, patient case notes
(which are destroyed every ten years), or monthly returns, though it may seem
that available records are not enough evidence to support the possibility of
Gambian sleeping sickness existence in Tanzania, however, unless proved
otherwise all documented evidence has to be reported. The only records
available are for the first outbreak of sleeping sickness from 1920s onwards;
these were in different forms varying from annual reports, patient
monthly/annual returns, maps and research reports findings. In most hospitals
visited, all patients' records particularly patient case notes, and files are
destroyed after every 10-15 years for lack of storage space in the hospital
archives.
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In the past, sleeping sickness wards at Tabora Regional Hospital were managed
by the National Institute for Medical Research, Tabora. Currently all NIMR
clinical staff have moved from the regional hospital to NIMR premises. Some
old patient files and most of old information related to sleeping sickness
patients were left in the hospital archives as the former sleeping sickness wards
(initially under NIMR) have been taken over by the hospital. However, NIMR
continue providing clinical expertise and consultation to all sleeping sickness
patients diagnosed at the regional hospital and referrals from endemic districts.
In the past, whenever a case of sleeping sickness was diagnosed in any district,
the requisite information was filled in a notification card and forwarded to the
sleeping sickness Headquarters (NIMR-Tabora) as detailed in section 2.1.5
above. Therefore all archival documents available at NIMR (Figure 2.3) as well
as visited hospitals were reviewed.
These include hospital registers monthly and annual returns, patient notes as
well as documented communication details related to sleeping sickness in the
visited centres. All the available findings were compiled and analyzed.
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Figure 2.3: Old record shelves at National Institute for Medical Research Tabora
archives
2.3.3 Data Management and Analysis
All available documentation was reviewed and analysed using graphical
methods, data obtained from the review was compiled, summarized and
analyzed in (Microsoft Excel®, 2003). Respective graphs were plotted;
temporal and epidemic trends from first recording were produced and are
reported in the results section. These are based on the assessment of temporal
patterns and distribution of sleeping sickness in Tanzania
2.4 Results
Analysis of historical data revealed very high epidemic peaks in the late 1920s
and early 1930s (Figure 2.4), which denotes the period of great depression
which followed immediately after the WW1, shown as Section A on the graph
in Figure 2.4.
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The epidemic maintained a high rise trend which lasted until 1935, when a
significant decline was observed. The subsequent decline was observed across
most of the highly endemic districts of western Tanzania (section B). This
denotes the period of the World War II (WWII), this lasted until 1948 when the
rise was observed again.
There are several suggestions that can be associated with this decline and they
are discussed later on in this chapter (section 2.5). This high rise which was
immediately followed by decline (shown as section C in Fig 2.4), and a slight
rise was not stable and kept fluctuating until 1960 when another decline was
observed. Most of these cases were recorded along the shores of Lakes Victoria
and Tanganyika (Kilama, 1981; Temu, 1981)
This review also shows that the highest records of sleeping sickness were
recorded from the only few districts of western Tanzania. The cumulative data
(Figure 2.4) also shows that few epidemics occurred during this period. The
first epidemics lasted for 11 years starting from 1925 to 1936, during this
epidemic, 17,772 cases were recorded (NIMR Archives).
During the decline period which started from 1937 and ended around 1949, a
total number of 8765 sleeping sickness cases were recorded. This was followed
by a slight rise lasting for about ten years when 8712 cases were recorded. The
final period (section D) shown on the Figure 2.4 which started in 1961 to 1986,
was not much different from the decline period comprising of 13,938 cases.
Figure 2.4 below is a cumulative incidence graph showing all the sections
described.
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Figure 2.4 Graph of incidences of sleeping sickness cases in Tanzania from
1922 & 2006
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To allow clear observation of the actual situation in the districts, this chapter
carried out a review and analysis of all available data of sleeping sickness since
the disease was first recorded in 1922 until 1980.The annual incidence are
plotted separately in Figure 2.5. The comparisons of temporal trends of sleeping
sickness between neighbouring districts are plotted separately in Figures 2.6 to
2.8.
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The graphs (Figure 2.5) compare temporal trends in different districts of the
western part of Tanzania in different years. In the graph shown in Figure 2.5,
high rise peaks are observed across four out of the six districts (Kahama,
Kibondo, Tabora and Mpanda) between mid 1920s and mid 1930s. However,
there was a subsequent decline observed from late 1930s followed by a slight
increase in two out of the six districts (Kahama, Maswa, Kibondo, Kasulu,
Mpanda and Tabora) observed around 1940s, extending to 1949. There was
another peak observed in Tabora between 1949 and 1956. In the graph also it is
observed that there are small peaks between late 1950s and mid 1970s in
Kasulu and Kibondo districts. To allow a clear picture of this small peak the
two districts are plotted separately in Figure 2.6.
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Figure 2.6 Sleeping sickness incidences from 1922 - 1958 in Kasulu and
Kibondo districts
—Kasulu
1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010
Period (Year)
It is observed that Kibondo district recorded a high rise peak in number of
sleeping sickness cases which started in 1931 and lasted for four years until
1938, as compared to Kasulu which recorded a moderate rise around the same
years. There was another small peak staring form 1939 lasting to 1946,
followed by subsequent decline across both districts. It's interesting to note that
there was an unusual uniform several small peaks in the two districts between
1958 to 1968, 1970 and 1974 and also the last one observed in 1996 and ended
in 2004. Figure 2.7 compares the trends in the Mpanda and Tabora.
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From the graph it is observed that Tabora district recorded the highest peaks
which started in 1929 and lasted until 1934. This was followed by a decline
lasting for about 15 years until 1949. In 1949 and 1954 two peaks were
recorded and each lasted for just one year. From 1959 to 1974 both districts
maintained low pace of incidences the highest number being 76 cases in 1966.
On the other hand Mpanda observed moderate peaks in 1925, 1930, 1939/1941
and finally the one of 1966.
The review demonstrated that despite Maswa and Kahama being amongst the
districts which recorded the first cases in Tanganyika territory, they also
recorded the highest ever recorded peak in the territory. An outbreak was
recorded in Maswa for the first time in 1922 and maintained moderate
incidence until 1935 when the disease disappeared from the district. However,
during this low records duration, the disease then entered Kahama district,
which shares border with Maswa, in 1929 when annual incidence reached 948
cases. The following year 1930 the highest ever peak observed in the country
when annual incidence for one district (Kahama) reached 2121 cases.
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This was followed immediately by subsequent decline observed the following
year, it continued to decline and by 1938 the annual incidence reached 50 cases
(Figure 2.8).
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The findings from the review of existing records also show that there were few
Gambian cases recorded from the shores of Lake Tanganyika. The documented
records show that Gambian sleeping sickness was first recorded in 1924. Figure
2.9 is the graph showing incidence of Gambian sleeping sickness in the territory
and Figure 2.10 is the map of Tanganyika showing the exact location of
Gambian sleeping sickness.
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Figure 2.9 Graph showing incidences of Gambian sleeping sickness in the
western Tanzania.
Figure 2.10 Map showing the areas marked with a small circle at the shore of
Lake Tanganyika are the areas where Gambian sleeping sickness
were recorded. (Map adapted from the archives at NIMR Tabora)
DISTRIBUTION OF SLEEPING SICKNESS - 1958
TANGANYIKA
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The results described from the archive reports suggest that both Rhodesian and
Gambian sleeping sickness have existed in Tanzania. Fairbairn documented
that the possible occurrence of Gambian type of disease, on the eastern and
southern shores of Lake Tanganyika needed to be discussed (Fairbairn, 1948).
It was known since German colony times that human sleeping sickness occurs
along the whole extent of that shore habited by G. f. fucipes. However,
subsequent entomological studies conducted along Lake Tanganyika shores
shows that G. morsitans and G. palidipes, exist in the same areas and an
outbreak reported in 1943 was found to be due to T. b. rhodesiense (Fairbairn,
1948).
Findings from the current review analysis demonstrated a high epidemic peak
which started around the 1920s and lasted for about ten years, the observed rise
was likely associated with a number of things, first was a period of great
depression following the WWI, secondly the transition from Germany colony to
British mandate. Most of the control programmes which were under German
authority were left without funding and proper supervision as most of the
programmes were manned by European experts, David F. Clyde (1962) wrote
that, owing to shortage of medical officers in the years immediatly following
the war the disease was not reported (Clyde, 1962). It is therefore possible that
the high rise trends observed were due to the stability in number of medical
staff recruited after the power take over from the German administration.
The decline observed after the beginning of the 1930s is the result of
combination of issues, which can be suggested to contribute towards this
achievement. Amongst the most important ones again being the improvement in
numbers of the medical staff who facilitated the diagnosis and treatment
(Clyde, 1962). Second, was probably the introduction of a new effective drug
(Suramin) for the treatment of sleeping sickness in Tanganyika (Duggan, 1970).
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And third there were large scale mass bush clearing campaigns around the
villages and along the roads, at least 150 yards on each side of the road
(Swynnerton, 1924), the impact which can be observed until today. Local
residents of Kahama and Shinyanga, the districts which were involved in these
campaigns believe that the semi-desert feature observed in most of these areas
today is the result of the campaigns (personal communication). Kahama is
among the districts which recorded the highest sleeping sickness numbers in the
past. However, the last four cases were diagnosed in 1972 and since then no
new cases have been diagnosed in the district.
In 1919 it was reported that, while epidemics prevailed in the Congo basins,
sporadic cases of the virulent form of trypanosomiasis were reported from
Tanganyika (Duggan, 1970). The virulent kind of unusual trypanosomiasis
mentioned by Duggan suggests that this was Rhodesian sleeping sickness. It is
also documented that the mentioned virulent trypanosomiasis was transmitted
by riverine tsetse flies. This raises concern since Rhodesian sleeping sickness is
rarely transmitted by this species of tsetse. However, later studies suggested
that both species of tsetse flies existed in the region
It may be argued that, available data does not provide enough evidence for the
existence of gambiense sleeping sickness in Tanzania. Also considering
diagnostic facilities which were available in the past which relied on
microscopy, there is probably not enough evidence to support the existence of
T. b. gambiense. When comparing the two forms of the disease, clinically
Rhodesian sleeping sickness is more acute than Gambian (Apted, 1970).
Beside, records show that there were more cases of T. b. rhodesiense (23,955
cases between 1922 and 1946) as compared with T. b. gambiense which totalled
an annual incidence that hardly reached 170 since it was first recorded in 1924.
It is not clear and not documented anywhere how these cases were diagnosed or
even how they were differentiated from Rhodesian HAT cases.
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When looking at the kind of control measures which existed between 1920 and
1958, which included intensive bush clearings, settlement in new areas,
treatment of cases and vector spraying. Apart from all these measures, an
officer was sent to a gambiense focus in Kenya to acquire experience and skills
of controlling gambiense form of the disease, it is, however, unclear why there
was so much attention given to the focus with such small number of cases along
the shores of Lake Tanganyika to eradicate G. palpalis as compared to other
areas in the same province where large number of cases were reported. The
only possibility is that, the authorities were trying to avoid serious
consequences which were likely to occur if the disease was allowed to develop
further and cause an overlap to rhodesiense sleeping sickness which was
already widespread.
It was documented that in East Africa existed "A Pass System" (Granville
Edge, 1938) for the control of population movements across the borders. This
reduced the chance of introducing the disease to the other side of the border.
Although chances still exist for the people who contacted the disease and
travelled before parasite could be demonstrated in their blood. In the Annual
report for the tsetse survey and reclamation for 1958, it was reported that there
was a massive spraying campaign between Kigoma and Ruanda - Burundi
border (Annual-report., 1959). Beside there was another re-spraying operation
in some parts of the river where few flies persisted, such that by December
1958 not a single G. palpalis was found in Kigoma (Annual-report., 1959). In
the veterinary report from 1959 they reported that the surveys conducted shows
that, although eradication campaigns were still on, traces of G. palpalis were
reported particularly in the southern parts of the lake shores. But still no cases
of T. b. gambiense were found. The two reports contradict each other and it is
possible that one of the groups which conducted the survey was probably not
accurate enough, as it is unlikely that there would of been re-invasion just one
year following eradication.
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Beside, presence of G. palpalis group does not always warrant the existence of
gambiense sleeping sickness as research findings shows that G. palpalis (G. f
fuscipes) also transmit Rhodesian sleeping sickness (Southon and Robertson,
1961; Willett, 1965).
Sleeping sickness epidemics were controlled in some parts of Tanzania before
1960s using conventional methods which included bush clearing; large scale
spraying campaigns, mass diagnosis and treatment of cases. In Uganda for
example political and economical upheaval has been associated with the
resurgence of disease epidemics in the country (Mbulamberi, 1989a). In
addition a number of factors and hypothesis have been advanced as possible
cause of the outbreaks of sleeping sickness which occurred in Uganda at the
beginning of the 20th century which were attributed to T.gambiense
(Mbulamberi, 1989a). However, reanalysis conducted later to old patients
documentation suggested that probably rhodesiense HAT was responsible for
the outbreaks (Odiit et al., 2004) It is very possible that similar confusion exist
in available documentation. In Tanzania on the other hand no T. b. gambiense
epidemic has ever been reported, moreover the overall annual total of T. b.
gambiense cases in the country hardly reached 170. The re-invasion of G.
palpalis group was reported in areas where previously controlled (Report, 1960;
Officer, 1960). This gives an interval of only one year after the area was
declared free from the Palpalis group. It seems, however, unlikely that the
disease could have disappeared so suddenly particularly in areas with reported
re-invasion, if we assume both reports are correct. Considering that, gambiense
sleeping sickness is chronic in nature, meaning that an individual may harbour
the disease for several months or even years without developing any symptoms
(Apted, 1970). Diagnosis has always been difficult particularly in the past,
when the only means of diagnosis was purely parasitological. Moreover,
parasitaemia in Gambian form is usually lower when compared to Rhodesian
HAT.
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This may have provided chances for the disease to maintain itself and spread
even to other areas since no treatment would have been given, due to late
diagnosis.
If it is assumed that the failure to find cases during those years was probably
due to disease under-detection, it however, becomes difficult to explain why no
single case of gambiense has been diagnosed in Tanzania since 1958. There is a
risk that the disease may re-appear at any time since there no evidence of
sufficient surveillance activities particularly in the old gambiense foci.
There is very limited documentation of similar control achievements with
gambiense sleeping sickness endemic areas in sub-Saharan Africa, even in
areas with better surveillance systems, with the use of mobile teams in active
case findings, and with the use of modern and sensitive diagnostic options such
as serology (Magnus et al., 1978) in field environment.
Similar confusions were reported in Busoga (Uganda) where gambiense
sleeping sickness was initially thought to be behind the 1900 - 1920 epidemics
until later studies (Fevre et al., 2004) highlighted that T. b. rhodesiense was
probably responsible for the outbreak. Although the possibility of T. b.
gambiense existence in Tanzania in the past cannot be ruled out especially if it
is assumed that the reported successes which managed to eradicate Gambian
form of the disease, were probably due to massive control campaigns conducted
in the region during the 1950s, then several questions remain unanswered. It is
understood that the control campaigns were extensive and directed towards
tsetse eradication in general and were not targeted towards eliminating a
particular species of the fly. It does, however, become questionable how other
species of tsetse flies managed to maintain themselves around the shores of
Lake Tanganyika with such massive and extensive control interventions in the
region (Brun et al., 2001).
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T. b. rhodesiense would have been probably the first to be eliminated in the
region considering its virulence and acuteness feature which forces patients to
seek medical attention. Also the higher parasitaemia levels in Rhodesian form
make the disease easy to be diagnosed and treated hence better chances of
disappearance.
Similar achievements have been documented in other districts of Tanzania
where with the use of such massive control campaigns the Rhodesian form has
not been reported (Tsetse report, 1935-1938; Tsetse report, 1940)
It was once speculated that sleeping sickness was introduced in Kigoma region
by livestock transported by trains, as abundances of tsetse were observed to be
carried by cattle in the trains. This means that rhodesiense sleeping sickness has
long been present around Lake Tanganyika and with T .b. rhodesiense known
to be a zoonotic disease (Hide, 1991; Maudlin et al., 1990; Onyango et al.,
1966) could provide evidence for an animal reservoir. In most areas in the
western part of the country, transmission occurs along the roads as well as
railway lines. Today from personal observation this can also be confirmed as
most of the affected villages are located along the transportation lines. A
number of rhodesiense sleeping sickness cases are still present in some parts of
Kigoma, and also the disease managed to maintain itself in the region since it
was first diagnosed in 1920s. However, so far there is no single case reported
from the gambiense focus at the shores of Lake Tanganyika.
During the historical data review, there was no enough documented materials of
clinical evidence was found, which would have enabled analysis to be
conducted to prove the existence of T. b. gambiense in Tanzania.
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However, the following communication documents were found; letters between
Dr. F.C.I. Apted and Dresser in charge of Kagunga dispensary (Figure 2.9), as
well as communication between Michael Ashcroft from Tinde tsetse research to
Dr. Apted (Figure 2.10). In the first letter Dr. Apted, who was then the medical
officer in charge at Tabora Research Station and also the sleeping sickness
specialist, was responding to the then in charge of Kagunga dispensary who
was seeking advice on how to deal with cases of sleeping sickness which were
not responding to treatment. Dr. Apted suggested a new line of management for
these patients and also promised to send stock of drugs including Pentamidine
to the dispensary.
Kagunga was reported to be one of the gambiense sleeping sickness focuses,
and Pentamidine is known to be the drug of choice for early stage gambiense
sleeping sickness. In the second letter they were arranging a visit to Kagunga to
collect gambiense strains for the research purposes. While the author respects
the outstanding clinical experience of these staff and since this may suggest
some clues of gambiense, it is however unclear why Suramin which is the drug
of choice for first stage rhodesiense sleeping sickness was stocked in a
gambiense focus, if pentamidine was available.
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Tinde research laboratory is well documented for the outstanding research on
trypanosomiases, some of the documentation being (Ashcroft, 1959; Butt,
1947; Corson, 1931, 1936, 1937, 1938, 1939; Maclean, 1932; Vanderplank,
1941). Also according to the letter shown in Figure 2.11 it is assumed that one
of the visits to Kagunga or another gambiense focus was made, and although
this existing documentation suggests the presence of Gambian sleeping sickness
there is still not enough evidence to affirm Gambian sleeping sickness in
Kigoma (Tanzania) between 1924 and 1958. It is unclear why in all these
research documentations there is so little information to show studies conducted
either in Tabora, Shinyanga or Tinde laboratories using gambiense strains of
trypanosomes, and these two research centres in Western province share a
common border and also the transport network has always been very good.
There was a railway communication between Kigoma and Mwanza trough
Tabora and Shinyanga constructed during colonial times.
After Independence (1961) most of the control programmes which were in
place during colonial era collapsed due to either lack of stable source of funding
or shortage of enough qualified staff to manage the programmes or both
(Report, 1964; Tsetse Report, 1960). The Palpalis group which made a
comeback to the gambiense focus are probably still present and in large
abundances as there are no sustainable control interventions in place. It is
assumed that if T. b. gambiense was present in the region, there are chances that
it would have also made a come back especially during this time when the
control measures did not exist.
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2.6 Conclusion
All the evidence discussed in this chapter suggests that there was a possibility
of introduction of T. b. gambiense sleeping sickness into Tanzania from the
shores of Lakes Victoria and Tanganyika, because the disease was introduced
from the Belgian Congo (now DRC).
However, the bulk of the disease in Tanzania has always been the Rhodesian
sleeping sickness. Tanzania needs to remain vigilant about the possibilities of
re-introduction of T. b. gambiense. Hence, there is an urgent need to strengthen
surveillance activities particularly in the former foci and other risk areas, such
as DRC border where vectors are still available.
2.7 Study Limitations
The review observed that storage is a big problem in Tanzania, also the little
available data are not consistent with the situation which makes it difficult to
track the records and conduct a proper analysis, to confirm when exactly the
disease was first recorded in Tanzania and also to affirm existence of Gambian
form of sleeping sickness in Tanzania, either in the form of historical patient
genetic materials or old patient case notes which would allow answer the
question regarding existence of Gambiense sleeping sickness in Tanzania.
Therefore based on the diagnostic technique used in Tanzania in the past which
were mainly microscopy and the inconsistency and data storage this review was
not possible to find enough evidence to confirm either the exact period when
sleeping sickness was first recorded in Tanzania or confirm the Gambian
sleeping sickness existence in Tanzania from the existing archive.
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CHAPTER THREE:
ESTIMATING RHODESIENSE SLEEPING SICKNESS UNDER¬
REPORTING IN URAMBO DISTRICT TANZANIA
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3.1 Introduction
In 2000, all 192 United Nations member states unanimously pledged to meet eight
Millennium Development Goals (MDGs) by the year 2015. By definition Millennium
Development Goals are eight international development goals that 192 United Nations
member states and at least 23 international organizations have agreed to achieve by the
year 2015. They include reducing extreme poverty, reducing child mortality rates,
fighting disease epidemics such as AIDS, and developing a global partnership for
development. However, though the MDGs do not explicitly address the neglected tropical
diseases, these neglected tropical diseases share a high prevalence in rural and poor urban
regions of low-income countries (Sachs and Hotez, 2006). Among other things addressed
in the agenda are the explicit goals of eradicating extreme poverty and hunger (MDG-1)
and ensuring environmental sustainability (MDG-7).
Communicable diseases are overarching issues for sustainable development rather than
exclusively health matters, as evidenced by the high long-term costs, loss of productivity
and social burdens associated with illness and disability from neglected tropical diseases,
which go beyond the usual economic analysis of ill health. The goals cannot be fully
achieved without an integrated approach, which will target prevention and control of the
neglected tropical diseases and some which are zoonoses. In designing these approaches,
the expertise of medics as well as vets must be considered as an important aspect in order
to achieve substantial outcome in the control. Suggestions have being made, that
targeting control interventions towards proper investigation and treatment of livestock
which carry zoonotic infections are suitable options in preventing further transmission for
most of these disease in both humans and animals (Welburn et al., 2001a)
Surveillance has been highlighted as an important tool for the prevention and control of
neglected tropical diseases.
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In realizing the importance of this tool, World Health Organization Regional office for
Africa in 1998, developed the Integrated Disease Surveillance and Response (IDSR)
strategy, as an approach to build nationally-owned sustainable disease surveillance
systems among its 46 member states (WHO-AFRO, 1999). The primary goal of IDSR
was to strengthen public health surveillance and response to priority infectious diseases at
the district level, second was to integrate surveillance with laboratory support, and finally
to translate surveillance and laboratory findings into specific and timely public health
actions. Indeed IDSR is an important tool, particularly for developing countries where
resources are limited, and also emerging and re-emerging infections continue to pose
severe threats. Especially since pathogens develop drug resistance (Bailey et ah, 2005;
Nsubuga et ah, 2002). Hence early detection is an important step towards preventing
complications, which are likely to arise from improperly managed diseases in developing
countries. Unfortunately, despite the serious threat posed by neglected diseases, the
majority of the existing national surveillance systems fail to offer neither timely detection
nor effective response to many of these diseases (Nsubuga et ah, 2002; Sandiford, 1992).
Human African Trypanosomiasis (HAT) or sleeping sickness is one of the severe
disabling zoonotic infections, and one of Africa's most prevalent and economically
devastating illnesses. It is also one of the most neglected vector-borne diseases, affecting
poor populations in remote areas of sub- Saharan Africa. Neglected tropical diseases
usually affect the marginalized and impoverished rural populations, and have the
tendency of maintaining a very low profile. As a result such diseases are often left out
when most of the public health agendas are formulated (Banerji, 2003; Trouiller, 2002).
Since the disease affects mainly poor and take a low profile in addressing health agendas,
it is most likely to be under-reported, compared to other diseases (Komba et ah, 1997;
Mbulamberi, 1989b; Odiit et al., 2005; Okia et al., 1994).
Tanzania witnessed decades of devastating suffering from sleeping sickness epidemics
which occurred between 1920s - 1960s (Fairbairn, 1948; Moloo et al., 1973).
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Sadly, it is still among the most severely affected countries, and also some districts,
which recorded substantial number of cases in the past, are among the few districts where
the disease is still present. Furthermore, the disease has recently re-emerged in two
districts of Mainland Tanzania, where it was initially controlled (Kibona et al., 2002).
In order to strengthen communicable disease surveillance and to allow health teams to
respond more quickly to diseases, the Ministry of Health of the United Republic of
Tanzania adopted a IDSR strategy, as one of the five approaches used in country's Health
Management Information Systems (HMIS) MTUHA in Swahili, the national language.
HMIS particularly IDSR has been praised for having good communication and
coordination qualities with other sectors in terms of sharing information and resources,
however, they been challenged for several inadequacies (Rumisha et al., 2007). First, the
systems were found to be unable to receive reports from facilities timely, second they
were not able to manage the received reports at the district levels and third, they were
unable to monitor their performance of the surveillance systems (Rumisha et al., 2007).
Another big concern, which was likely to contribute to the disease under-reporting, is that
the system does not provide option to capture all diseases occurring at the facility level.
Some of the diseases including most of the neglected diseases which do not feature
among the top ten priority diseases of the facility's catchments are, reported under others,
meaning that such a disease will definitely not feature in the district records especially in
communities where the disease is not among the major concern.
Several suggestions have been given for the current under-estimation of neglected-
tropical diseases, and they have been categorized into two main groups as follows: Firstly
most of these diseases which are also zoonotic are inherently difficult to diagnose due to
the fact that they are often not exhaustive and unevenly spread geographically and/or are
known by one locality but unknown by another.
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They share symptoms with many other common diseases, and they have complex
definitive diagnosis, furthermore the reliable, cheap diagnostic tests are currently
unavailable, and secondly, the channels through which disease would normally be
reported do not function properly and effectively (WHO, 2006a). For many years now,
there has been very little investment on research and development of drugs to treat
neglected communicable diseases (Trouiller, 2002), that affect mostly the poorest
communities, such as sleeping sickness.
The reason for this is mainly due to the fact that there is very little revenue from such
investments. Public research institutes in the industrialized world do not view HAT like
many other neglected diseases as either a priority or a major threat to their populations,
and research-based drug companies do not pursue promising compounds for drugs to
treat these illnesses because of an inadequate return on investment (MSF-DND, 2001). It
has also been documented that HAT is a disease that affects only isolated rural poor
communities and in most cases it is either missed or misdiagnosed on the first health
facility visit (Picozzi et al., 2005; Welbum et al., 2006). Besides it relies on low sensitive
techniques under field conditions such as microscopy which has been a major concern, as
it makes it more difficult to estimate the true occurrence of the disease (Cattand et al.,
2001; Picozzi et al., 2005).
The concept of under-reporting (i.e. incomplete coverage) of different infectious diseases
has been conducted both in the developed as well as the developing world. However, the
accuracy of predicting under-reporting of diseases using assumption and proportions of
reported cases from hospital records has recently been challenged due to the unreliability
of the data used. In most cases, under-reporting calculations use single value estimates
reported at each step which are later multiplied and the inverse taken. This does not give
*
room to understand how randomly the data was collected, the situation which may
introduce some degree of bias to the calculations (MacDougall et al., 2007). Over the
recent years, many studies on the quantification of disease under-reporting have been
conducted both in developed as well as developing countries, using different approaches.
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Among the few methods used in different places are the capture-recapture technique
which was used to estimated malaria under-reporting in the Netherlands (N.A.H.Van
Hest, 2002). In the United Republic of Tanzania (Cleaveland et al., 2002) developed a
decision tree model for predicting probability of rabies death following the bite of a
suspected rabid dog. Following the achievements of these advancements, these methods
were adopted in studies for re-evaluating rabies burden in Africa and Asia (Fevre, 2005;
Knobel et al., 2005; Picozzi et al., 2005). In low prevalence areas of Piedmont Region of
Italy, Baussano et al. (Baussano, 2006) studied under-reporting of tuberculosis, using
record linkage of multiple information systems to assess the performance of the
surveillance systems. Subsequently they conducted capture-recapture analysis to estimate
TB incidence.
In the Netherlands studies using analysis of Pyrazinamide use was used for estimating TB
under-reporting (van Loenhout-Rooyackers et al., 2001). Serious under-reporting of
visceral leishmaniasis (van der Werf et al., 2003) through passive case reporting has been
documented in Bihar India, where Singh and colleagues conducted active house to house
surveys to estimate the incidence of VL in endemic areas of India and compared the
results to passive surveillance cases reported in public health facilities (Singh, 2006). In
Britain, a study on malaria under-reporting was achieved using a review of all telephone
enquiries from doctors seeking advice from their colleagues at the hospital for tropical
diseases (HTD), London (Davidson, 1993).
In Uganda, Odiit et al (2005) developed a decision tree model for sleeping sickness
under-reporting. Using this model, 39% of HAT cases were under-reported with
approximately 92% unreported deaths due to HAT occurring in rural communities of
Uganda (Odiit et al., 2005) . The measure of early to late stage presentation presented in
this model was found to be useful, hence it was recommended for the use in other
rhodesience sleeping sickness endemic areas across sub-Saharan Africa.
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However, it was advised to take pre-cautionary measures in drawing conclusion with the
results of the model, as the data used in its development was obtained from an area with a
relatively low probability of under-reporting because of a better infrastructure and a
better health services when compared to other sleeping sickness areas of sub-Saharan
Africa.
Tanzania National Health Policy is based on the concept of Primary Health Care (PHC).
Its overall objective is to improve the health and well being of all Tanzanians, with the
main focus on the most risk, and to encourage the health system to be more responsive to
the needs of the people (Ministry of Health, 1994). However, it has been difficult to
achieve the expected goal, particularly in rural settings where insufficient resources both
human (in term of staff) and materials (equipments, drugs and finance) have always been
problematic. Furthermore some communities have been ignored by the health authorities,
either unwittingly or perhaps due to lack of adequate resources and/or lack of sufficient
awareness or sometimes even both. Most of rural health facilities have no capacity to
diagnose most infectious diseases including HAT. Recent studies suggest that even in
areas with a reasonable number of staff, not all of them can properly diagnose and treat
cases of sleeping sickness (Adams et al., 2006). This situation exposes rural communities
to risk of disease under reporting, and as a result this impinges on the rights of the people
with less income to obtain basic health services, such as early detection of diseases which
are treatable, including sleeping sickness. As a result, these diseases are severely
underreported and consequently they receive less prioritization. This therefore exposes
HAT to the high risk of been under-reported.
World Health Organization in its 1997 assembly passed a resolution to eliminate HAT in
all endemic countries by 2015 (WHO, 1997). Although this may look very ambitious
given the existing resources (WHO/AFRO, 2005), it is an achievable goal particularly ff:
all required logistics are timely put in place.
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The meaning is that in order to achieve the targeted goal, there is an urgent need to look
for the best ways of preparing multi-sectorial integrated approaches, which will allow
proper utilization of the little available resources, and these will require full community
awareness and commitment. Besides there have been significant achievements in the
control ofHAT in the past twelve years. Worldwide cases reported for the past five years
show a remarkable reduction in the total number of new cases reported per year, which
reached 17,500, and a new estimated cumulative rate of 50 000 - 70 000 cases (WHO,
2006b)
In Tanzania, a significant reduction in total number of cases reported each year from 422
in 1995 to 157 cases in 2004. However, it's unlikely these figures represent the true
disease situation in the country considering the factors associated with under-reporting
which comprises the bulkiness of this chapter. It have been observed over the last few
years, that HAT cases are not regularly reported to the coordinating centre, Tabora as
they should have been and there is no documented evidence which changed this mandate.
The system of notification discussed in detail in Chapter II required all treatment centres
to report every case of sleeping sickness diagnosed in their health facilities to the
National Institute for Medical Research, Tabora. This makes it difficult to track back
records of all sleeping sickness cases in the country, hence providing room for possible
under-reporting. The 157 cases reported here were based on passive surveillance data
reported from only three regions of western Tanzania Kigoma, Tabora and Rukwa with
over 95% reported from the districts of Mpanda (Rukwa) and Urambo (Tabora Regional
Profile). Furthermore all these cases were diagnosed and treated in one health facility the
rest of the health facilities reported no cases ofHAT to the district hospitals.
The present study is concerned about the level of rhodesiense sleeping sickness under¬
reporting. Like many other countries of sub-Saharan Africa, Tanzania which had brought
the disease close to elimination in 1960s (using control measures discussed in Chapter I),
is facing a dramatic resurgence, even in areas where it was initially well controlled
(Kibona et al., 2002).
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It therefore becomes more difficult to obtain the accurate occurrence of the disease from
the local levels. Also there is no evidence of sufficient research conducted to assess the
needs of respective communities; this may result in inadequate and inappropriate resource
allocation, as well as failing to target the diseases in question. Moreover, the majority of
the recent relief programs clearly emphasize implementation of primary health care
(PHC) to focus on prevention programs such as immunization. This again does not
capture most of the neglected diseases such as sleeping sickness, highlighting the urgent
need to estimate the level of neglected diseases under-reporting. The findings of which
will provide useful inputs to be incorporated in the quantification of disease burden
imposed on local poor communities.
3.1 Material and Methods
3.1.1 Study Area and Population
The study was carried out in Urambo district in Tabora region, western Tanzania. The
District occupies an area of 25,995 square kilometres and is located at latitude (4° 00" -
5° 53") S and longitude (30° 00' - 32° 37") E. The district is divided into four
Administrative divisions, which are Urambo, Ulyankulu, Usoke and Kaliua; twenty six
wards and one hundred and four villages. According to national census the total
population for the district is 369,329 and 63,256 households (National Bureau of'
Statistics, 2002).
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Figure 3. 1 Map of Urambo district showing the location of all health facilities
3.1.2 Health Profile and Sleeping Sickness in Urambo District
Urambo is served by one district hospital, four health centres and thirty five
dispensaries. The health facilities are distributed as follows: Urambo division
one hospital and nine dispensaries, Ulyankulu one health centre and ten
dispensaries, Usoke two health centres and two dispensaries, Kaliua division
one health centre and fourteen dispensaries. Three out of the fourteen
dispensaries of Kaliua have not been functional since construction was
completed more than three years ago due to lack of staff. In the district, drugs to
treat HAT are only supplied to Kaliua health centre, therefore all sleeping
sickness patient are referred to Kaliua for treatment. The decision to supply
drugs only to special centres was reached due to several factors; first Kaliua is
located close to all sleeping sickness endemic villages in the district, second the
centre has the capacity to diagnose, confirm and treat cases of sleeping sickness
and third the centre has enough space to admit and manage all cases of sleeping
sickness.
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Beside the factors listed above, the decision was reached as part of an attempt
to ensure proper drug utilization and monitoring following severe drug
shortages, which hit the country in late 1990s. Urambo district has not
experienced sleeping sickness since 1996.
3.1.3 Data Collection Methods
The National Institute for Medical Research, Tabora research centre is
mandated at coordinating and documentation of all sleeping sickness activities
in the United Republic of Tanzania. However, over the last few years a
significant number of cases of sleeping sickness are not regularly reported to
the centre from all treatment centres as used to be. This therefore makes it
difficult to track back and achieve proper records of all sleeping sickness cases
in the country. Apparently there is no written documentation which amended
the card notification. The data used in the current study are therefore based on
active and passive surveillance data, extracted from Kaliua health centre in¬
patient registers.
This data also includes all patients diagnosed during active surveillance
exercises, as cases are always referred to HAT treatment centres such as Kaliua
HC for treatment. In order to be able to estimate the level of rhodesiense
sleeping sickness under-reporting in Tanzania, the detailed retrospective study
of sleeping sickness cases diagnosed and treated at Kaliua health centre
between January 2000 and December 2004 was conducted.
3.1.4 Case Definition
A case of HAT for this study was defined as "a person presented for treatment
at Kaliua health centre between January 2000 and December 2004, with clinical
and parasitological confirmation of sleeping sickness using WHO criteria for
diagnosis of sleeping sickness (National Bureau of Statistics, 2002), or having
white cell count >5mm3 for late stage).
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Figure 3.2 Total number of new sleeping sickness diagnosed and treated in
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Between 2000 and 2004, 328 cases of sleeping sickness were diagnosed at
Kaliua health centre (Figure 3.1) above, out of them 69 reported in early stage
of the disease, 237 in late stage and 22 patients were not staged. Out of them 15
patients died.
In cases where patients had more than one hospitalization for the same
condition all duplicates were removed based on first occurrence per patient.
This was simply achieved using patient medical record numbers. All this
information was fitted in the decision tree model structure for sleeping sickness
under detection (Odiit et al., 2005).
3.1.5 Model Structure
According to (Odiit et al., 2005), the decision tree model structure shown in
Figure 3.3, and its parameters shown in Table 3.1, works using conservative
assumption that there is no increased mortality due to early stage sleeping
sickness, in terms of estimating the proportion of sleeping sickness that die
undetected.
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The model takes into account that clinical presentation of sleeping sickness
progresses from early to late stage and subsequent death especially if no
treatment is provided. It also assumes that there are little chances of increased
possibility of death in the early stage when compared to late stage. The model
structure comprises a series of probabilities and it underwent two main
structural stages: under-detection model structure and structure for estimating
undetected deaths.
3.2 Structure for Under-Detection Stage
This was achieved using survival analysis using the Monte Carlo Simulation.
The list of all possible probability outcomes are as follows: A proportion of
sleeping sickness cases that did present at health facility, will present as early
stage patients E, with a probability /early. The other proportion of cases that do
not present at early stage (E), will either present as late stage cases (L), with a
probability / late, or die undetected (U), with a probability 1 -/late. Therefore,
the model has only three possible outcomes for each sleeping sickness case: (1
#172) presentation with early stage disease, E, with probability /early, (2)
presentation with late stage disease, L, with probability (l-/early)/late or (3)
dying undetected, U, with probability (l-/early)(l-/late), where E, L and U are
all proportions and sum to 1 (Odiit et al., 2005).
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Figure 3.3 Structure of the decision tree model for rhodesiense sleeping
sickness.
The boxes are the different outcomes of sleeping sickness cases. The arrows
show the directions of clinical progression. Probabilities for each stage of the
model are shown in italics.
The coefficient for under-reporting; U.
Under-reporting was quantified by the under-reporting coefficient (U), which is
calculated using the formula:
U = (1 -/early) (1 -/late)
Where, /early is the ratio of early cases observed and the sum of detected and
undetected cases.
And /late is the probability of sleeping sickness cases presenting at late stage.
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Figure 3.4 Summary of definition of decision tree model parameters
Model state
E Proportion of sleeping sickness cases presenting as early
E Proportion of sleeping sickness cases not presenting as early
L Proportion of sleeping sickness cases presenting as late, not early
E/L Ratio of early to late cases - estimated from empirical data
Rates
It
Hazard function for onset of symptoms at which late stage cases
present at health facilities - estimated by survival analysis, using a
Weibull distribution with parameters aI and XI
ut
Hazard function for onset of symptoms at which late stage cases die
- estimated by survival analysis, using an exponential distribution
with parameter X u
Probabilities
/early Probability of presenting at early stage, calculated using E/L and/late
flate
Probability of presenting at late stage, calculated by numerical
simulation of integrals of the rates at which late stage cases present
at health facilities, /, and die of sleeping sickness, u
Outputs
U Proportion of sleeping sickness cases that die undetected




A total of 366 (69 early, 275 late and 22 unstaged) sleeping sickness cases were
diagnosed and treated at Kaliua health centre in Urambo district between 2000
and 2004. The observed ratio of early to late stage sleeping sickness cases was
0.25. The decision tree model for under-reporting predicted that apart from the
366 reported cases, the probabilities of reported and unreported late stage
deaths were 56% and 44% respectively. The model also predicted that 233
cases were unreported deaths, making a combined total of reported and
unreported cases to 599. The ratio number of unreported deaths per recorded
deaths in Urambo during this period was 16 (Table 3.2).
3.3.2 Outputs of the Decision Tree Model for Under-Detection
The outputs of the model show a slight increase from what it predicted,
although all the output results lie within the range of the confidence intervals to
what was predicted. These findings suggest that on average a proportion of 11%
(95% CI: 09, 13) of all HAT cases presented at early stage, while 43 % (95%
CIs: 38, 51) presented at late stage. In general 45% (95% CI 36, 53) of all
sleeping sickness were undetected death (Table 3.3). This is an average of 299
cases (95% CI: 194, 389) which died unreported in the district. The model also
suggested that an average proportion of reported to unreported is 18 (95% CI:
13, 25), in other words this is to say, for every reported sleeping sickness case
an approximately 18 others went unreported in Urambo district. The results
therefore suggested that apart from the 15 cases which were reported deaths,
299 (95% CI: 194, 389) more cases went undetected and died somewhere
within the community making a total number of deaths in Urambo district to be
314 (95% CI: 209, 404). Hence the new number of reported and unreported
sleeping sickness cases totals 643 (95% CI: 538, 733).
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The interpretation of the model outputs is made bearing in mind, that the data
used to develop the model was obtained from a health facility in south east
Uganda according to Odiit (2005), health facility form which data was collected
had a better condition (well equipped with resources) as compared to other
disease endemic areas of sub Saharan African such as most of facilities in
Urambo district. The use of this model in this chapter is to provide an overview
of the possible HAT situation in Tanzania. It has been used in this chapter with
great caution with the assumption that the disease situation across eastern
Africa follows the same patterns as in Uganda.
Table 3.1 Decision tree model inputs and predicted outputs
Observed Variable
Number of early stage patients E 69
Number of late stage patients L 275
Number patients not staged N 22
Ratio E/L E/L 0.25
Total presenting P 366
Total deaths M 15
Model predictions
Probability of a late stage case presenting s* 0.56
Probability of a late stage case dying before presenting u* 0.44
Outputs
Probability of case presenting early f 0.12
Probablitiy of case presenting late (l-f)S* 0.48
Probability of case dying undetected (l-f)U* 0.38
Ratio E/L f7(l-f)S* 0.25
Probability of reporting f+(l-f)S* 0.61
Total cases T 599
Total undetected sleeping sickness deaths D 233
Number of unreported deaths per recorded death D/M 16
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Table 3.2 Summary of actual decision tree model outputs
Model output
Mean 95%CIs
Proportion presenting at early stage E = /early = 69 / (344 + D) 0.11 0.09 0.13
Proportion late stage presentation L = (1-/early)/late = 275 / (344 + D) 0.43 0.38 0.51
Proportion of undetected deaths, U = (1-/early) (l-/late) = D / (344 + D) 0.45 0.36 0.53
Proportion of undetected to detected deaths, D /M 18.00 13.00 25.00
Ratio of early to late stage, E / L 0.25 0.23 0.26
Total number of undetected deaths, D 299.00 194.00 389.00
Total number of detected and undetected deaths, D + M 314.00 209.00 404.00
Total cases 643.00 538.00 733.00
KEY: Cls = Confidence intervals
Note: All unreported sleeping sickness cases are assumed to be unreported deaths
The model also suggests that 25% (95% CI 23, 26) is the average of early to
late stage ratio. Using these ratios as well as 45% (95% CI 36, 53) which is the
proportion of undetected deaths, the estimation of the number of sleeping
sickness deaths which would have occurred in Tanzania as well as other
rhodesiense sleeping sickness in sub Saharan Africa was achieved as follows:
Between the same period of 2000 and 2004, a total of 1099 and 3168
rhodesiense sleeping sickness cases were reported from Tanzania and
worldwide respectively (WHO, 2006b). If it is assumed that these HAT cases
follow the same patterns of disease as Urambo, which is 0.25 (95% CI: 23, 26)
early to late ratio, and 45% under-reporting, then it means that 495 and 1425
HAT cases would have died in Tanzania and worldwide (sub Saharan African)




Findings from the current study suggested that levels of rhodesiense sleeping
sickness under-reporting in Urambo (Tanzania) are very high, a little bit higher
than what was observed in Uganda's study (Odiit et al., 2005). These higher
levels are likely to be the results of infrastructure in Tanzania in comparison to r
Uganda (Odiit et al., 2005), where data to develop the model was obtained.
This does not necessarily reflect the actual situation in other rhodesiense
sleeping sickness endemic areas of sub Saharan Africa.
The model works by assumptions and, it is assumed that, the 15 patients who
died in Urambo were admitted at a very late and serious state and died before
they received any kind of treatment. However, in a normal situation this is very
unlikely. There are many misdiagnoses as well as delayed diagnoses in most of
the rural health settings, but it seems unlikely that all 15 patients received no
treatment. It is possible some of them may have received treatment but still died
due to a number of factors such as drug sensitivity, severe anaemia or other
concomitant conditions. Also from the original data it was observed that 6.0%
(22 out of the 366) of cases, were not staged which makes it unclear whether
these un-staged patients did receive any kind of treatment. The treatment of
HAT entirely relies on proper stage determination. Suramin is normally used
for early stage and melasorprol for late stage for rhodesiense sleeping sickness.
The possible assumption in such a situation is that patients were diagnosed at
Kaliua health centre, but received treatment elsewhere or they received no
treatment for some unclear reasons and died in the rural areas. Presently there is
no evidence of any traditional treatment for sleeping sickness in Tanzania so
any untreated case would have died.
The model suggests that an average of 299 (95% CI: 194, 389) were undetected
deaths in Urambo district, for the period between 2000 and 2004. Several
factors are likely to be associated with such high rate of under-reporting.
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These include lack of enough health facilities with the capacity to diagnose and
treat the disease, staff shortage, long distance travelled by the sick people in
search for health facilities which can manage the disease and inadequate
awareness among endemic communities. It is also very possible that, some of
the unreported deaths may have attended some of the health facilities during
this period, probably with clinical presentation resembling sleeping sickness but
were misdiagnosed to several other vector borne diseases presenting in a similar
way. As a result they were allowed to go home without receiving proper
investigation and ultimately treatment, this allowed the disease to develop
further resulting in death. It is suspected that majority of the undetected
sleeping sickness die in the rural communities due to unavailability of facilities
to diagnose and treat the disease.
Knowledge of the disease is also an important factor which may have
contributed to high level of disease under-reporting. Some cases present in a
very obvious way, which can give a direct clue, assuming one has a basic
knowledge of the disease. In some areas, particularly where the current study
was conducted, most of the health facilities were severely understaffed, while
some are manned by nurse auxiliaries who have very limited clinical
knowledge. Also some facilities are not staffed at all (NIMR, 2004). Out of the
fourteen dispensaries visited in the study area were not staffed or lacked
equipment (not opened yet), this situation may have existed since they were
constructed more than three years back. All the three dispensaries are located in
sleeping sickness endemic villages. This may probably be one of the reasons for
the high levels of disease under-reporting in the district. It is appreciated that
the willingness to contribute towards controlling diseases among communities
exist; the only problem is that authorities had a different priority when
communities planned to build the health facilities, as it seems unlikely that
district health authority was consulted during the planning of the unstaffed
facilities . This therefore stresses the need for community involvement in health
priority setting in the rural areas (Makundi et al., 2005).
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A number of logical research questions have arisen following the findings of
this under-reporting study. It is therefore important to start considering
possibilities of conducting under-reporting studies in livestock disease endemic
areas, especially if the intention is focused towards increasing the degree of
understanding of epidemiological dynamics for African trypanosomiasis. This
will increase the capacity for early detection and treatment of neglected
zoonoses, hence proper planning and strategise the management and control of
these diseases. It has been documented that proper control measures against
human sleeping sickness should be directed towards animal reservoirs through
chemotherapy (Welburn et al., 2001a).
Outbreaks of sleeping sickness have been documented in various parts ofAfrica
(Moore and Richer, 2001; Moore et al., 1999; Smith, 1998; Van Nieuwenhove
et al., 2001) and from the estimates of the level of under-reporting; it is obvious
that many patients died in the past and will continue to die as a result of
sleeping sickness under-reporting in the rural areas of disease endemic
countries. Studies conducted in Zaire, observed the same order ofmagnitude in
mortality caused by AIDS and HAT (Ekwanzala et al., 1996) and also the
number of HAT related deaths which occurred in 1994 was at least 80 times
higher than the total number of deaths recorded during the 1995 Ebola fever
epidemic in Kikwit (CDC, 1995). Moreover HAT management is conducted in
a controlled way due to the toxicity of the drugs used. In Tanzania the drugs are
only available in the treatment centres (drugs are neither available in the drug
stores nor private clinics) and the assumption is, no treatments are conducted
outside hospital settings or treatment centres. This excludes any possibilities of
self-medication, meaning that all sleeping sickness patients who did not attend
treatments centres died, as sleeping sickness is fatal if left untreated.
In connection with the current findings, several other factors can be suggested
in association with high levels of rhodesiense HAT under-detection in
Tanzania.
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First; the majority of communities under study cannot afford to pay transport to
reach the health facilities with capacity to diagnose and treat sleeping sickness.
Most of endemic villages in Urambo are remotely located. The road
communication between these villages is very poor and as a result the majority
are not accessible throughout the year. The only reliable means of transport
connecting HAT endemic villages and the treatment centres is the train, which
is again not always reliable. In most cases there are serious delays and
sometimes trips are even cancelled without providing prior notice to travellers.
The situation therefore poses very serious challenges to these communities,
which sometimes forces them to carry their patient on a bicycle and travel very
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Infectious diseases place a considerable burden on communities and health authorities
in developing countries. The highest disease burdens, about 21.4% of global total were
estimated for sub-Saharan Africa (World Bank, 2004). The burden of deaths and
disability caused by neglected infectious diseases in developing countries also stands
very high. In sub-Saharan Africa alone, it is estimated that mortality accounts for 80%
of total disease burden. In 1990, it was estimated that out of almost 90% of the global
disease burden carried by these countries, only 10% of global health care funding was
allocated to them (Murray and Lopez, 1997a). About 15 million (>25%) of the 57
million annual deaths worldwide are estimated to be directly related to infectious
diseases (Morens et al., 2004).
Despite remarkable advances in antimicrobial therapies, infectious diseases have
claimed millions of lives as well as causing enormous pain, suffering, and disability, in
addition they have also created a constant sense of fear and panic in societies (Kombe
and Darrow, 2001). Several factors have been identified to be associated with Africa's
high disease burden. These are a lack of new tools for timely diagnosis, the long
duration of treatment schedules for most of the infectious zoonotic diseases, particularly
human African trypanosomiasis (Moore, 2005), physical ecology which favours habitats
of most vectors, poor nutritional status resulting from low agricultural productivity and
excessive poverty which leads to lack of good quality medical access and finally
inadequate disease knowledge which leads to the low awareness of disease situations,
particularly in rural areas where high impact of disease burden is often observed.
The emergence and re-emergence of infectious disease has been one of the biggest
challenges to scientists in developing strategies for sustainable control measures. Close
collaboration, comprising medical as well as veterinary experts is crucial in designing
strategies for the control of these diseases, bearing in mind the current existence of wide
range of zoonotic infectious diseases (Morse, 1995).
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Available evidence suggests that around 61% of the 1,415 species of human pathogenic
organisms and 60.3% emerging infectious diseases (Hendrickx el al., 2001) are zoonotic
(Cleaveland et al., 2000; Cleaveland et al., 2002; Jones et al., 2008).
Moreover the majority of the emerging infectious diseases 71.8% originate from
wildlife (Jones et al., 2008). The biggest number of these zoonotic infections as well as
other infectious diseases exist in Africa, particularly in sub-Saharan Africa; this justifies
the reason leading to prioritization of Africa for future investment (WHO, 2002a).
Human African trypanosomiasis or sleeping sickness which is amongst the most
neglected diseases, and one of the prominent zoonotic diseases has also remerged
recently. The current resurgence has been reported in several countries of sub Saharan
Africa the most recent ones being Uganda (Ochan, 2004; Smith, 1998), in Tambura
county in Sudan (Moore and Richer, 2001), in Tanzania (Kaare et al., 2007; Kibona
2001), and in the Democratic Republic of Congo (Van Nieuwenhove et al., 2001).
About two decades ago there were no reliable epidemiological data-set to support
proper identification of priorities for health services and research. However, many
countries still maintained reliable information on the traditional vital registration
systems to provide data on the number of deaths by cause and the sex, and age of the
victims. The Global Burden of Disease project (GBD), a worldwide collaboration of
over 100 researchers, sponsored by WHO and the World Bank published its findings in
1993. The widely publicized GBD which is probably a better option presented a bold,
new analysis, providing the first quantitative description of the world's health. This
study used a new metric tool - disability -adjusted-life-years (DALYs) - to quantify
the burden of diseases, injuries and risk factors with a single currency based on years of
life lost due to premature mortality (YLL) and years lived in less than full health (YLD)
(Lopez, 2001).
DALYs were developed as the unit measurement to quantify the burden imposed by
disease and injury on human population for the GBD study (Murray, 1994). It is a
generic health gap measure, which combines information about both morbidity and
mortality in numbers of healthy years lost. It is a standardized objective normally used
in public health as an important measure for different disease conditions.
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The morbidity component accounts for the degree and time of morbidity suffered by
patients with a particular health condition, whereas the mortality component accounts
for loss of life years at different ages due to a particular health condition in a population.
In the DALY approach, a panel of experts assigned a disability weighting to each state
of health on a scale from zero which stands for perfect health to one which stands for
death (Murray and Lopez, 1996a). In order to be able to calculate burden of a certain
disease in a population, the disability weighting is multiplied by the number of years
lived in that health state added to the number of years lost due to that disease. The result
of this, makes years of life in childhood and old age count less in burden estimations, a
discount rate of 3% per year and value of life time is weighted.
The public health burden imposed by HAT was estimated to be 1.5 million DALYs in
2002 (WHO, 2004). The disease is placed 2nd and 4th amongst the most important
vector-borne diseases in Africa in terms of mortality and DALYs respectively. "The
global figure for the burden for sleeping sickness, calculated using a conservative
estimate of 50,000 cases per year, is 1.78 million DALYs per year (Murray, 1994).
Although small in comparison with the DALYs for the two leading infectious diseases
tuberculosis (38.4 million DALYs) and malaria (31.7 DALYs), this is significantly
greater than for other vector-borne disease such as onchocerciasis (0.88 million (WHO,
2002b) DALYs) and dengue fever (0.75 million DALYs), and is comparable with the
burden due to leishmaniasis (2.06 million DALYs), despite there being some 350
million people at risk to leishmaniasis in 88 countries. The most recent global figures
estimate that there were 2.0 million DALYs lost due to HAT (WHO, 2002b). And also
it was estimated that HAT is responsible for 48,000 deaths (WHO, 2004). In addition,
the HAT figure is largely based on the T. b. gambiense form of the disease. T. b.
rhodesiense is more acute and may therefore impose a greater morbidity than T. b.
gambiense; this has been observed in similar studies conducted in Uganda and DRC.
Findings of these studies, discourage the use of global figures in priority setting at the
local level (Kapiriri and Norheim, 2002; Kapiriri et al., 2003; Lutumba et al., 2007)
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The burden imposed to communities by HAT has been estimated; the findings from
these studies which were conducted at different administrative levels suggested that
such estimates are very important for proper resource allocation. A study conducted at
the village level in Buma DRC suggested that, without intervention gambiense HAT
was responsible for 2,145 DALYs. The intervention carried out by the control
programme averted 1,408 DALYs at the cost of US$ 17 per DALY averted (Lutumba et
al., 2007).
In Uganda a study conducted at the district level in Soroti shows that, DALYs lost due
to HAT in the district between 1999 and 2005 were estimated at 1405 and 1136 with
and without age weighting respectively (Fevre et al., 2008). When 69% under-reporting
was incorporated the mean annual DALY burden were 1157 and 86 with and without
age weighting (Fevre et al., 2008).
4.1.1 Burden of Neglected Tropical Diseases in the HIV Era
It is known that Acquired Immune Deficiency Syndrome (AIDS) has already
significantly increased mortality in many countries, particularly in sub Saharan Africa,
and the impact of AIDS upon mortality has grown substantially over the past two
decades. Understanding the significance of AIDS in the burden of disease estimation is
important particularly in the countries of sub Saharan Africa where more severe AIDS
epidemics have occurred. AIDS contributes significantly in reducing the life expectancy
of communities living in most of the severely affected countries. The World Bank
estimates that because of the AIDS epidemic, life expectancy by 2010 will revert to 47
years instead of the projected 56 years in the absence of AIDS. Besides, communities
living in severely affected areas suffer a number of several neglected disease. Hence
studying the association between the burden of neglected tropical infections .'and
eventually the impact of HIV/AIDS on these diseases to affected communities is
essential for daily planning and monitoring trends locally, nationally as well as
internationally. Recent research findings observed that diseases that were once rare such
as Cryptococcus are now increasing, and HIV-associated diseases are the main cause of
bed occupancy in hospitals and deaths in many African countries, with most morbidity
and mortality caused by preventable tropical infectious diseases (Corbett et al., 2002).
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A large number of clinical observations have indicated that the presence of concurrent
infections-sometimes preceding, and often following the HIV infection, and
concomitantly, HIV infection may alter the course and manifestations of other
infections (Bentwich et al., 2000). However, research conducted so far suggests that
there is no direct increased risk of gambiense sleeping sickness among HIV infected
patients (Louis et al., 1991; Pepin et al., 1992).
There is significant geographical overlap between HIV, sleeping sickness as well as
many other neglected infectious diseases in HAT endemic countries in SSA, meaning
that even a very small interaction could lead to a substantial impact to affected
communities. Available documentation suggests that a combination of HIV and
Tuberculosis or HIV and any other neglected tropical diseases impose a double burden
to communities particularly in low income countries (Hotez et al., 2006; Msamanga and
Fawzi, 1997). However, in most cases the burden imposed by a less common disease
tends to be ignored or overlooked. There exist large uncertainties about the course of
mortality between high and low income countries particularly sub-Saharan Africa
ranging from high income 1% to low income 15-20%. Available evidence shows that
sub Saharan Africa is severely burdened by the HIV epidemic, and in connection with
this, the impact and the burden imposed to rural household is very significant
(Kwaramba, 1998). Moreover the disease tends to affect the household workforce
during their best economic productive years, when they are responsible for the highly
needed support and expected to provide care to others (Quinn, 1996). HIV infection
significantly increases the level of poverty, and as a consequence contributes to
increasing the burden of other concomitant diseases to most of the affected
communities. Furthermore AIDS deaths are always preceded by a prolonged period of
illness and suffering, which gives majority of the sick person sufficient time to utilize
available resources on medical care and to move to a preferred place of dying (Urassa et
al., 2001). Despite the fact that sub Saharan African countries contain only 10% of
world's population, it was estimated that by June 1994, there were 14 million people
living with HIV infection (WHO, 1994). AIDS causes a very high burden in terms of
DALYs, which were estimated at 14.7 million (World Bank, 1993).
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In many developing countries, a significant proportion of deaths may occur in
communities without any medical attention, sometimes deaths may be registered
without even a medical opinion about the possible cause of death (Mathers et al., 2005).
There is also enough evidence that there is a very strong negative association between
adult HIV prevalence and life expectancy (McGuire et al., 2005), meaning that HIV
infection significantly decreases life expectancy especially in resource poor countries.
Neglected tropical diseases account for 57 million disability adjusted life years lost
annually in sub Saharan Africa alone, and it is estimated that more than 500 million
people are infected by HIV. The burden imposed by these diseases crosses over and
affects childhood education as well as economic development, as a result they promote
poverty (Hotez et al., 2006). In both developing and developed countries, legal, societal
or other reasons may lead to the under-reporting of causes of a sensitive nature, such as
suicide or HIV/AIDS (King, 1989; Klatt and Noguchi, 1988). Furthermore, the selection
of a single underlying cause of death is frequently problematic particularly in elderly
people, who often present with several chronic illnesses that concurrently lead to death.
Treatment of HAT is determined by the type and stage of the disease. Unlike many
other infectious diseases which are easily treatable; sleeping sickness is 100% fatal if
left untreated. Besides, the only few drugs which are currently available for treating the
disease are expensive, contain arsenic and anti-freeze compounds, and were developed
more than 70 years ago. Most of the drugs are administered parenterally, some of them
are extremely painful when injected, require hospitalization during administration and
often ends up with very severe adverse effects (WHO, 1998). Furthermore the patients
who do survive the side-effects of treatment, there is still no guarantee of complete cure,
as the drug fails in 25-30% of cases in some areas (Hutin et al., 2004).
The United Republic of Tanzania has the misfortune to have not only a number' of
several active foci for rhodesiense sleeping sickness but also a number of other
neglected tropical diseases and zoonoses. In addition, both forms of sleeping sickness
are believed to have existed in country on different occasions, the last case of
gambiense sleeping sickness being documented in 1958 (Fairbairn, 1948; Ormerod,
1961).
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Over the recent years, the burden of the disease in the country has been compounded by
a number of issues including an increased influx of refugees and unstable weather,
which forces farmers and big livestock keepers to migrate from place to place in search
of suitable environments for agriculture as well as favorable feeds for their herds.
Indeed sleeping sickness is a disease of major socio-economic and public health
concerns to the majority of rural communities, with over four million people at risk.
Endemicity has been reported in 10 regions of mainland Tanzania and between 1996
and 2006 more than 2748 cases were reported, with over 95% of these figures, recorded
from only three regions of the western part of the country. In light of these facts, there
is an urgent and obvious need to prioritize the little available resources in health
interventions by employing the objective measure of the burden of neglected disease.
Hence, an accurate estimate of the burden ofHAT for Tanzania is urgently required, so
as to fill the existing gaps and provide updated information to relevant authorities there
by contributing towards the design of sustainable cost-effective control interventions.
4.2. Material and Methods
4.2.1 Study area and population
The study area was Urambo District, Tabora, Tanzania (Figure 4.1). The district is
situated in the western part of the country between latitude 4° 00" - 5° 53"S and
longitude 30° 00' - 32° 37" E. It occupies 25,995 square Km with a population of
369,329 (National Bureau of Statistics, 2002).
Chapter 4 93
Figure 4.1 Map of Tanzania showing the location of Urambo district.
The predominant ethnic groups are mainly Nyamwezi and a few Fipa and Sukumas.
Kinyamwezi is the most widely spoken language although Swahili, the national
language, is also used. The main activities for the population are subsistence farnjing
and livestock keeping. The main crops are tobacco, rice and maize. The district borders
Mpanda district to the south and Kigoma rural and Kasulu districts which are also
known to harbour a high number of sleeping sickness cases in recent years.
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4.2.2. Data Collection
Between 2000 and 2007 only five districts in the western part of Tanzania reported
sleeping sickness cases. Urambo District was purposefully selected out of the five
districts, others being Kigoma rural, Kasulu, Kibondo and Mpanda, because of having
the highest number of cases, and also due to the difficulties encountered in tracking
sleeping sickness records in other districts. All patients recorded in Urambo district
were diagnosed and treated in Kaliua Health Centre, a missionary health facility which
was selected by the sleeping sickness coordinating centre in Tanzania, to manage
sleeping sickness cases due to the fact that it is located in the disease catchment area,
easily accessible and has proper record keeping. Relevant patient information was
collected from hospital registers, for all cases diagnosed and treated in Kaliua from
January 2000 to December 2007. All patient records were categorized by sex, age
groups, stage of the disease, dates of admission and discharge, initial and final
diagnosis; treatment provided which was done with the intention of confirming the stage
of the disease, duration of hospitalization and finally the outcome of the disease. For
comparison reasons, records for other diseases such as in-patient malaria, acute
respiratory infections (pneumonia) and injuries were also obtained from the same
registers. It was difficult to obtain stage of the disease for 22 patients diagnosed at
Kaliua as the stage was not recorded in patients register and also patient case notes were
not available, which would have assisted in determining the stage of the disease based
on type of treatment provided. All un-staged patients recovered and were discharged
from the hospital, therefore using the conservative measure that there are less non drug
related complications and also no increased non drug related mortality in the early stage
of the disease all the 22 patients were assumed to be early stage.
4.2.3. Data Analysis
All data were entered in Microsoft ®Excel 2003 and summarized. Population,
incidences and number of deaths were summarized in age groups as follows: <1 year,
1-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44. 45-49, 50-54, 55-59, 60-64,
65-69, 70-74, 75-79 and 80+ years. All summarized data were entered in special
spreadsheet obtained from WHO website: http://www. who.int/evidence/.
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These were modified and fitted in stochastic model using the methods detailed in Fevre
et al. (Fevre et al., 2008) in order to allow capture both uncertainty and annual
variability in the current estimates. Life expectancy data were obtained from the life
tables' specific for African standards specific for Tanzania, also obtained from WHO
website. All YLL, YLD and DALYs analysis were conducted in @ Risk software
package (Palisade, Newfield, NY, USA version 5.0);
To achieve the burden of HAT calculation for Tanzania, established methods(Murray,
1994), as well as methods used in previous rhodesiense HAT estimations in Serere,
Uganda (Fevre et al., 2008; Odiit, 2005), were adopted and followed. To allow capture
uncertainty in the current estimates, one calendar year was chosen from variability in
the data obtained from 2000 to 2007.
4.2.4. Disability Adjusted Life Years (DALYs) for Rhodesiense
HAT
Generally, total DALYs score for each cause-age-sex group are calculated as the sum of
non-fatal burden (YLD) and the burden of premature mortality (YLL):
DALY = YLD + YLL
In order to be able to calculate a DALYs score due to rhodesiense sleeping sickness in
Urambo, Tanzania, the methods used in the first Global Burden of Disease Study
(Murray and Lopez, 1996a) as well as World Health Report (WHO, 2000) were
followed. A discount rate of 3% was applied with and without age-weighting. During
the DALY estimations due to sleeping sickness features such as patient's demographic
data such as age and sex, severity of illness, case fatality rate, age-specific production
losses and duration of disability were considered. Between 2000 and 2007, highest cases
of sleeping sickness were recorded in 2004.
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The population data used in the current calculations was also adjusted so as to match
2004. These were extrapolated from 2002 Tanzania population and housing census
(National Bureau of Statistics, 2002) using the formula:
Pn = Pe(l +r/100)n
where Pn = population at time n
P0 = initial population
r = population growth rate







To achieve the calculations a stochastic model that captures uncertainty and annual
variability as described in a previous documented study (Fevre et al., 2008) was adopted
and followed. 10000 Monte-Carlo simulations were run, the model was constructed in
such a way that random sample of input values was consistently chosen for the same
year data at each iteration. All output data were given in means and 95% confidence
intervals.
4.2.5. Years of Life Lost (YLL)
To calculate YLL for Urambo, Global Burden of Disease recommendations were
followed. Hence the used number of death were categorized in age groups as follows 0-
4, 5-9, 10-14, 15-29, 30-44, 45-59, 60-69, 70-79, 80-85 and 85+.
The formula for calculating YLL using 3% discounting and uniform age weighting as
given (Murray and Lopez, 1996b) is:
YLL = N/0.03 (1-e '003L)
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In the current study the formula was not used instead standard life expectancies were
used. All information required to achieve the calculation are detailed in Table 4.1. Total
number of both reported deaths and estimated under-reports for Tanzania (Chapter 3) of
this thesis based on the rate of 0% or no under-reporting and 45% under-reporting
parameters.
Table 4.1 Information required for the estimation of disability adjusted life years
(DALYs) score for rhodesiense sleeping sickness.
Information trype Type of data required Source of data used
Years of life lost (YLL) 1) Number of deaths Health facility records of case fatality and also number of under-reporting estimates
obtained from chapter three of this thesis, all these data were caytegorized by age and sex
2) Life expectancy Life tables obtained from WHO website, based on African standard life tables specific for Tanzania
for the year 2004, with life expectancy at birth of 48.0 years (WHO, 200) which was assumed to be
representative for the population of Urambo district for the year 2004.
3) Distribution of deaths Health facility records, summarized for each age group (with and without age weighted case fatality
at birth rate and under-reporting rate).
Years of life lived with 1) Number of cases Health facility records and total number of unde-reporting estimated using methods detailed in
disability (YLD) chapter three.
2) Disability weighting from rhodesiense sleeping sickness records as per Murray (1994) methods and also using
expert opinion as detained methods in Fevre et al (2008).
3) Duration of illness health facility records excluding post treatment duration
4) Age weighting health facility records at different age groups
of productivity
4.2.6. Years Lost due to Disability (YLD).
YLD are the disability component ofDALYs. The basic formula for YLD is:
YLD = I X DW X L
Where I is the number of incident cases in the reference period, DW is the disability
weight (in the range 0-1) and L is the average duration of disability (measured in years).
According to WHO reports clinically, T. b. rhodesiense is a more severe form of the
disease than T. b. gambiense (WHO, 1998). Until recently a disability weighting 0.35
has been used in the burden ofHAT estimation (Murray and Lopez, 1996a).
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Recent burden of rhodesiense HAT estimates (Fevre et al., 2008) recommends to use a
disability weighting of 0.21 for early stage which is equivalent to malaria episode and
0.81 recommended by Murray (1994) for the late stage rhodesiense HAT as well as 0.35
in the final output so as to allow comparison.
4.2.7 Estimating Disability Adjusted Life Years in the absence of AIDS
It is known that the HIV epidemic decreased life expectancy significantly in countries
of sub-Saharan Africa.
Life expectancy has a significant contribution in DALYs estimation. If it is assumed
that HIV did not occur, then burden due to most of the diseases would have probably
been different from what is observed today. In an attempt to compare this, it was
decided to recalculate DALYs using assumption that HIV epidemic did not occur.
Therefore life expectancy for the year 1990 was used for the component of estimations
when HIV infection was not very severe and the results are shown in the results section.
4.2.7. Comparing relative burden of HAT and other common
conditions admitted at Kaliua Health Centre
During the period between 2000 and 2007 malaria was the commonest diagnosed
infection at Kaliua. However, since the highest HAT cases were recorded in 2004,
relative impact of other common conditions admitted at Kaliua health centre for the year
2004 were looked at. Hence in-patient malaria, pneumonias and injuries diagnosed at
Kaliua health centre in 2004 were obtained, however, in 2004 several causes of injuries
were recorded at Kaliua such as burns, animal traumas, particularly attacks by lions,
fractures of different bones of the body as well as head injuries of various severity
caused by bicycle accidents and fall from trees, stab wounds and snake bites. Due to the
fact that very few deaths due to injuries were recorded at the facility and also because
all the cause of injuries have different disability weighting, DALYs estimates due to
injuries were not estimated in the current study.
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However, age distribution of all sleeping sickness, malaria, pneumonias and injuries
recorded at Kaliua health centre were calculated and compared with the age-
productivity function curve (Murray, 1994), which shows the contribution of different
age groups in the society and it regards children and elderly to be less productive.
Table 4.2 Definition of disability weighting (Murray, 1994 #43)
Class Description weight
1 Limited ability to perform at least one activity in one of the following
areas; recreation,education,procreation or occupation
0.096
2. Limited ability to perform most activities in one of the following
areas; recreation education procreation or occupation
0.220
3. Limited ability to perform activities in two of the following
recreation education .procreation or occupation
0.400
4. Limited ability to perform most activities in all of the following areas;
meal preparation,shopping or housework.
0.600
5. Needs assistance with instrumental activities of daily living
such as meal preparation,shopping and housework.
0.810 \
6. Needs assistance with activities of daily living such as eating,
personal hygiene ■ or toilet use.
0.920
4.2.8 Estimating the Direct Costs of Hospitalization at the Health
Facility
The costs to the health system per sleeping sickness patient were estimated as the
product mean hospital stay in days multiplied by a standard daily cost for hospital
services. Mean hospital stay for every individual patients was calculated as the. total
hospital stay due to sleeping sickness divided by the number of parasitologic'ally
confirmed sleeping sickness cases at Kaliua health centre for 2004.
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Based at local health facility level, a standard cost per hospital day in 2004 was
estimated in terms of admission costs and initial basic laboratory investigation collected
on admission to Kaliua health centre. Kaliua Health Centre being a Missionary hospital,
patients are only charged a nominal amount of Tanzanian Shillings (Tshs) 1000
(approximately 1US$), per every patient per night bed occupancy, plus a one off
payment of Tshs 500 (approximately 0.5 US$) for basic laboratory investigation on
admission, the charges for all other services such as any extra laboratory investigation
and treatment incurred by individual patient depending on the diagnosis and severity of
condition were not included in this study.
Therefore the total costs of hospital admission and one off payment for laboratory
investigations for all 143 sleeping sickness patients were estimated in order to obtain
total costs of hospitalization. If it is assumed that the drugs to treat sleeping sickness
were sold then, then the costs for the 30 early and 113 late stage cases were estimated
and added to the costs using the rate estimated by WHO (WHO estimate cost of
treatment to be US$ 35 for early and US$ 63 for late stage). All drugs used to treat HAT
cases are provided free of charge by WHO. Ministry of Health and Social Welfare,
Tanzania is responsible for ensuring smooth availability of these drugs to all treatment
centres.
All other additional charges were difficult to quantify and were regarded as extra costs
and were not taken into consideration, so were excluded from the current estimates as
they differ according to every individual presentation. These costs include; drugs to
treat all individual presentation such as fever, anaemias, pains, adverse drug events and
all concomitant conditions. However, transport to and from the hospital, living costs
during stay in hospital and expenses to cover living expenses for one accompanying
person in hospital are regarded as indirect costs and are estimated in section 4.2.9. All
sleeping sickness patients require assistance with instrumental activities of daily living
such as meal preparation, shopping and housework. Total hospital stay for malaria,
pneumonias, and injuries was also calculated and multiplied by standard cost for
treating every individual condition. Comparisons were made to relative hospital costs of
sleeping sickness cases to all the other conditions mentioned above, for which patients




4.2.9 Estimating the Burden of Rhodesiense HAT in Urambo inTerms of
Indirect Cost to the Health System
Indirect costs in the current study were estimated in terms of transport and costs
incurred by each patient during the duration of hospital stay. Costs incurred for drugs to
treat other concomitant condition and additional charges were not included in this study,
Data used for this part of study were collected from relatives of the patients who were
admitted at Kaliua health centre during the course of the study and also patients who
recovered from sleeping sickness who were visited in their homes during the case-
control study which occupies the next chapter of this thesis.
Travel costs were estimated using rails costs which were assumed to be reasonable
considering the fact that roads in disease endemic villages are impassable during rain
season so the only reliable means of transport is through railway and all sleeping
sickness villages were accessible by train.
Villages for all the 143 patients, who were admitted at Kaliua health centre for the year
2004, were obtained from the hospital register. Standard travel costs were estimated
based on the information provided by some of the patients and relatives who reported
that they travelled in the third class train. 143 patients spent a total of Tshs 479,500.00
(approximately 479.5 US$) on transport form their home village to Kaliua health centre.
This is equivalent to 3353.15 Tshs per patient on a single trip to Kaliua. Sleeping
sickness patients require assistance with food preparation and personal care, meaning all
patients required one accompanying adult person (over 18 years) for the entire period
they stayed in hospital. One accompanying person required an estimation of Tshs 600
per day to buy food for their patient from a local restaurant, it was estimated to cost
around 100 Tshs less if food products were purchased from the local market and cooked
for their patients, but this requires to have a relative or friend living near hospital where
the food would be prepared, since most of the patients came from villages located far
from Kaliua it was decided to estimate using modest costs of ordering food from a
nearby restaurant. This was estimated at approximately 0.6 US$ per person per day. If
it is assumed that the accompanying person spent the same amount per day on meal$.
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The living costs for one accompanying person were estimated at the rate Tshs 500 per
room per night spent in at a local guest house which was approximately US$ 0.5. It was
estimated that the accompanying person spent almost the same amount as the patient on
food. Other costs such as the costs spent on general care of patient were not included in
these estimates as they vary from patient to patient.
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4.3 Results
Between 2000 to 2007, a total of 521 sleeping sickness cases were diagnosed and
treated at Kaliua health centre as follows; 29 patients were diagnosed in 2000, 38 cases
in 2001, 58 cases in 2002, 98 cases in 2003, 143 cases in 2004, 83 in 2005, 33 in 2006
and 39 cases in 2007. Highest cases of HAT were observed in 2004. Other conditions
diagnosed at Kaliua for the year 2004 are shown in Figure 4.3
Figure 4.2 Number of health condition recorded at Kaliua health centre form January














S.Sickness Malaria Injuries Pneumonia
Disease
4.3.1. Disability Adjusted Life Years (DALYs) score due to
Rhodesiense sleeping sickness
The overall DALYs burden due to rhodesiense HAT in Urambo as stated in the
methodology above comprises a combination (sum) of all YLLs and YLDs estimated
from the model using annual age specific data for both detected and estimated (at 0.45
(95% CI : 0.36-0.53) undetected deaths, and non age weighted discounted YLL (DYLL)
are shown in Table 4.4 below. The model detected that, apart from seven deaths which
were detected at Kaliua 64 (52 - 77) more cases were undetected, therefore are assumed
to be unreported deaths. That is to say that for every reported death at Urambo nine
more cases went unreported and died in the community.
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The model also estimated that premature mortality due sleeping sickness was
responsible for 190.1 (95% CI: 17.5 - 250.0) years of life if it is assumed that all cases
were reported. When 45% under-reporting with age weighting and without age
weighting are taken into account then sleeping sickness was responsible for 1030.5
(95% CI: 201.9-1747.3) and 610.8 (95% CI: 17.5-938.4) DALYs respectively. Table 4.4
below shows the results of years of life lost for each age group. The model also
estimated that rhodesiense sleeping sickness was responsible for 22 (95% CI: 0-63.8)
years of life lost as a result of disability in Urambo district, when no age weighting and
no under-reporting was applied. When age weighting was added then the result
increases to 25.5 (95% CI: 0-67.4) YLDs. A full list of age specific years lived with
disability in Urambo district is shown in Table 4.5 below.
From the above YLL and YLD results if it is assumed that all sleeping sickness cases
were reported and no age weighting was applied then the DALYs score for Urambo was
215.7(95% CI: 155.3 - 287.5), when age weighting is applied the result increased to
281.8 (95% CI: 209.1-362.6). If 45% under-reporting and no age weighting was applied
then the result was 622.5 (95% CI: 155.3 -1095.9), however, when 45% under-reporting
and age weighting is applied the DALYs score was 978.9 (95% CI: 201.9-1870.8). Age
specific DALYs scores are detailed in Table 4.6 below. If disability weight of 0.35 as
per Murray et al (1996) then the DALYs score was 573.5 (95% CI: 147.5-1002.1)
If it is assumed that DALYs were estimated in the absence of AIDS pandemic then
DALYs score with no under-reporting would have been 205.1 (95% CI: 147.5 - 273),
however, when 45% under-reporting with no age weighting was applied, then the
DALYs would have increased significantly to 585.7 (95% CI: 17.5 - 1029.8) and 761.6
(209.3- 1325.3) when age weighted respectively.
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Table4.5:



























































































































































4.3.5. Total Costs of Hospitalization for Sleeping Sickness
Between January and December 2004, 143 rhodesiense sleeping sickness cases were
parasitologically confirmed at Kaliua health centre, out of them 30 cases were early
while the other 113 were late stage sleeping sickness cases. These patients stayed in
hospital for a total of 3601 days, resulting in mean hospital stay per patient of 25
days. The costs of hospital stay estimated for all 143 patients at the rate of Tshs 1000
(1US$) per patient per night and one off payment of Tshs 500 (0.5 US$) on
admission were estimated at Tshs 3,672,500.00 (approximately US$ 3672.5). If it is
assumed that the costs of drugs were incurred by the patients, then 30 early stage and
113 late stage patients would have paid US$ 1050 and 7119 respectively making a
total of 11,841.5 US$.
4.3.6. Indirect costs incurred sleeping sickness during stay in
hospital
Apart from the costs incurred by every individual patient on admission costs, each
patient required an additional of 63.4 US$ which were indirect costs to cover their
travel costs, meals and accommodation for one accompanying person during their 25
day stay in hospital. Other costs such as costs incurred by health providers were not
estimated in this study since Kaliua is a missionary hospital and most of the care
providers are based on voluntary basis. Table 4.7 shows the indirect costs as
estimated for each individual patient and total cases ofHAT at Kaliua.
Table 4.7 Indirect cost incurred by sleeping sickness cases in health system
estimated in US$.
Patient costs Acompanying person costs Total costs
travel meal travel meal accomodation
Costs single case 6.7 12.5 6.7 12.5 25 63.4
Total costs all cases 958.1 1787.5 958.1 1787.5 3575 9066.2
110
4.3.7. Relative burden of HAT compared to other diseases
In all, 449 cases of malaria, 111 cases of pneumonia, 47 cases of injuries and 143
cases of sleeping sickness were diagnosed and treated at Kaliua health centre. To
compare relative impact of the four diseases, the age distribution of sleeping
sickness, malaria, pneumonia and injuries admitted at Kaliua between January -and
December 2004 were calculated and compared with the age-productivity function
curve ofMurray (Murray, 1994)
Figure 4.3 Graph showing age distribution of the four diseases compared to age-
productivity function curve
4.4. Discussion
Findings from the current study confirmed that the re-emergence of HAT in Urambo
district continues to impose a very heavy burden to health care systems as well as
Chapter 4 111
communities affected by the disease. This study utilized datasets from hospital
records combined with estimates of rhodesiense sleeping sickness under-reporting in
Urambo (Chapter III) which allowed an overview of populations living in rural
communities to be captured. Rhodesiense HAT is severely neglected zoonotic
disease, which does not appear among the top priority diseases in any of the disease
endemic districts of Tanzania. This study has demonstrated how local burden can be
important in prioritization of resource allocation. Existing GBD estimates for sub
Saharan Africa are based on a regional model that utilized vital registration data from
South Africa (Mathers et al, 2000) and cannot account for any local situations.
Previous burden of disease studies conducted in Tanzania estimated that, Tanzania
loses 10 million years of life annually through illness and death. This amounts to four
months life lost per year for every man, woman and child in the country as estimated
by the Tanzanian Ministry of Health (Ministry of Health, 2001). These studies also
suggested that people often seek health services from more than one source,
including local drug stores and sometimes traditional healers. Apparently it was
observed that about 20% of the communities along the coast used no health services
at all, this is a very interesting finding as communities living along the coast may. be
considered to have a higher level of awareness on health matters and also a better
health services as compared to most of the rural communities in remote areas of
Tanzania.
The current study suggested a very similar situation, as most ofHAT cases presented
to health facilities in late stage of the disease is probably the patients that spent most
of their time seeking health support from alternative sources of health service
providers, after failing to recover they decided to seek medical attention. To date,
however, there is no evidence of any traditional medication used for the treatment of
HAT, and also it is known that drugs used for the treatment of HAT are no longer
being manufactured for commercial purposes, indicating that HAT drugs are not
available in any of the drugs stores.
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Findings from the current study confirmed that significantly high levels of burden are
imposed on local communities are largely attributed to the HIV pandemic which
severely affected most of the sub Saharan African countries. The findings suggest
that ifHIV/AIDS did not occur in Tanzania the burden due to HAT would have been
averted by a margin of about 200 DALYs, which is a very significant figure.
The study also confirmed that communities incur very high costs to maintain their
patients in the health systems. All villages from which HAT patients arise are located
very far from the treatment centre. Considering the fact that HAT requires assistance
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with instrumental assistance such as food preparation (Murray, 1994) communities
with HAT patients incur enormous costs to maintain them in hospital for prolonged
duration. It's also important to note that these communities are poor and have a
number of other priority health conditions to attend, including a number of other
infectious diseases affecting the same families. Considering all these facts it's
unlikely that these people will afford such enormous costs without any stable source
of income. The majority of families in these communities live below the poverty line,
studies conducted in other districts suggest that 26% of rural communities subside on
less than 1 US$ per day during 1990-1996 (UNICEF, 1999). Besides, Tanzania has
one of the lowest gross national income (GNI) per capita of sub Saharan African
countries, estimated at US$ 340 (World Bank, 2006). For rural communities to spend
such huge amount ofmoney in a single patient is obviously a serious burden.
Although this is the first attempt to estimate the burden of diseases due to
rhodesiense sleeping sickness in Tanzania and the second for East Africa. Burden of
other several neglected diseases and zoonoses have been estimated including' the
burden of rabies (Knobel et al., 2005) and the burden of brucellosis (Kunda, 2006),
the results of which show the similar high levels of burden imposed to health systems
as well as communities.
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The observation from this study shows evidence, that disease burden for individual
conditions and using the local settings data which does not require much resources
rather than generalizing using estimates from other areas, which in most cases may
not reflect the actual situation in the affected communities. A good example of such
generalization is the use of GBD estimates which were estimated using extrapolation
of only 1% of South Africa data (Murray and Lopez, 1997b), which apart from not
been reflective, the does not comply with the actual disease situation and mortality in
other sub Saharan countries.
One of the major control challenges for HAT is the resurgence of the disease, which
has been observed in many countries of sub Saharan Africa.
Some of the recent example of these resurgences have been reported in several
countries (Kaare et al., 2007; Kibona 2001; Moore and Richer, 2001; Van
Nieuwenhove et al., 2001) and there have also been reports of the occurrence of new
foci of the disease in many areas of sub-Saharan Africa including Uganda and
Tanzania (Enyaru et al., 1999; Kibona et al., 2002). There is lack of adequate
knowledge regarding disease transmission and prevention among affected
communities as well as policy makers (Fevre et al., 2006b). There is also a lack of
sufficient resources to sustain regular surveillance activities. This confirms the need
for good burden of disease estimation in such communities, as it will allow proper
allocation of the few available resources.
In the current study it was observed that some patients with health conditions such as
pneumonia, stayed in hospital for a very short duration of time, the shortest recorded
duration being two days; given the severity of the condition it is unlikely that these
patients had recovered completely at the time of discharge. Two possibilities are
suggested for the early discharge; one is that relatives may have requested early
discharge due to financial difficulties meaning they could not afford to pay for a
longer hospitalization. Second possibility is that they were misdiagnosed for
pneumonia; probably they simply had upper respiratory tract infections. Tanzania
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Burden of Disease Profile 2001 clearly stated that despite Health reforms in
Tanzania, expecting the districts to move from managing diseases to managing
health systems from a prospective of equity, the poor societies carry the heaviest
burden of diseases. It is therefore difficult for any health system to target the poor
accurately. However, it is possible to target the major component of the burden of
disease (Grebaut et al., 2004) and thus increase equity in resource allocation with
more emphasis on the rural poor. For districts, this means a greater focus on cost
effective interventions that address the largest shares of disease burden.
This study demonstrated that HAT imposes a very high burden on rural communities
as compared to many other health conditions; this therefore stresses the need to
advocate for conduction of disease specific studies particularly in rural settings.
Previous documentation suggests that most of the rural population suffers combined
burden of diseases (Msamanga and Fawzi, 1997), as most of the socio-economic
activities carried at the rural household level do not provide enough resource to cover
health care services. Household studies conducted in Kenya and DRC have
confirmed that household incomes are very limited and the cost of treatment are
considered high, this can compromise the timely receipt of medical care, early
diagnosis for sleeping sickness for effective treatment so as to avoid unwanted
complications. It has been observed elsewhere that patients take a very long time to
prepare for health care services and in most cases the preparations depend on the
solidarity of the family members or even communities (Lutumba et al., 2007).
The costs of managing sleeping sickness cases are very high and it is unlikely that
the local communities in poor rural areas of sub-Saharan African countries will
afford without support from their respective governments. This is in the context of
other important priorities and serious health constrains they have to attend to. It has
been observed that household members take time to prepare themselves and mobilize
resourses, relying on solidarity of the extended family, before they seek treatment for
HAT (Lutumba et al., 2007; Odiit et al., 2005)
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In DRC it was observed that despite acceptability of screening activity in most
places, the introduction of a 'symbolic' card fee was cited to be a major obstacle for
the whole exercise (Robays et al., 2007), and for bigger and extended families may
add one or two times a household income.
The situation may be even worse in Tanzania considering presence of a large
numbers of refugee influxes from gambiense sleeping sickness endemic areas based
in camps in the western part of the country, which pose a serious risk of introducing
different species of the disease into the country. The complexity of civil instability
and control of the disease have been well described in Uganda (Picozzi et al., 2005).
The Tanzanian study also observed that that there are enormous high indirect factors
attributed to this burden, such as post treatment expenses, long distance travelled by
sleeping sickness patients in search for health facilities. In most cases the
neighbouring health facilities may have no capacity to diagnose and treat sleeping
sickness (Malele et al., 2006).
It is therefore important to always incorporate the aspect of indirect expenses in
burden of disease studies. It always takes HAT patients several weeks to recover
fully and resume their daily productive activities.
4.5. Conclusions
Being one of the most neglected diseases, in most cases HAT is not considered an'
important disease in most of the affected communities as there is a tendency for
policy makers to rank the disease according to their importance in the communities
simply by looking on the numbers or figures. Findings from the current study have
highlighted that rhodesiense HAT consumes a very significant proportion of
workforce resource, time and hospital space. Also the results of this study
demonstrated the importance of conducting disease specific burden to different
common disease conditions at local settings rather than generalization using national
figures.
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Burden of disease due to rhodesiense sleeping sickness study conducted in Uganda
recently also confirm that the outbreaks are very costly as they have focal
distribution in term of time and space (Odiit, 2005). This therefore stresses the need
to allocate sufficient resources towards preventing further outbreaks in these rural
communities. In deciding areas that need prioritization it is important to use
estimates from community perspectives rather than using health sector or national
level data. Local burden of disease estimates are important aspects as they provide
good epidemiological data which can be used for timely planning and proper
resource allocation in most of the local health care settings, as this will contribute
towards reducing greatly the burden of rhodesiense sleeping sickness.
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CHAPTER FIVE:
INVESTIGATING THE RISK FACTORS FOR HUMAN AFRICAN
TRYPANOSOMIASIS IN URAMBO DISTRICT
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5.1 Background
Establishing the major risk factors for sleeping sickness transmission is important in
understanding the nature of the disease and its transmission dynamics; this will
eventually contribute greatly to an increased understanding and offer opportunities to
formulate strategies for the disease control. Available documentation suggests that
the disease tends to spread in previously known sleeping sickness foci and also to
villages where disease has previously never been reported (Kibona 2001). However,
to date not enough epidemiological documentation exists to show the patterns of
disease in these areas, what might be the possible cause as well as the possible risks
for transmission and maintenance.
Like many other sub Saharan Africa countries where sleeping sickness is endemic,
Tanzania has shown a substantial reduction in the number of HAT cases reported
between 1999 and 2006 (Simarro et al., 2008). This indicates a good result of the
controlled measures implemented by the Tanzanian Ministry of Health and Social
Welfare (MoH&SW) and the Ministry of Livestock Development, with constant
technical and financial support from World Health Organization (WHO). Among the
widely used control options are medical surveillance both active and passive and
control of tsetse flies (the main vector of the disease) using impregnated targets.
However, despite ah these tremendous control efforts made by the relevant Tanzania
authorities to curb sleeping sickness and prevent further spread, it continues to be a
major public health concern, particularly in the western part of the country. The
situation is even more complicated with a number of issues, not least of which is the
presence of substantial numbers of refugees based camps in Kigoma region in the
western parts of the country, some of them originating from T. b. gambiense endemic
regions. This therefore poses a risk of re-introducing gambiense sleeping sickness to
the western part of the country where it is speculated to have occurred in the past




The western part of Tanzania is mainly occupied by agro-pastoralists who keep a
variety of livestock, including domestic pigs which have also been suggested to be
possible potential reservoirs for gambiense HAT, although the principal host for
gambiense sleeping sickness remains to be humans (Nkinin et al., 2002; Penchenier
et al., 1996)
Recently, a resurgence of HAT has been observed in several villages of Urambo and
Mpanda districts (Kibona et al, 2002). Both Urambo and Mpanda are historic
sleeping sickness foci which were silent for a number of years. The districts share a
common border with Kigoma region at Ugalla game reserve and are located in the
western part of the country in Tabora and Rukwa regions respectively. The re-
emergence was first reported in these districts early 1999, since then a number of
new cases are reported to Ministry of health every year. Between January 2000 and
December, 2006 a total of 446 cases were recorded. The most common vectors
associated with the current re-emergence in Urambo are mostly Glossina morsitans
(MoH report, 2004) It is estimated that 60-70% of the country is infested with tsetse
flies (Kihamia et al., 1991).
*
In 2005, in response to the existing resurgence, the Ministry of Livestock
Development deployed a number of insecticide impregnated targets in most of the
endemic villages of Urambo district. The impact of this effort reduced the number of
cases to 85 in 2005, and 33 in 2006. All these cases were diagnosed and treated at the
Kaliua health centre, in Urambo district, which acts as HAT treatment centre for the
district. The health centre, was also receiving patients from neighbouring Kigoma
rural and Mpanda districts until mid 2005. However, Mpanda district then started
receiving supplies of drugs for the treatment of rhodesiense sleeping sickness
resulting in less need for sick patients to travel to Kaliua in search of treatment for
HAT (Annual Report, 2005).
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Much is already known regarding sleeping sickness in other sub Saharan African
countries where the disease is endemic.
Despite the existing disease challenge and also concern expressed by some authors
about the challenge ahead by comparing the current resurgence with the epidemics of
1930s (Nkinin et al., 2002), in Tanzania little has been achieved in terms of
understanding the epidemiological dynamics of the disease in all affected areas.
There still exist many unaddressed gaps, such as identifying the source of infection
and possible factors exposing people to disease risk which must be dealt with before
we can predict the future outcome of the disease in all the affected districts. There is
an urgent need to investigate properly the factors which may have contributed
towards the current resurgence of the disease in the district as well as the occurrence
of new foci in Tanzania. In dealing with this issue, involvement of all stakeholders
responsible for human health, vectors and reservoir hosts are essential.
Though it is known that spatial distribution of vector-bome diseases is demarcated
by the geographical distribution of vectors and their vertebrate hosts, there is always
a tendency to use political boundaries to investigate the disease processes in both
epidemiological as well as in daily public health surveillance systems. In opposing
this tendency (Cattand et al., 2001) recommended the use of village and hamlets as
the most appropriate reporting units for sleeping sickness. Despite the wide spread
use and potential benefits of geographical information systems in epidemiological
studies, there are so far no or very limited documentation to show its use in studies
conducted in Tanzania to investigate the spatial distribution of sleeping sickness.
There is always an increased benefit using multiple techniques in the disease
investigation, as they may provide potential information which may contribute
toward designing better options for disease control. Higgs et al (2001) recommends
the use of GIS in targeting resources for disease prevention by highlighting areas of
significantly high rates and to predict areas for future risk (Higgs and Gould, 2001).
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Hence adding GIS analysis in epidemiological studies may play an important role in
the assessment of geographical patterns of the disease in order to detect unusual
spatial aggregations of the disease incidence or clusters.
5.1.1 Case Control Studies
Case control studies are studies whereby researchers compare medical and lifestyle
histories among two groups of people with similar settings: those with the disease or
health condition under study and a similar group of people without the disease or
health condition. The aim of such studies is normally to establish the association of
the established factors with the health condition among these two groups of people.
There are some documented case control studies for HAT which were conducted in
other endemic countries. These are important to review when conducting studies of
responsible factors for the resurgence of sleeping sickness in Urambo. A study on
gambiense HAT conducted in Ivory Coast (Meda et al., 1993) observed that people
sleeping in farms (encampments) and people fetching water in natural holes and
pools were more likely to become infected than those living at the village. In Busoga
Uganda (Okia et al., 1994) found that spending more time outside the village of
residence, visiting areas where rhodesiense sleeping sickness is endemic, collecting
firewood in the forest and having incidents of sleeping sickness in the family were
observed to be significantly associated with the risk of acquiring sleeping sickness.
Another case control study conducted in a gambiense area in Cameroon found that
hunting was a risk factor for sleeping sickness (Grebaut, 2001). Recently several risk
factor studies were conducted in a rhodesiense HAT area in Uganda. In the first
study Odiit et al (2006) used remote sensing and GIS to detect villages of high risk,
they also observed that distance to sleeping sickness hospital, long vegetation
swampland and low population density influence the population of tsetse flies and
hence were predictive of reported sleeping sickness presence (Odiit et al., 2006).
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In another study highlighted the importance of considering animal movement as an
important risk for zoonotic infections, and finally (Zoller et al., 2008) observed that
having a family member with a history of HAT as well as proximity of a homestead
to a nearby wetland to be strong risk factors for infection. However, in Tanzania, no
risk factor studies for HAT have been conducted in any of the disease endemic areas,
although several suggestions have been put forward as the possible factors which
were likely to expose residence of disease endemic areas to the risk of infection.
Kilama (1981) reviewed the relationship between human activities and
trypanosomiasis over ten years (1970 to 1980) and suggested that farming, clearing
the land for the purpose of establishing new home, fetching water, travelling,
collecting building materials and honey collection as the most important activities
exposing human population to tsetse contact (Kilama, 1981). This study aimed to
investigate the risk factors associated with sleeping sickness transmission in Urambo
district through a matched case-control study. The above factors were also
considered during the study design.
5.2 Material and Methods
5.2.1 Description of the Study Sites
5.2.1.1 Study area
The study was conducted in Urambo district, which is located in Tabora region in the
western part of Tanzania. The district was established on the 1st July 1975 and it is
the largest out of the six districts in the region. It lies 1,100m above sea level,
between latitude 40°00" and 50°00"south and longitude 30°00' and 32°00' east.
Urambo has a total area of 25,995. km2. Out of these 2,859.45 (11%) km2 are used
9 • '
for settlement and agriculture activities and 23,135.55 km (89%) is covered by
forest, bush and water bodies. The district has a warm climate, which reaches a peak
in August-October with a mean daily temperature of 21.5 - 27.0°C. May to July are
cooler months, followed by dry a period of dry wind which last up to September.
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The only rainy season in the district starts from November lasting to May and the
total annual rainfall varies from 900 mm to 1,300 mm.
The district comprises four administrative divisions, 23 wards and 108 villages
which includes 97 residential villages and 11 villages which are occupied by
refugees.
5.2.1.2 Agro - economic zones
Urambo has relatively homogeneous topography and temperature with two agro-
economic zones; the Western and Miombo zones. The western zone in which the
study was conducted is sparsely populated and varies in elevation ranging from 1000
- 1500 m. It is characterized by flat and featureless topography with area sloping
away to the rivers Ugalla, Malagarasi and Lake Sagara to the west and south. The
district produces both cash and subsistence crops including tobacco, maize, cassava
and beans, with paddy grown in depressions or wet areas.
■wC
5.2.1.3 Livestock development
Despite the district having the richest potential of grazing land the amount of
livestock kept in the district is very low. One of the factors limiting livestock keeping
is tsetse fly infestation. Livestock diseases in the district are quite a problem which
leads to poor livestock health and even death. The short hom Zebu is the
predominant breed of the indigenous livestock, which means low herd productivity.
The most important cattle diseases in the district are tick borne diseases namely East
Coast fever (ECF), Anaplasmosis, Babesiosis and Heart Water followed by
contagious bovine Pleuropneumonia, Trypanosomiasis and skin diseases. Evidence
of the actual tsetse infestation situation in disease endemic villages in Urambo is as
seen in Figure 5.1.
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Figure 5.1 Tsetse fly infestation as captured on the main route between
Usinga to Ukumbikakoko
5.2.1.4 Study population
According to the 2002 population and housing census 2002, Urambo district
had a population of 370,796. With the annual growth rate of 3.6%, the
district population was projected to be 471,143 at the end of 2007 (National
Bureau of Statistics, 2002). The predominant indigenous tribe of the district
are Nyamwezi followed by the related Sukuma. Significant minorities
include the Ha who originate from Kigoma. In recent years refugees from
Burundi have added variety to the district ethnic make up.
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Figure 5.2 Urambo map showing location of all villages; sleeping
sickness villages are marked in red and the village without
disease in blue
Legend
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The design of this study was matched case-control (Woodland, 1999),
investigating risk factors for rhodesiense HAT in Urambo. Two stages of
the study were conducted by investigation of the risk factors at both village
as well as within village level scales.
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5.2.2.1 Village level survey
This study was carried out to examine village-level risk factors, involved
detailed mapping of all 108 villages in the district. The aim of this kind of
spatial study was to explore the possibility of having disease clustering in
the district.
All villages as well as health facilities in the district were surveyed and geo-
referenced using GPS. During this survey information regarding whether
sleeping sickness has ever been reported in the village was gathered from
the clinical staff. The aim of collecting such information was an attempt to
validate the information obtained from the district hospital. The information
collected at the health facility level included previous number of sleeping
sickness cases. This was done concurrently with the mapping exercise of all
village centroids as well as all the health facilities in the district. For this
particular study the village reference point for mapping was taken as the
common meeting point in the village. This stage also included collection of
all geographical information which was considered to be related to sleeping
sickness in the area, such as location of livestock markets, watering points
(rivers, lakes and wells) and swamps.
5.2.2.2 The Within Village Survey Risk Factors
The within village level survey was sub-divided into two parts as follows:
The first part which aimed at exploring the possibility of disease clustering
within the village included total mapping of all homestead in six selected
disease endemic villages. A criterion for selecting the six villages was to
have five or more sleeping sickness cases, recorded between 1st January
2004 and 31st July 2007. All homesteads in these villages were mapped
entirely using hand held Geographical Positioning System (GPS). The
reference point for the homestead was taken on the front door of every
surveyed household.
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The second part of the within village survey aimed at investigating the
behavioural risk factors for sleeping sickness using structured questionnaire
to all sleeping sickness cases identified during this exercise, as well as the
matching controls.
5.2.2.3 Behavioural Risk Factor for Sleeping Sickness in
the Villages
Between January 2004 and July 2007, when the study was conducted, a total
of 21 villages reported sleeping sickness in Urambo district
A list of names of all sleeping sickness patients from these villages was
obtained from both Urambo district hospital as well as Kaliua health centre.
Six villages with the highest number of cases (five or more) were selected
from the list and visited. All cases were traced back to their respective
villages, where age and sex matching controls were randomly recruited.
Interviews using structured questionnaire were conducted to both cases and
controls, in addition all homesteads for cases and controls were geo-
referenced. Detailed techniques used for the recruitment of cases and their
matching controls are explained in sections 5.2.7.2 and 5.2.7.3 respectively,
and the questionnaire used is attached in appendix 5.
5.2.3 Study Sample Size.
Win Episcope 2.0 (Thrusfield et al., 2001) was used to estimate the sample
for the study. The target was to enrol a minimum of 96 cases and a
minimum of 96 matched controls during the period of the study. With this
sample size the intention was to have 80% (alpha error 5%) to detect risk
factor with odd ratio of 3 that was assumed to be present in at least 10% of
the non-exposed, assuming a phi-coefficient up to 0.2 (Dupont, 1988).
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5.2.3.1 Recruitment of Cases
We define a case for this particular study as a "person who presented at any
health facility between January 2004 and July 2007 to seek treatment and
who was diagnosed to have sleeping sickness". Criteria for inclusion in this
study was first to be parasitologically confirmed as having sleeping
sickness, using WHO criteria for diagnosis of sleeping sickness. The criteria
include; demonstration of trypanosomes in the blood, gland aspirate or
• 3
lymph for early and demonstration of parasites in the CSF, WBC >5 mm
for late stage. A second criterion was to be residing from Urambo district
and having lived in the village for more than two years.
All sleeping sickness cases which matched the criteria were followed to
their respective villages. At the village a brief meeting was held between the
research team and village health team. The village health team comprises
one of the village leaders, a chairman, village executive officer (VEO) or
both, a medical expert from the village health facility if any and two other
key members chosen from the community members in most cases these
were influential people in the catchment area preferably the members of
village health, agricultural or educational expert or tsetse officers or any
other member chosen by the village team. The aim of the meeting was first
to introduce the research team and explain the purpose of the study and
secondly to seek permission to conduct the study in the respective village.
After obtaining consent for the study, the village level questionnaire was
then administered immediately. The list was produced and village leaders
were requested to locate homesteads for all the cases arising from their
respective areas.
All cases were traced and interviews were conducted, at the same time their
homesteads were assessed and geo-referenced. In situations where
interviews were conducted away from case homes, subjects were requested
to show the researcher their homestead where the mapping exercise was
done as well as assessment of the household.
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To avoid duplication in the mapping, the names of head of all households
were recorded and also the number matching the list and date of the
interview was marked on the front door of the homestead using a chalk.
This was done to avoid confusion in situation where two or more people
bare similar names.
5.2.3.2 Recruitment of controls
A control for this study was defined as "a person not diagnosed with
sleeping sickness, and had lived in Urambo district for the same period of
two years." This control age and sex matching each case was randomly
selected from the same village population. Using the list of villages which
reported sleeping sickness obtained from the district hospital, villages were
visited. At the village level, a brief meeting was held between the research
team and the team of village leaders.
During this meeting a village chairman or village executive officer (VEO)
was requested to provide a list of all ten cell unit1 leaders in their respective
village. At the ten cell level, a list of members of all household in the
respective ten cell units was produced, member listed by number from one
to ten. Without looking at the list a random village member was requested to
mention any number starting from one to the last number of our ten cell list.
The household matching this number was selected from the list and the ten
cell leader was requested to provide the names, sex and age of residents of
the selected household, a control age sex matching the case of interest was
picked from the household. In case no control was found from the selected
household, then another number was picked using similar procedures until
the required control was obtained.
In selecting the matching controls ten years age range was allowed so as to
avoid any possibility of missing a control matching the exact age, and
assuming that at that age range most of the community members share
1 A ten cell unit is the smallest village level administrative unit, and it normally comprises
of ten families (homesteads), in very rare cases more than ten families but less than twenty.
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similar risk activities. The minimum age for this particular study was 10
years. Hence the age-group which was considered in selecting the potential
controls followed the following range (10 - 19, 20 - 29, 30 - 39, 40 - 49, 50
- 59, 60 - 69, 70 - 79, 80 - 89, 90+). In situations where the control
matching the case was not found in the visited household or if the control
refuses to participate in our study, then another household was randomly
selected from the same ten cell unit using the same techniques, and in
situation where no suitable control was obtained from the visited ten cell
unit then the research team selected another ten cell unit until the suitable
control was obtained. The control was only included in the study after
verification that the household consists of hospital attendees (i.e. population
who would present to the health facility if suffering from any health
condition). Once a potential control was identified, the purpose of the study
was explained, and they were interviewed only if they agreed to participate
and they had been residents of the Urambo district for two or more years.
5.2.3.3 Household Surveys
Based on previous case control studies the questionnaire was structured to
gather information on a range of variable related to individual and
household behavioural characteristics such as socio-economical and daily
household activities, movement or travel history and a range of all possible
risk activities which expose an individual to tsetse fly bite such as farming,
honey gathering, lumbering, firewood collection, fishing, heading livestock,
hunting and business. The questionnaire used for this study can be found in
appendix 5. During the interview detailed assessment of economical status
of the selected homestead was carried out. This included a range of factors
such as structure and roofing of the house, number of rooms, and type of
toilet, size of the family. The questionnaire also investigated types of crops
grown by the family members and area where the farming was conducted,
type and amount of livestock kept by each family, as well as other sources
of household income. It also investigated the possibilities of contact with
wild animals in the village. The interview was recalled for the risk period
i.e. during the time when a matching case was infected. The questionnaire
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underwent two rounds of pre-testing, first round it was pre-tested among the
colleagues at the University of Edinburgh so as to avoid any ambiguity in
the questions and the second round it was pretested in the field in sleeping
sickness endemic area in Tanzania, which was outside the study villages.
5.2.4 Keys Informants
During our study in-depth discussion was held between principal research
team and village local leaders (village/sub-village) team which included a
team of influential people from the village, health/veterinary/agriculture
board members, livestock keepers, the aim of this meeting was to gather
information on land use practices, livestock keeping grazing, watering
points, cattle marketing centres and livestock routes.
5.2.5 Data processing and statistical analysis
Data processing was subdivided in the sub-section depending on the means
of data collection.
5.2.5.1 Geographical Information System
An in depth study of HAT in the study area requires a clear demarcation of
different ecological zones in and around the district, during this study spatial
data (geographical coordinates) of the residence of each cases and controls
(i.e. geo-referencing exact point locations of all homesteads in the villages
of active sleeping sickness cases) as well as mapping of location of kraal (if
any) in all homesteads, location of health facilities, village centres was
recorded using GPS. All the coordinates were compiled using Microsoft
Excel where were converted in Dbase IV, then imported into ArcView
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software which was used to convert them into a point map using Arc view
version 3.2 software. All maps in this chapter were conducted in ArcGIS 9.1
software. Spatial data were analysed using SaTScan software, which is
freely downloadable from the internet at http://www.satscan.org. SaTScan is
based on Kulldorff s spatial scan statistic (Kulldorff, 1997).
The SaTScan statistics which were used in the current study are space scan
statistics and are useful for the use in areas as well as point data. It can
utilize a Poisson-based model as well as Bernoulli based model. The first
model requires the number of events in an area which are Poisson
distributed under the null hypothesis, whereas the later model requires
events data such as cases and controls. Therefore the Bernoulli model was
used in the current analysis.
The spatial scan statistics is a local cluster test which detects the location of
the most likely cluster of events in a data set, and infers its statistical
significance using Monte Carlo replications. Grid points, (referred to as
centroids) are superimposed on top of the sampling area. Around each
centroid, circular zones with a continuous varying radius are constructed.
The likelihood test ratio statistics for each zone, which is based on the
population and the number of cases included within that zone is calculated.
The total number of zones around each centroid, although infinite in theory
due to the continuous variation of the radius, is in fact limited by the
possible combinations of population and case numbers. Usually the zones
are restricted in size to include a maximum of 50% of the population, as
high rate clusters larger than this signify a cluster of unusually low rates of
events in the remaining population. The program is also capable of reporting
secondary clusters, which are all other clusters which do not overlap the
most-likely cluster. This occurs if the likelihood ratio is larger than the
likelihood ratio for the most-likely cluster for at least one data set simulated
under the null hypothesis.
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5.2.5.2 Cluster detection
In order to investigate the spatial distribution of rhodesiense HAT in
Urambo, two levels of analysis carried out: The first part which was the
village level cluster analysis, included all the 21 villages which reported
sleeping sickness between January 2004 and July 2007. These 21 villages
were categorized as case villages regardless the number of cases reported
per village, the remaining 87 villages which did not report sleeping sickness
were categorized as the control villages. The second part of cluster analysis
is within village study, in this part the six villages with five or more cases
were chosen and surveyed. All homesteads in these six villages were
surveyed and mapped entirely. Homes with sleeping sickness cases were
categorized as case homesteads, while homes without sleeping sickness
reports within study time frame were categorized as control homesteads. All
spatial data were entered in Microsoft ® Excel software where it was
converted into text files and then imported into SatScan software version
7.0.3 (Kulldorff, 1997; Kulldorff and Nagarwalla, 1995). In the Sat Scan
software 50% was set as the maximum cluster size for total population at
risk, the analysis was run to identify areas of high rates clustering
(Kulldorff, 1998) rather than low rate clustering. The analysis was set to run
with 999 Monte-Carlo iterations.
5.2.5.3 Hard copy Maps
Maps used in this chapter were reproduced using the geographical
information system, ArcView and ArcMap9 (ArcGis 9, ESRI Systems,
Redlands, CA, USA).
5.2.5.4 Questionnaire data
Individual data was digitized using database software, Microsoft Access
(Microsoft Office XP, Redmond, USA) and transferred to Microsoft Excel
spreadsheet (Microsoft Office XP, Redmond, USA) where it was stored as
comma delimited (csv) files.
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It was then imported to R package (R: copyright 2004, The R foundation for
Statistical Computing Version 2.7.1, available free on the internet at
http://CRAN.Rproject.org ready for analysis) to summarize the
characteristics of cases and controls (Table 5.1).
Cases and controls were 1:1 matched and compared using a logistic
regression to determine the risk factors associated with Rhodesiense
sleeping sickness as a univariate analysis (R-commands are shown in Figure
5.3.1). All individual variables were examined for each of the village
variables separately. Both individual and village characteristics were treated
as fixed effects. For this analysis, a generalized linear model (GLM) with
binomial errors (Crawley, 2002) was used with R 2.7.1 to calculate the odds
ratios (OR), 95% confidence intervals (CI) and p-values for statistical
significance (P < 0.05).
Figure 5.3 Example of R command used in the current analysis
>clogit (CC~SSinFamily+strata(CCRrefNo.),data=CaseCont)
As a multi-variate analysis, logistic regression using a GLM with binomial
errors was performed for the factors that had a P < 0.2) at the univariate
level. Variables were removed from the model using backward stepwise
model simplification (Crawley) until all terms remaining in the model were
significant (P < 0.05). Figure 5.3 is the example of the commands used, and
the results of this multivariate analyse are shown in Table 5.4.




The GLM for the multivariate analysis identified single significant risk
factor: having a member of family with previous sleeping sickness history
(Odds ratio: 20.69 (95% CI: 4.79 - 89.33), P < 0.001, Table 5.5). All other
factors which were initially significant turned out to be insignificant in this
model. The codes used to obtain the odds ratio and 95% confidence
intervals are shown in Figure 5.5.
Figure 5.5 Example of the codes used to obtain the odds ratio and
95%Confidence interval in the multivariate analysis




5.3.1 Village Level Spatial Results
The first part of the study aimed to investigate the possibility of sleeping
sickness clustering at the village level in Urambo district. Twenty one
sleeping sickness case villages and 87 control villages were included in the
analysis of this first part Findings of the analysis demonstrated significant
clustering (P < 0.001) with a radius 82.88 km, in the district. Table
5.1.below shows the results of the model output. It also shows that 17 out of
108 villages were the most likely clustered sleeping sickness villages in the
district. These included; Ukumbikakoko, Usinge, Lumbe, Ukumbisiganga,
Kangeme, Zugimlole, Maboha, Ulindwanoni, West Kaliua, Tuombemungu,
Ulindwanoni, Limbula, Imalampaka, Luhanjo, Sheila, Kamsekwa and
Kombe.
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5.3.2 Within the Village Spatial Analysis Results
The second section of this part of the study aimed at investigating the
possibility of clustering within the village, six villages with five or more
cases were chosen and total mapping of all homesteads was conducted.
Location of all case homesteads in each village was identified. Non-case
homestead data were entered in SaTScan software for analysis as village
controls. (Table 5.2).
The model also suggests a small secondary cluster involving only two
villages which are Kazanaupate and Mtakuja, both in Igagala ward which
was statistically insignificant (P = 0.955).
Figure 5. 6 Insectside impregnated target as photographed on the
borders of Usinga and Ukumbikakoko villages
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Figure 5.7 Urambo map highlighting all high risk villages which are
included in the cluster
5.3.2.1 Lumbe Village
During review of hospital records 56 sleeping sickness patients from Lumbe
were diagnosed and treated at Kaliua health centre between January 2004
and July 2007. However, the current survey discovered only 36 cases out of
the 56 recorded came from Lumbe, 18 patients out of the 56 which were
originally reported under Lumbe were found in Ukumbisiganga which is
very close to Lumbe. Two cases could not be traced. We mapped 431
homesteads in Lumbe using GPS; out of these 36 were case homesteads and
the remaining 395 were entered in the analysis as control homesteads. The
results of the Lumbe village analysis suggested clustering (P = 0.109) but
was not statistically significant.
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The map showing the distribution of all case and control homesteads which
were included in the analysis is displayed in (Figure 5.8).
Figure 5.8 Lumbe map showing the distribution of homesteads with









Data collected from district hospital did not report Ukumbisiganga as a
village; instead it was reported under Lumbe. Originally these were known
as one village under the name Lumbe or "Kilometa sitini" in Swahili
(meaning 60 Km) this is the distance measured when travelling by train.
During the survey it was realized that 18 sleeping sickness cases reported
under Lumbe were in fact from Ukumbisiganga. In total, 406 homesteads
(18 sleeping sickness cases and 388 village controls) were surveyed and
mapped in Ukumbisiganga for the analysis. Findings from the analysis
suggested there was most likely a cluster (P = 0.69), relative risk 11.4,
radius 0.05, rate ratio (O/E) = 9.667 and Log likelihood ration 4.97.
However, statistically there was no association. Figure 5.9 shows the
homogenous distribution of all these cases of sleeping sickness as well as
the village controls.
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Ten cases of sleeping sickness for Usinga were obtained from the hospital
records; Usinga was different from the previous two villages due to the fact
that it is more remote, though it may not differ much in size from the other
villages. It is less populated and many of its residents live inside the forest
reserve. Accessing this village one has to travel a long distance through a
dense forest on a very narrow road which is heavily tsetse infested (picture
in Figure 5.7). There is also an increased danger of wild animals in Usinga
when compared to other villages. A small sub-village of Usinga called
Kasense (No. 3 Figure 4.5) is located on the shores of River Ugalla, and is
mainly occupied by the fishermen. We managed to trace only seven out of
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the reported 10 cases in this village. The seven cases and 135 village
controls were entered in the analysis, the results which suggested a small
cluster with 0.06 km radius, rate ration (O/E) = 7.4, relative risk 15.87 and
log likelihood ratio 6.388, which approaches statistical significance level (P
= 0.074). Figure 5.10 shows the distribution of these cases and village
control homesteads as well as the cluster.
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Figure 5.10 Usinga map showing the location of village homesteads in black
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Ukumbikakoko is the farthest of all the study villages, located 109 km from
Kaliua health centre when travelling by train. It is the smallest of all the
surveyed villages, and also least populated. It is found on the shores of
River Ugalla which divide Urambo and Mpanda districts.
It is occupied mainly by fishermen and small scale subsistence farmers.
With exception of train, access to the village is very difficult. Though
Ukumbikakoko was not listed in any of the health facilities as having cases
of sleeping sickness, it was observed during village level interviews in
Usinga that two names reported under Usinga were actually residents of
Ukumbikakoko. Ukumbikakoko was visited with the aim of conducting
interviews with the two cases and realized that there were three more
patients one diagnosed and treated in Tabora and two in Mpanda. The five
cases were combined with 81 village controls in the analysis. The results of
the analysis (Table 5.2) suggested statistically non significant cluster (P =
0.421). Figure 5.11 shows the distribution of the cases and village controls.
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Figure 5.11 Ukumbikakoko map showing case and control homesteads
5.3.2.5 Kangeme
Kangeme is among the most severely affected villages in the district,
reporting a total of 43 sleeping sickness cases between January 2004 and
July 2007.
The team was able to survey all the 483 homesteads in this village,
however; only 25 cases out of the 43 reported in the village were traced.
Findings of the analysis suggested one most likely cluster (P = 0.63), which
was statistical not significantly. Figure 5.12 below is a map showing the
location of all homesteads for cases and controls.
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5.3.2.6 Kombe village
From the hospital records only three cases were listed, three more cases
were discovered in the village during the survey and were combined with
195 village controls to make a total of 201 homesteads which were
analysed. Results suggested statistically non significant cluster (P = 0.216).
Figure 5.13 shows the distribution of case and control homesteads in Kombe
village.
Chapter 5 150
Figure 5.13 Kombe map showing location of case and control
homesteads.
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5.4 Socioeconomic and Behavioural Risk Factors
A total of 100 cases and 100 sex, age and place of residence matched
controls were selected and surveyed. Interviews were conducted with all
these subjects and analysed using methodology described above. The
distributions of demographic data for both cases as well as controls are
displayed in Table 5.3.
Findings from the current study demonstrated a very strong statistical
association between sleeping sickness and the presence of a family member
with a previous history of sleeping sickness P < 0.001; OR: 6.43 (95% CIs:
2.9 - 14.3). Contact with wild animals in the village was also associated as
follows; seeing hyenas P = 0.005; OR: 2.89 (95% CI: 1.37 - 6.10), seeing
lions in the village P = 0.01; OR: 2.49 (95% CI: 1.21 -5.10), and seeing
elephants in the village P = 0.03; OR: 2.39 (95% CI: 1.08 - 5.29). Visit to
the forest reserve was slightly associated P = 0.028; OR: 2.3 (95% CI: 1.09
— 4.83). However, having a knowledge about causes and transmission of
sleeping sickness appeared to have a negative association with sleeping
sickness infection in the study villages P = 0.01; OR: 2.0 (95% CI: 0.86 -
4.67).
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Table 5.3 Characteristics of cases and controls
Characteristics HAT Cases Population controls












Firewood collection 6% 6%
Honey gathering 3% 2%











Table 5.4 Risk factors for human African trypanosomiasis (Univariate-
analysis)
Rcter G±kRatio(CR) mOs P-WlE
Rrest visit 230 1.09-4.8 0.028
SSintheforily 6.43 29-14.3 <Q001
Visit totsefaa area 200 Q68-5.85 0.190
SaenLier inthevillas 249 1.21-5.10 0.010
SaanHepharts 239 1.08-5.10 0.031
SaenT^ena 289 1.37-617 0.005
SenMLizand 221 1.17-4.17 0.140
SaanWrtbogs 1.50 Q81-278 0.200
SaanRats 0.65 Q32-1.31 0.230
Famrgactivities larfimhcme 1.20 Q52-278 0.670
Avcana cfcauseofss (tsetse) 200 Q86-4.67 0.110
Keeping livestockat homestead 1.20 Q61-238 0.600
Cdtivalemaize 1.40 Q44-4.41 0.570
When all significant risk factors were fitted in conditional logistic
regression model (multivariate), only having a member of family with
previous sleeping sickness history remained highly significant OR: 20.69
(95% CI: 4.79 - 89.33), P < 0.001 (Table 5.4). All other factors which were
initially significant turned out to be insignificant.
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Table 5.5 Risk factors for sleeping sickness in Urambo district,
conditional logistic regression model for matched data
(Multivariate analysis)
Factor Adjusted Odds Ratio95% CI P- Value
SS in the family 20.69 4.79 - 89.33 <0.001
Figure 5.6 Picture of wild animals (Waterbucks) which was




This was the first time a study of this kind was conducted in rhodesiense
sleeping sickness endemic area in an attempt to investigate the possible
spatial and behavioural risk factors for rhodesiense sleeping sickness in
Tanzania. Therefore, based upon previous risk factors studies conducted
both in gambiense and rhodesiense sleeping sickness endemic areas in other
sub-Saharan African countries (Meda et al., 1993; Okia et al., 1994; Robays
et al., 2004; Welburn et al., 2006), a wide range of potential factors which
were reported to be associated with an increased risk of sleeping sickness
transmission, were examined and considered while designing this survey.
Results of the current study demonstrated a very strong clustering of
rhodesiense sleeping sickness endemic villages in Urambo district. The
clustering was observed only at the village level analysis (P< 0.001). The
model also suggested a possibility of having clustering at within village
analysis in all six surveyed villages; however, statistically there was no
significant association in any of the suggested clusters. This means that
clustering in Urambo is only limited at the village level, and localized to
specific parts of the district, particularly in villages bordering Kigoma rural
and Mpanda districts which are also covered in the cluster.
These finding were not unexpected as the homogeneous distribution of
sleeping sickness cases in all the villages surveyed was also observed during
the mapping exercise. These findings suggest that, residing in any of these
villages is a risk itself rather than having a specific activity in the village.
Hence village residents are exposed to risk of being infected with sleeping
sickness. This means that all residents of the six surveyed villages have an
equal chance of sleeping sickness infection
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Having a family member with previous history of sleeping sickness was also
found to be associated with increased risk of sleeping sickness in the
district.
This findings are consistent with earlier risk factor studies conducted both
in rhodesiense (Okia et al., 1994), and also findings of a more recent study
conducted in South East Uganda (Zoller et al., 2008), as well as another
study conducted in gambiense sleeping sickness endemic areas (Gouteux,
1988). In all these studies the authors suggested that the probable
explanation for this finding is that, families tend to share similar patterns of
risk activities, they also suggested that biting by infected tsetse may be
occurring around homesteads. Given the fact that several studies have now
observed this finding is a serious challenge to researchers. On the other hand
it opens a door for further studies, to investigate the potential genetic factors
existing among family members in HAT affected families, which are likely
to play role in increasing susceptibility to infection. Studying host-parasite
genetic interaction has been suggested to be considered as important tool for
eradication campaigns (Garcia et al., 2006). Another possible reason which
may be suggested is that there is an increased awareness in regarding
clinical presentation among family members with previous HAT patients,
which forces patients to seek medical attention as soon as they see similar
clinical presentation, this increases the chances of been diagnosed early.
Contrary to the authors expectations, the current study found no statistical
association with a number of high risk activities conducted in the study area;
such as firewood collection, lumbering, fishing and honey gathering, despite
the fact that honey gathering came out clearly as one of the potential activity
which forces people to encroach on the forest. Most of the older study cases
(age between 40-80 years) were involved in honey gathering activities,
which forces them to enter and spend a number of days inside the forest
reserve. Results of this study should not in any way be used to draw any
conclusion as they do not exclude the possibility of honey gathering or any
of the activities mentioned above being potential risk factors in future
studies or in other areas of Tanzania. The probable explanation for non
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statistical association in any of the studies activities is that all mentioned
activities were homogenously distributed among both cases and controls in
the study villages.
A risk factor study conducted in Cameroon (Grebaut, 2001), observed
significant association between hunting and sleeping sickness transmission.
In this study it was difficult to capture this factor in any of the study
villages. Hunting in Urambo is restricted to permit holders only, with most
of the hunting activities conducted by private companies, both local and
international. The companies would normally hire professional hunters and
for short periods mostly during dry season when most of the hunting
activities are conducted. Most professional hunters, the study team came
across during survey were temporary residents and did not meet the study
criteria which was to have lived in the study area for two or more years.
Most of the study villages were considered to be almost inaccessible during
rainy seasons, as all major roads in the district are unpaved and majority are
in very bad shape. Surprisingly, almost all the study villages are accessible
by train throughout the year, but it is unlikely that the some of the risky
activities such as hunting would be conducted during the rainy season for
security reasons. The fact that all hunting activities require one to have a
hunting permit does not exclude possibilities of illegal hunting by poachers,
although it was not possible to verify this fact, as none among the study
subjects was identified to conduct hunting activities.
A very similar study conducted recently in Uganda (Zoller et al., 2008),
observed significant clustering in five out of six survey villages. The spatial
risk factors identification in both studies is important aspect as it may
contribute towards reducing the number of costs in future control
programmes. To achieve this goal the policy markers may need to consider
targeting specific focal areas instead of allocating the resources throughout
the entire endemic area. For this particular case for example it is obvious
that deploying tsetse impregnated targets in any of the six villages will not
produce the desired impact in the control of tsetse, instead they should be
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targeted to specific areas, where there is obvious increased man-tsetse
contact such as watering points and areas of increased forest activities.
Studies conducted elsewhere (Odiit et al., 2004) observed association
between rhodesiense HAT and water sources [Odiit, 2005, Zoller, 2008]
however, in the current study it was not possible to establish this association
as most of the surveyed homesteads are located very close to one another
(about two to five minutes walk). Apparently there was no common source
of water supply which could be regarded as a meeting point which would
have increased the risk of tsetse fly bite in any of the surveyed villages. In
most cases people use water from shallow wells which were observed in
some of homesteads particularly in homes which are located near or inside
reserve forest. The only reliable source ofwater was observed in the villages
located along Ugalla River, which is very wide and can be accessed in
several points and hence no single area could be regarded as a single
common point.
The results of the univariate analysis which are explained in this chapter
also suggested that wildlife are the possible risk for the current resurgence
of sleeping in Urambo district, meaning that probably the disease is still
been transmitted in a traditional way as compared to what has been
happening in other regions of rhodesiense HAT. This finding fits well to the
hypothesis made by Fairbain (1948) who suggested that the 1922 -1948
HAT epidemic in Tanzania was probably the spill-over infection from wild
animal reservoirs to humans (Fairbairn, 1948).
During the village level discussion, some of the village elders associated
presence of sleeping sickness with the existence of wild animals particularly
elephants and this was repeatedly mentioned in different study villages. This
study was however not able to confirmed this association, as wild animals
which appeared to be potential risk factors for sleeping sickness in
univariate analysis were eliminated by multivariate analysis.
Chapter 5 159
It is well understood that animals are the preferred hosts by tsetse flies when
compared to humans, and also most of the wild animals including elephants,
enter the villages late at night when tsetse flies are not present, it is
suspected that the remains of animal dung and the smell of their urine may
attract some tsetse to these villages, posing possible risk to population.
Documented research findings show that, odours released by tsetse's natural
host may act as a potential attractants for tsetse flies (Spath, 1997).
The finding that wild animals could still play a big part in the transmission
of sleeping sickness in Tanzania is a serious and biggest challenge, given a
large number of wild animals in game reserves and National Parks all over
the country and particularly, in the western and south western parts of
Tanzania where the disease has always been endemic, also where it has re-
emerged in recent years (Kibona 2001).
The study noted that the residents in all surveyed villages keep a very small
number of domestic animals in their catchment areas, despite the district's
richness in grazing land. When asked to comment on this, the local residents
explained the reason preventing them from keeping livestock is basically the
dangers of tsetse flies as well as wild animals such as lions and leopards.
Tsetse fly abundance was also listed in regional profile as the main reason
preventing livestock keeping in the district (RALG, 2007). It was also noted
that apart from government effort to control the disease, several other
parties are playing part in the control of the disease, the only problem
observed is lack of coordination between these parties and the experts, this
is due to the fact that some of the control measures placed did not follow the
recommended standards, the good example is the target in figure 5.6 which
is made of green and blue colour instead of the recommended colours which
are blue and black (Vale and Torr, 2004). The blue colour act as a visual
attractant to tsetse flies and the black colour forms the main alighting
surface (Leverssiere et al, 1990).
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It was, however, observed that there were markedly large numbers of
livestock movements in the district. Pastoralists from Shinyanga, Kahama
and Mwanza travel on foot with large numbers of herds through dense
forests of Urambo, particularly during the dry season. These pastoralists
travel to Mpanda to secure grazing areas for their herds. There is a high
chance that the increased number of sleeping sickness cases in Urambo as
well as Mpanda were re-introduced through this route, as the forest reserve
is heavily infested with tsetse flies, as seen in Figure 5.1.
Domestic animals particularly cattle are known to be potential reservoirs for
sleeping sickness (Onyango et al., 1966). While a study conducted in
Uganda highlighted the importance of cattle movement as the potential risk
for sleeping sickness transmission (Welburn et al., 2006). Effective control
options can only be achieved by considering direct efforts to be targeted to
the protection of the livestock. The only possible cost-effective option for
the rural settings is the use of restricted insecticide application (Eisler et al.,
2003), to all livestock travelling through forest reserve, as well as use of
insecticide treated tsetse control techniques may offer a better option in






Trypanosomiasis is known to have existed in the western part of Tanzania for over eighty
years. Despite this part of the country having some of the oldest active HAT foci, over
recent years, little has been achieved in terms of understanding the actual disease
magnitude in the country; the main reason for this has been the lack of sufficient and
sustainable funds for research. Compounding this scenario is that there has been no
national HAT control programme in the country which could aid in validating
epidemiological dynamics. This thesis therefore attempted to investigate the
epidemiology of HAT in western Tanzania, as a way of gathering some baseline
information which in future will provide an insight of the disease situation and hence
contribute towards better planning of control interventions. Hence in Chapter II, findings
of a historical review suggested that both forms of HAT probably existed in Tanzania in
the past, although at present time only Rhodesian sleeping sickness is reported to exist in
the country. It is possible that Gambian sleeping sickness was present in the past. The
introduction of T. b. gambiense into Tanzania was believed to originate from the Belgian
Congo (now Democratic Republic of Congo (DRC) and occurred mainly at the shores of
Lakes Victoria and Tanganyika.
Chapter III assessed the level of sleeping sickness under-reporting in Urambo district,
Tanzania and suggested that HAT under-reporting is extremely high, and it is clear that
considering the remoteness of communities affected with the disease, and the
unavailability of sufficient health facilities with the capacity to manage the disease
(Malele et al., 2006), it is clear that most of the sleeping sickness cases are always missed
and die probably undiagnosed in rural communities. Clearly, given the seriousness and
extent of sleeping sickness under-reporting and also due to the fact that all under-reported
cases did not attend any health facility meaning were not diagnosed and therefore receive
no treatment, these are assumed to be unreported deaths (sleeping sickness is invariable
fatal if no treatment is provided).
Chapter 6 163
Findings of under-reporting were incorporated into chapter IV which deals with the
quantification of the burden of disease due to rhodesiense sleeping sickness in the
country, and hence the DALY scores for rhodesiense sleeping sickness in Tanzania were
determined. Findings which show significant burden are imposed by HAT to local
communities as well as health care systems.
In order to be able to properly plan control strategies for any particular disease, it is
important to understand the disease trends in that particular area. During the literature
review and also the historical review of existing HAT records, it was discovered that no
previous study had been conducted in Tanzania to investigate the factors which may have
contributed towards human African trypanosmiasis transmission and maintenance.
Therefore using combination of tools and techniques, Chapter V of this thesis attempted
to fill this gap by conducting a matched case control study both at the village and within
village scales. This enabled for the first time to establish both spatial and behavioural risk
factors for HAT in Urambo district, Tanzania. The study observed that apart from risk
factors identification, the significant level of poverty observed in the district is
attributable partly to the very small scale level of subsistence farming conducted in the
district, which basically uses very poor tools. Lack of livestock keeping behaviour
observed among the villagers which may seem to be a positive factor as far as HAT
transmission and maintenance is concerned, and also regardless the fact that domestic
animals were not identified as a possible risk factor for HAT in this thesis, a significant
number of livestock movement was reported by residents of all the study villages, which
were reported to be transported between two neighbouring districts Shinyanga and
Mpanda passing through Urambo, also a large number of different species of wild
animals were reported to enter habitants. Animal movement have been identified as a
important risk factor for zoonotic HAT in other east African countries (Fevre et al.,
2006a)
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It is, however, strongly advised that the findings of this thesis be treated with caution and
should not under any circumstances be generalized for other HAT endemic districts of
Tanzania. The main reason for this is that Urambo has a completely different scenario as
compared to rest of the country.
It is probably one of the poorest districts of Tanzania in terms of infrastructure and gross
national income (GNI) ranking, all its roads (urban and rural) are unpaved and the
villages are located far apart from one another and it is the district with probably the
worst health facility coverage in the country. Also the type of agricultural activities and
crops which are cultivated are different from other disease endemic districts and it is the
district with probably the largest mixture of different ethnic groups in the country, about
17 different ethnic groups were identified during this study. In view of all above listed
findings it is unlikely that the studies from other districts will necessarily follow similar
disease patterns to that found in Urambo district.
6.1 Disease Control Measures
HAT continues to be recorded in Tanzania (Kibona 2001) and the evidence from this
study shows that new villages have been reporting sleeping sickness. This suggests that
there is an urgent need to investigate the actual disease situation in order to be able to
plan long term control programmes, as well as strengthening the existing surveillance
activities. Historically, gambiense sleeping sickness is believed to have occurred in
Tanzania in the past. Although the disease situation before World War I is not very clear,
some cases are believed to of occurred during German rule. However, it is unlikely that
gambiense HAT has ever been endemic in the country, with the epidemic rhodesiense
driven largely by human contact with animal hosts either domestic or wild. Tanzania
needs to remain vigilant about the possibilities of re-introduction of T. b. gambiense. The
chances of gambiense sleeping sickness being reintroduced into the country still exist,
particularly in the areas where transmissions were observed in the past on the shores of
Lake Tanganyika particularly on the DCR border. The finding that patient's medical
records are destroyed after 10 years is unacceptable; patient's data need to be protected,
as this will allow proper tracking of patient's medical history.
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Therefore there is an urgent need for the responsible administrative units to unite efforts
and design effective and sustainable means of storage of medical data.
Wild animals play an important role in maintaining Rhodesian sleeping sickness in areas
where the disease is endemic.
During the current work wild animals were suggested to be important risk factor for HAT
with most of the villages surveyed being sited inside forest reserves and/or protected
areas where they interact with wild animals on a daily basis. Besides it was observed that
there is a large abundance of tsetse flies in human populated areas with the communities
also reporting that apart from tsetse flying freely in their residential areas, a large number
of wild animals were seen in the villages as well as in the farms. This is a big concern, as
apart from contributing to increase poverty in the area by destroying crops, the presence
ofwild animals increases the chances of sleeping sickness transmission as well as causing
danger to humans as there were some reports of humans been attacked and been injured
by wild animals such as lions. So instead of placing HAT control interventions such as
targets randomly inside the forest, it is advised to direct control interventions such as
insecticide impregnated targets to targeted areas such as areas with increased tsetse-
animal and tsetse-human contacts such as watering points, along the paths to farms,
particularly those which are located close to or inside forest reserves, and along busy
roads. This is probably the most cost effective way of reducing the chances of humans
coming into contact with infected tsetse flies and will play an important role in reducing
the abundance of tsetse flies in the area, it will also be easier to maintain the targets and
prevent their constant destruction by wild animals.
6.2 Policy Implications
Recently, a number of studies have found that case detection and treatment provision to
humans may not be sufficient in controlling rhodesiense sleeping sickness in most of the
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affected countries. This is partly due to the large number of animal reservoirs which play
a pivotal role in the transmission and maintenance of the disease in respective areas.
This thesis therefore suggests several policy implications, first lowering physical distance
between villages and health facilities with the capacity to manage HAT, This may
contribute towards increasing the numbers of early case detection resulting in proper
treatment, hence reducing the amount of under-reporting and mortalities.
Secondly, improving the quality of care in the available health facilities, by equipping
these facilities with sufficient manpower and supplies, this may play a vital role in
reducing the burden imposed to local communities, improving the infrastructure such as
roads may allow easy transportation to treatment centres thoughout the year, hence
reduce the amount of under-reporting caused by poor access to centres with capacity to
manage the disease. Screening, treatment provision and providing prophylactic measures
such as pour-on to all livestock transported through these villages may assist in reducing
the number of transmissions caused by these animals. Finally awareness creation to
people living in these communities on the risk posed to them by tsetse flies as well as
animal reservoirs.
6.3 Way Forward
Apart from beeing one of the most neglected diseases, HAT is severely under-reported in
most of the disease endemic countries. This thesis managed to establish the level of HAT
under-reporting in Tanzania using a decision tree model which was developed for
Uganda (Odiit et al., 2005) This was done as way of getting an overview of what the
situation may look like in Tanzania, assuming that the disease follows the same patterns
across east Africa. One of the initial steps in planning the way forward of this thesis is to
develop a model which will be specific for Tanzania.
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The most important concerns in sleeping sickness under-reporting and in general in HAT
control is lack of easily accessible, affordable and sensitive diagnostic tools which can be
considered as pen side and can be easy to use in most of disease endemic rural areas of
Tanzania. Todate, the only method which is regarded as the gold standard for HAT
diagnosis relies on microscopy which is not sensitive enough. Besides, most of the good
quality microscopes which are currently available in the market require stable power
source which is again is a big concern as is not available in most of the disease endemic
rural communities of Tanzania. Even so, in areas where electricity is available the power
supply is not always stable as the currently used power in Tanzania relies mostly on
hydropower.
Given fluctuations in weather condition, power rationing is obviously an unavoidable
obstacle. However, recently developed Loop-mediated isothermal amplification (LAMP)
has shown to provide a suitable option for this (Notomi et al., 2000)
In this thesis the risk factors for HAT in Urambo were established, though the aim of this
thesis is not to generalize the findings of Urambo to the rest of Tanzania. Most of the
findings may play important role in other parts of the country as they have been reported
in other countries as well. Although this thesis did not establish any direct link or any
evidence of direct association between domestic animals and current disease resurgence
in the study area The fact that among other things there is an increased number of
livestock movements in the area during the dry season, is an important finding as it calls
for an urgent need to conduct intensive studies in the area so as properly investigate the
role played by both wild and domestic animal reservoirs in transmitting as well as
maintaining the disease in the area. It is also useful to try and properly investigate the
areas of disease transmission as this will suggest areas needing special attention for future
control programs.
There is also an urgent need to conduct studies on tsetse distribution, particularly in areais
where gambiense HAT occurred in the past. In order to update the existing
epidemiological data, it is also fundamentally important to properly investigate the actual
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disease magnitude for both rhodesiense and gambiense sleeping sickness in the western
part of Tanzania.
It is also proposed to conduct another risk factor investigation in another district of
Tanzania where the disease is endemic in order to compare the findings and allow proper
planning of control interventions.
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1.1. Name of respondent GPS of h/hold S E...
1.2 Case/control




















Any other occupation (Specify) ifmore than one occupation.
1.10 Village/sub-village (Kitongoji)
1.11 Distance from nearby h/facility (est. hours it will take to walk)
1.12 Distance from your home to the village centre
1.13 Distance from the nearest neighbour
1.14 Ward
1.15 District
1.16 GPS coordinates of village centre: Long Lat Alt
1.17 How much does it cost to travel to the Health Centre
II
2.0 Knowledge of the disease
2.1. Are you aware of any disease that affects both humans and animals? 1. Yes
2.No




2.2. Can you mention any disease that is caused by tsetse fly bite?
1
2
2.3 Please mention the names of the areas where you find most of tsetse flies in your
village
2.4 How long will it take you to walk to that place
2.5 have you ever visited that place? □ Yes I |No
2.6 Does your community member take any actions to control the tsetse flies?
□Yes DNo
If yes please mention any two;
III





2.8 How far is the forest reserve from your house (est. time taken by walking) ...
2.9 Which of the following wild animals do you see in your village? (Household)


















5. Other (specify relationship)
2.11 Mention areas you visited outside your area/village in the past three months
Village Ward/district time spent
Reason for the visit




2.13. Have you or any of your family members ever suffered from SS?
1. Yes ( ) 2. No ( )
If yes, please answer the following:
Name
When was it (month/year) Age
Occupation Outcome




3.1. Which and how many of the following do you keep in this homestead? Please
tick yes or no and provide the quantity (Household)








3.2 Please record the number of people in each age group who live in your household




30 - 44 years
45 - 59 years
60 & above
VI
3.3. Do you own any of the following? (Household/individual)














If farming is among the source of family income, then answer the following question
(if is not then move to question 3.6)
VII
3.5. You have mentioned farming as a one of source of your family income, please
estimate the amount and value of for each crop (in case farming is not listed then
skip this question)
Product (crop) Amount Estimated value
3.6. Have you conducted any of the following the following activities over the past
one year?








Travel out of the village
VIII
3.7 Assessment and recording the condition of the household of the case/control
basing on the following criteria a: structure; roof type: type of latrine (tick
according to your observations)
Household structure Roof type Latrine
Mud Iron sheet In-door
Timber/wood Grass thatch Pit
Cement Tiles None
Any other Other
3.8 Have you ever visited the forest reserve? I |Yes I I No
If yes how often do you go to the forest
What is the main reason for the visit
3.9 have ever visited the forest during the night QYes I |No













2. Can you describe the activities carried out by village members?








3. What kinds of crops do people in this village grow?
X
4. Do you see wild animals in your village? 1. Yes 2. No
If yes then please answer the following
Type of animal Area where found
5. Do you have cattle market in this village? O Yes I |No
If yes, please name it
Where is it
Distance from village centre
If no then which nearest cattle market in this area
6. Do you have any migration of people into or out of your village over the past 2
years?
7. Do you have any herds' migration in or out of your village over the past two
years?
If the answer for questions 5 or 6 is yes then what was the reason for
migration
8. Please describe cattle movement pattern in your village?
From To period
From To period....
9. Please explain what do you think was the main reason for this movement
XI
